Studies on preconditioning with adenosine, glutamate and ouabain in rat hippocampal slices by Ferguson, Alexandra Laura
 
 
 
 
 
Ferguson, Alexandra Laura (2008) Studies on preconditioning with 
adenosine, glutamate and ouabain in rat hippocampal slices. PhD thesis. 
 
 
 
 
http://theses.gla.ac.uk/465/
 
 
 
Copyright and moral rights for this thesis are retained by the author 
 
A copy can be downloaded for personal non-commercial research or 
study, without prior permission or charge 
 
This thesis cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the Author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the Author 
 
When referring to this work, full bibliographic details including the 
author, title, awarding institution and date of the thesis must be given 
 
Glasgow Theses Service 
http://theses.gla.ac.uk/ 
theses@gla.ac.uk  
 
 
STUDIES ON PRECONDITIONING WITH 
ADENOSINE, GLUTAMATE AND OUABAIN IN RAT 
HIPPOCAMPAL SLICES 
 
 
by 
 
 
 
Alexandra Laura Ferguson B.Sc. (Hons.) 
 
 
 
 
A thesis submitted in fulfilment of the requirement for the degree of  
Doctor of Philosophy to the University of Glasgow 
 
Neuroscience and Molecular Pharmacology, 
Faculty of Biomedical and Life Sciences, 
University of Glasgow 
 
August 2008 
 2 
 
ABSTRACT 
Preconditioning is the phenomenon whereby tolerance to lethal insults is induced by 
exposing the tissue to a prior sublethal stimulus. This exists in several forms, such as 
ischaemic preconditioning, adenosine preconditioning and excitotoxic preconditioning. 
Adenosine preconditioning is known to be mediated by activation of A1 receptors and 
ATP-sensitive potassium channels whilst excitotoxic preconditioning mainly involves 
stimulation of NMDA receptors, nitric oxide and most likely ATP-sensitive potassium 
channel activation. ATP-sensitive potassium channel openers such as pinacidil and 
diazoxide are also known to exert preconditioning against various types of insults. There 
have been several models of ischaemia used to study preconditioning in vivo and in vitro 
leading to some confusion over the effects of preconditioning agents. High concentrations 
of glutamate or NMDA have been used as models of excitotoxicity in many experimental 
paradigms. Some molecular changes are associated with preconditioning phenomena, the 
most prominent being an increased expression of heat shock protein 72 (HSP72). The aims 
of the current study were to: 1) investigate the effects of exogenous glutamate and other 
depolarizing agents in the slice preparation and their validity for use as toxic agents 2) 
examine any potential preconditioning neuroprotection induced by adenosine against 
various depolarizing agents and elucidate the underlying mechanisms where relevant 3) 
examine the excitotoxic preconditioning phenomenon and possible underlying mechanisms 
4) look at the effectiveness of other known preconditioning agents e.g. ATP-sensitive 
potassium channel openers against depolarizing agents and identify the underlying 
mechanisms of protection 5) identify any molecular changes that may occur during acute 
models of chemical ischemia or acute preconditioning. The rat hippocampal slice 
preparation was used to investigate the effects of depolarizing agents and preconditioning 
paradigms upon the extracellularly evoked field epsps, orthodromic and antidromic 
population spikes. Western blotting was used to detect any changes in the levels of HSP72 
in the slices that may have occurred as a result of the depolarizing agents or the 
preconditioning treatments. It was first established that 5mM and 10mM glutamate induced 
depressions in the amplitudes of orthodromic population spikes which recovered to a stable 
plateau. The degree of recovery of the spikes depended partially upon the initial size of the 
response. As adenosine is known to be released in response to glutamate receptor 
stimulation, the effects of 5mM glutamate upon the orthodromic spikes were studied in the 
presence of the A1 receptor antagonist, DPCPX. It was observed that DPCPX did not 
attenuate the depression of the response during glutamate perfusion but there was a 
significant elevation in the post-glutamate recovery of the response. This effect was not 3 
 
observed when the protocol was applied to antidromic population spikes and field epsps, 
both of which showed a depression in response during 5mM glutamate perfusion but 
recovered fully when glutamate was removed. The field epsps showed a trend whereby 
smaller epsps recovered to a far greater degree than population spikes. Although this effect 
was not significant, the NMDA receptor blocker, MK-801, was co-perfused with glutamate 
during epsp recordings to examine this further. The degree to which MK-801 alone 
affected the response correlated with the post-glutamate recovery. To study this effect, 
isolated NMDA-receptor mediated epsps were recorded and the effects of 5mM glutamate 
upon them were studied. There was a similar tendency for small NMDA-receptor mediated 
epsps to recover to a higher level following glutamate treatment compared with larger 
potentials. In the presence of DPCPX, the larger potentials showed a significant elevation 
in recovery following treatment with glutamate. It was also shown that the post-5mM 
glutamate recovery of the orthodromic population spikes was elevated by the presence of 
the A2a receptor antagonist, SCH 58261. Further experiments using the ATP-sensitive 
potassium channel blocker, glibenclamide, indicated that this effect may be due to 
increasing the opening of these channels.  Adenosine preconditioning was attempted using 
10mM glutamate as an insult. It was shown that adenosine could not precondition against 
this effect in antidromic or orthodromic population spikes. The effects of the sodium-
potassium ATPase inhibitor, ouabain, upon the evoked responses were studied as an 
alternative insult. It was shown that ouabain induced depressions in field epsps, 
orthodromic and antidromic population spikes. The antidromic population spikes showed 
significantly smaller depressions than the orthodromic responses. Further experiments 
using the glutamate receptor antagonist, kynurenic acid, showed that glutamate receptors 
mediated the effects of ouabain upon the orthodromic population spikes but not the 
antidromic spikes. Adenosine preconditioning was attempted against ouabain. It was 
shown that adenosine preconditioned against the effects of ouabain upon orthodromic and 
antidromic population spikes but not field epsps. Further experiments were conducted 
using antidromic population spikes. It was shown using various antagonists, that adenosine 
protection against ouabain was mediated by A1 receptors, ATP-sensitive potassium 
channels, NMDA receptors and nitric oxide. To extend these results further, 
preconditioning using the ATP-sensitive potassium channel opener, pinacidil, was 
attempted against 10mM glutamate and ouabain. It was shown that pinacidil was able to 
precondition the antidromic population spike against either insult. Using the NMDA 
receptor antagonist, DL-AP5, showed that the preconditioning effect of pinacidil against 
ouabain was mediated by NMDA receptors. Another preconditioning paradigm was 
attempted to see if glutamate could precondition against ouabain. It was shown that pre-4 
 
treatment with glutamate resulted in enhancing the depressant effect of ouabain upon field 
epsps and antidromic population spikes. To further examine the effects of ouabain upon 
antidromic population spikes, ouabain was co-perfused in the presence of the intracellular 
calcium chelator, BAPTA-AM. This resulted in enhancing the depressant effect of ouabain 
upon the response. A similar result was observed when the calcium concentration in the 
perfusion medium was lowered to 0.5mM from 2.5mM whereas increasing the 
concentration to 5mM attenuated the depressant effect. Ouabain was also co-perfused in 
the presence of charybdotoxin, a blocker of large-conductance calcium activated potassium 
channels. It was observed that charybdotoxin enhanced the effect of ouabain upon the 
antidromic spikes. No changes were detected in HSP72 expression in the slices in response 
to ouabain treatment, 10mM glutamate treatment, pinacidil preconditioning treatment or 
glutamate preconditioning. The present results show that glutamate and ouabain can induce 
depressions in the evoked responses from the rat hippocampal slice and that the effects of 
5mM glutamate can be attenuated by adenosine receptor antagonists. In addition, 
adenosine can precondition against ouabain but not glutamate and this effect involves A1 
receptors, NMDA receptors, nitric oxide and ATP-sensitive potassium channels. It has also 
been observed that pinacidil can precondition against ouabain or glutamate and NMDA 
receptors may be involved in this effect. The inability of glutamate to precondition against 
ouabain in evoked responses was also demonstrated. The study highlights the effectiveness 
of preconditioning agents against different depolarizing agents and the interactions 
between adenosine and glutamate receptors which play a role in preconditioning. 
 
 
 
 
 
 
 5 
 
CONTENTS 
TITLE ...................................................................................................................... 1 
ABSTRACT ............................................................................................................ 2 
CONTENTS ............................................................................................................ 5 
LIST OF FIGURES ............................................................................................... 11 
DECLARATION .................................................................................................... 16 
ABBREVIATIONS ................................................................................................ 17 
ACKNOWLEDGEMENTS .................................................................................... 20 
PUBLICATIONS ................................................................................................... 21 
1 - INTRODUCTION ............................................................................................. 22 
1.1 - Ischaemia ................................................................................................. 23 
1.2 - Ischaemic preconditioning – a historical perspective ......................... 25 
1.2.1 - Evidence and paradigms ................................................................ 25 
1.2.2 - In vivo preconditioning .................................................................... 25 
1.2.3 - In vitro preconditioning ................................................................... 26 
1.3 - Glutamate ................................................................................................. 27 
1.3.1 - Ionotropic glutamate receptors ....................................................... 27 
1.3.1.1 - NMDA receptors ................................................. 27 
1.3.1.1.1 - Molecular biology ................................. 28 
1.3.1.1.2 - Pharmacology ...................................... 29 
1.3.1.2 - AMPA receptors ................................................. 29 
1.3.1.3 - Kainate receptors ............................................... 30 
1.3.2 - Excitotoxicity ................................................................................... 30 
1.3.3 - Glutamate preconditioning  .............................................................. 31 
1.3.3.1 - NMDA receptors mediate excitotoxic 
preconditioning ................................................... 31 
1.3.3.2 - Mechanism for ischaemic tolerance induced by 
NMDA receptors ................................................. 32 
1.4 - Adenosine ................................................................................................ 33 
1.4.1 - Metabotropic adenosine receptors ................................................. 34 
1.4.1.1 - Adenosine A1 receptors ..................................... 34 
1.4.1.2 - Adenosine A2a receptors ................................... 34 
1.4.1.3 - Adenosine A2b receptors ................................... 35 6 
 
1.4.1.4 - Adenosine A3 receptors ..................................... 35 
1.4.2 - Adenosine metabolism ................................................................... 35 
1.4.3 - Adenosine during ischaemia .......................................................... 35 
1.4.4 - Adenosine preconditioning ............................................................. 36 
1.4.5 - Mechanism of adenosine preconditioning ...................................... 37 
1.5 - ATP-sensitive potassium channels ....................................................... 38 
1.5.1 - Molecular biology ........................................................................... 38 
1.5.2 - Pharmacology ................................................................................ 39 
1.5.3 - Subcellular localization and function .............................................. 39 
1.5.4 - Role of ATP-sensitive potassium channels in preconditioning ....... 40 
1.6 - Heat shock protein 72 ............................................................................. 41 
1.7 - The hippocampal slice preparation ....................................................... 43 
1.7.1 - Formation of evoked potentials ...................................................... 44 
1.7.1.1 - Field epsps ......................................................... 44 
1.7.1.2 - Population spikes ............................................... 46 
1.7.2 - Synaptic plasticity ........................................................................... 46 
1.7.2.1 - LTP  ..................................................................... 46 
1.7.2.1.1 - Synaptic potentiation ........................... 47 
1.7.2.1.2 - E-S potentiation ................................... 47 
1.7.2.2 - LTD  ..................................................................... 47 
1.7.3 - Using hippocampal slices to study preconditioning ........................ 48 
1.8 - Aims of the project .................................................................................. 48 
2 - METHODS ....................................................................................................... 49 
2.1 - Electrophysiology ................................................................................... 49 
2.1.1 - Preparation of rat hippocampal slices ............................................ 49 
2.1.2 - Extracellular recording .................................................................... 49 
2.2 - Molecular methods  .................................................................................. 51 
2.2.1 - Protein extraction and Bradford assay............................................ 51 
2.2.2 - Western blotting ............................................................................. 52 
3 –STUDIES REGARDING THE EFFECTS OF GLUTAMATE UPON EVOKED 
RESPONSES AND THEIR MODULATION BY PURINE ANTAGONISTS .. 55 
3.1 – Introduction ............................................................................................ 55 
3.2 – Results .................................................................................................... 55 
3.2.1 - The effects of glutamate on evoked responses .............................. 55 
3.2.2 - Adenosine antagonists modify recovery from glutamate ................ 62 7 
 
3.2.3 - ATP-sensitive potassium channels mediate the effect of SCH 58261 
on the response to glutamate ................................................ 68 
3.2.4 - Adenosine A1 receptor blockade does not modify the response to 
NMDA  .................................................................................... 68 
3.2.5 - Antidromic population spikes and epsps are unaffected in their 
response to glutamate by A1 receptor blockade ................... 73 
3.2.6 - The effects of NMDA receptor blockade on the response to 
glutamate in epsps ................................................................ 77 
3.2.7 - The effects of adenosine A1 receptor blockade on NMDA receptor 
mediated epsps ..................................................................... 81 
3.2.8 - Varying the stimulus intensity induces a potentiation of the post-
5mM glutamate orthodromic spike ........................................ 85 
3.3 - Discussion ............................................................................................... 89 
3.3.1–The effects of exogenous glutamate upon evoked responses from 
the CA1 neurons ................................................................... 89 
3.3.1.1 –The use of exogenous glutamate as an excitotoxin 
in the hippocampus ............................................ 89 
3.3.1.2 -The effects of exogenous glutamate on 
orthodromic population spikes ............................ 90 
3.3.1.3 - The effect of exogenous glutamate on antidromic 
population spikes  ................................................ 91 
3.3.1.4 - The effects of exogenous glutamate upon field 
epsps  .................................................................. 92 
3.3.2 - Interaction of adenosine antagonists with post-glutamate recovery: 
orthodromic population spikes ............................................... 93 
3.3.2.1 - A1 receptor blockade and glutamate .................. 93 
3.3.2.2 - A2a receptor blockade and glutamate ................ 94 
3.3.3.3 - The role of ATP-sensitive potassium channels in 
the effect of A2a receptor blockade upon post-
glutamate recovery ............................................. 95 
3.3.3.4 - Selectivity of ZM241385 ..................................... 96 
3.3.3.5 - Interactions between adenosine receptor subtypes
 ........................................................................... 96 8 
 
3.3.4 - The effects of NMDA upon orthodromic population spikes and 
interactions with A1 receptors ............................................... 97 
3.3.5 - Interactions between exogenous glutamate and DPCPX ............... 98 
3.3.5.1 - Effects on antidromic population spikes ............. 98 
3.3.5.2 - Effect on composite epsps ................................. 98 
3.3.5.3 - Effects on isolated NMDA receptor-mediated 
epsps  .................................................................. 99 
3.3.6 - Relationships between response sizes and their percentage post-
glutamate/NMDA recovery .................................................. 102 
3.3.6.1 -  Glutamate and population spikes .................... 102 
3.3.6.2 - NMDA and orthodromic population spikes ....... 102 
3.3.6.3 -  Glutamate and composite field epsps  .............. 103 
3.3.6.4 - Glutamate and NMDA receptor-mediated epsps
 ......................................................................... 103 
3.3.7 - Examining the toxicity of glutamate .............................................. 105 
3.3.8 – General Discussion ..................................................................... 107 
4 – THE EFFECTS OF ADENOSINE PRECONDITIONING AGAINST 
EXOGENOUS GLUTAMATE AND OUABAIN........................................... 109 
4.1 – Introduction .......................................................................................... 109 
4.2 – Results .................................................................................................. 109 
4.2.1 - The effects of 10mM glutamate upon hippocampal slices ............ 109 
4.2.2 - Adenosine does not precondition against glutamate .................... 117 
4.2.3 - Effects of ouabain, a Na
+/K
+ ATPase inhibitor, on evoked responses
 ............................................................................................ 121 
4.2.4 - The effects of ouabain on synaptic plasticity ................................ 129 
4.2.5 - Adenosine can precondition against ouabain but not glutamate .. 131 
4.2.6 - Adenosine preconditioning against ouabain requires activation of 
NMDA receptors  .................................................................. 139 
4.2.7 - Adenosine preconditioning against ouabain is suppressed by 
blocking ATP-sensitive K+ channels ................................... 144 
4.2.8 - Pinacidil, an ATP-sensitive K+ channel opener, preconditions 
against glutamate and ouabain ........................................... 144 
4.2.9 - Studies on HSP72 changes in response to pinacidil preconditioning 
against ouabain ................................................................... 153 9 
 
4.2.10 - The role of ATP-sensitive potassium channels and NMDA 
receptors in the pinacidil preconditioning effect against 
ouabain ............................................................................... 153 
4.2.11 - Stimulation with brief applications of glutamate causes a reduction 
in the size of evoked responses following ouabain ............. 159 
4.2.12 - Modulation of the effects of ouabain in antidromic spikes by 
calcium manipulation ........................................................... 165 
4.3 – Discussion ............................................................................................ 169 
4.3.1 –The effects of 10mM glutamate upon the hippocampal slice ........ 169 
4.3.1.1 - 10mM glutamate: effects on evoked responses  169 
4.3.1.2  - 10mM glutamate: effects on LTP  ..................... 171 
4.3.1.3 - 10mM glutamate: effects on heat shock protein 
expression ........................................................ 171 
4.3.1.4  - Assessing toxicity to acute injury ..................... 172 
4.3.2 - Adenosine preconditioning: interaction with exogenous glutamate
 ............................................................................................ 172 
4.3.3  -  Effects of ouabain on evoked responses: excitatory transmission
 ............................................................................................ 173 
4.3.4  - Effects of ouabain on evoked responses: inhibitory transmission  176 
4.3.4.1  - Adenosine ....................................................... 176 
4.3.4.2  - GABA .............................................................. 177 
4.3.5 - Effects of ouabain on evoked responses: calcium modulation ..... 179 
4.3.5.1 - Intracellular calcium .......................................... 179 
4.3.5.2 - Extracellular calcium  ......................................... 180 
4.3.5.3 - Large-conductance calcium-activated potassium 
channels ........................................................... 182 
4.3.6 - Effects of ouabain on the induction of LTP ................................... 184 
4.3.7 - Post-adenosine effects on evoked responses .............................. 185 
4.3.8 - Adenosine preconditioning: interaction with ouabain .................... 188 
4.3.9 - Mechanism of adenosine preconditioning against ouabain .......... 189 
4.3.9.1 - Role of A1 receptors ......................................... 189 
4.3.9.2 - Role of NMDA receptors ................................... 190 
4.3.9.3 - Role of nitric oxide ............................................ 191 10 
 
4.3.9.3.1 - Interaction with ATP-sensitive potassium 
channels ............................................ 191 
4.3.9.3.2 - Interaction with BK+ channels ........... 192 
4.3.9.3.3 - Interaction with sodium-potassium 
ATPases. ........................................... 193 
4.3.9.4 - Role of ATP-sensitive potassium channels ...... 193 
4.3.10  - Pinacidil preconditioning ............................................................ 194 
4.3.10.1 - Rationale for the use of pinacidil over diazoxide
 ......................................................................... 194 
4.3.10.2 - Protection against ouabain and the requirement 
for NMDA receptor stimulation ......................... 196 
4.3.10.3  - Protection against glutamate ......................... 198 
4.3.11 - The interaction between glutamate preconditioning and ouabain
 ............................................................................................ 201 
4.3.12 - Issues regarding the interpretation of Western blots .................. 202 
4.3.13 - General Discussion .................................................................... 203 
5 – CONCLUDING DISCUSSION ...................................................................... 205 
5.1 - Main Findings ........................................................................................ 205 
5.2 - Future directions ................................................................................... 206 
5.3 – Conclusion ............................................................................................ 207 
6 – REFERENCES ............................................................................................. 208 
 
 
 
 
 
 11 
 
LIST OF FIGURES 
Figure 1 Diagram of the rat hippocampal slice and electrode positions.  .... 45 
Figure 3.1a Time course graph showing the effect of glutamate on the 
amplitude of orthodromic population spikes. ......................... 57 
Figure 3.1b Sample traces of orthodromic population spikes taken from the 
time points as indicated in figure 3.1a. .................................. 58 
Figure 3.2 Scatterplot showing the relationship between orthodromic spike 
size and the % recovery of the response following treatment 
with 5mM and 10mM glutamate. ........................................... 59 
Figure 3.3 Repeated glutamate application increases the rate of 
repolarization of the response. .............................................. 60 
Figure 3.4 Histogram outlining the changes in the rate of repolarization of 
the response following glutamate after each application as 
shown in Figure 3.3. .............................................................. 61 
Figure 3.5a The effects of adenosine antagonists on the recovery of post-
glutamate responses. ............................................................ 63 
Figure 3.5b Sample traces taken from time points as indicated in 3.5a.  .... 64 
Figure 3.6 50nM ZM241385 antagonises the inhibitory response of 10µM 
adenosine  .............................................................................. 65 
Figure 3.7a The effect of SCH58261 upon the post-glutamate recovery of 
the orthodromic population spike amplitude .......................... 66 
Figure 3.7b Sample traces taken from time points as indicated in Figure 
3.7a ....................................................................................... 67 
Figure 3.8a Blockade of ATP-sensitive potassium channels attenuates the 
modulatory effect of SCH 58261 on glutamate-induced 
depression of orthodromic population spikes ........................ 69 
Figure 3.8b Sample traces taken from the time points as indicated in 3.8a.
 .............................................................................................. 70 
Figure 3.9 The adenosine A1 receptor antagonist DPCPX does not 
attenuate the reduced recovery of orthodromic population 
spikes following depolarization of the response with NMDA . 71 
Figure 3.10 Scatterplot showing the inverse relationship between 
orthodromic spike size and % recovery of spike size following 
treatment with 25µM NMDA for 5min. ................................... 72 
Figure 3.11 DPCPX does not attenuate the effects of 5mM glutamate on 
antidromic population spikes ................................................. 74 12 
 
Figure 3.12 DPCPX does not attenuate the effects of 5mM glutamate on 
field epsps. ............................................................................ 75 
Figure 3.13 Scatterplots showing the size of epsp parameters against the 
% recovery of each parameter following treatment with 
glutamate alone or in the presence of DPCPX. ..................... 76 
Figure 3.14 Time course graphs showing the effect of glutamate on epsp a) 
slope and b) amplitude alone (n = 13) or in the presence of 
MK-801 (n = 12) .................................................................... 78 
Figure 3.15 Scatterplots showing the size of epsp slopes or amplitudes 
against the % recovery of either parameter following treatment 
with glutamate alone or glutamate in combination with MK-801
 .............................................................................................. 79 
Figure 3.16 The relationship between the effect of MK-801 on epsps and 
the resulting post-glutamate recovery ................................... 80 
Figure 3.17 A1 receptor antagonist DPCPX attenuates the depression in 
NMDA receptor mediated epsp amplitude following 
depolarization of the response with glutamate ...................... 82 
Figure 3.18 Scatterplot showing the amplitude of NMDA receptor-mediated 
epsps versus the corresponding percentage recovery following 
perfusion of glutamate ........................................................... 83 
Figure 3.19 Histogram showing the difference in outcome between 
glutamate treatment alone (n = 7) and in combination with 
DPCPX (n = 6) on NMDA receptor-mediated epsp parameters
 .............................................................................................. 84 
Figure 3.20 The effects of different stimulus strengths on the response to 
glutamate in orthodromic population spikes .......................... 86 
Figure 3.21a,b (c, overleaf). The effect of glutamate on synaptic plasticity in 
orthodromic population spikes ............................................... 87 
Figure 3.21c Time course graph showing pooled data from the experiments 
above .................................................................................... 88 
Figure 3.22 Diagram showing possible interactions between adenosine 
receptor antagonists and glutamate .................................... 101 
Figure 4.1a The effects of glutamate on evoked responses from CA1 
neurons ............................................................................... 111 13 
 
Figure 4.1b Sample traces showing the effects of 10mM glutamate at 
various time points on the evoked responses from the rat 
hippocampal slices. ............................................................. 112 
Figure 4.2 The effect of 10mM glutamate exposure on synaptic plasticity in 
orthodromic population spikes ............................................. 113 
Figure 4.3 Electrophysiological data from the slices used to generate the 
Western blots for the detection of HSP72 in Figure 4.4  ....... 114 
Figure 4.4 Western blots showing the immumodetection of HSP72 and 
actin levels in slices receiving glutamate treatments ........... 115 
Figure 4.5 Histogram summarising the changes in HSP72 expression in 
glutamate treated slices from the Western blot in Figure 4.4
 ............................................................................................ 116 
Figure 4.6 Adenosine does not precondition against glutamate .............. 118 
Figure 4.7 A sustained application of 100µM adenosine failed to 
precondition against the effects of 10mM glutamate upon 
orthodromic responses. ....................................................... 119 
Figure 4.8 A sustained application of 100µM adenosine failed to 
precondition against 10mM glutamate in antidromic 
responses. ........................................................................... 120 
Figure 4.9 The effects of ouabain on evoked responses from CA1 neurons
 ............................................................................................ 123 
Figure 4.10 Sample traces showing the effects of ouabain at various time 
points on the evoked responses from the hippocampal slice
 ............................................................................................ 124 
Figure 4.11 Reduction in antidromic spike amplitude in response to ouabain 
is independent of glutamate-receptor mediated damage .... 125 
Figure 4.12 The effect of ouabain upon orthodromic spikes in the presence 
of kynurenic acid ................................................................. 126 
Figure 4.13 The effect of ouabain upon orthodromic spikes in the presence 
of DPCPX ............................................................................ 127 
Figure 4.14 Blockade of GABA receptors does not attenuate the ouabain-
induced depression in orthodromic spikes .......................... 128 
Figure 4.15 Ouabain impairs but does not prevent the induction of LTP in 
the rat hippocampal slice  ..................................................... 130 
Figure 4.16a. Adenosine preconditioning attenuates ouabain-induced 
changes in orthodromic spike size ...................................... 133 14 
 
Figure 4.16b. Sample traces of preconditioning experiments and controls 
taken from the time points as indicated in Figure 4.16a. ..... 134 
Figure 4.17 Adenosine preconditioning effects against ouabain are absent 
in epsp responses ............................................................... 135 
Figure 4.18a,b/ Protection against ouabain is induced by adenosine 
preconditioning in antidromic spikes  .................................... 136 
Figure 4.18c Sample traces taken from time points as indicated in Figure 
4.18a. .................................................................................. 137 
Figure 4.19 Adenosine preconditioning is suppressed by A1 receptor 
blockade using 30nM DPCPX ............................................. 138 
Figure 4.20 Modulation of adenosine preconditioning by kynurenic acid  . 140 
Figure 4.21 Blockade of NMDA receptors during adenosine preconditioning 
against ouabain ................................................................... 141 
Figure 4.22 Histogram summarising the results outlined in Figure 4.21. . 142 
Figure 4.23 Adenosine preconditioning in the presence of 100µM L-NAME 
attenuates any modulation of the response to ouabain ....... 143 
Figure 4.24 The role of ATP-sensitive potassium channels in mediating the 
preconditioning effects of adenosine against ouabain  ......... 145 
Figure 4.25 Blockade of mitochondrial ATP-sensitive potassium channels 
during adenosine preconditioning ....................................... 146 
Figure 4.26a,b. Time course graphs showing the changes in antidromic 
spike amplitude during the preconditioning protocol with 30µM 
pinacidil against glutamate .................................................. 147 
Figure 4.26c Sample traces of antidromic population spikes taken from the 
time points as indicated Figure 4.26a. ................................. 148 
Figure 4.27a,b. Pinacidil can precondition against the effects of glutamate 
upon orthodromic population spikes .................................... 149 
Figure 4.27c Sample traces of antidromic population spikes taken from the 
time points inidicated in Figure 4.27a. ................................. 150 
Figure 4.28 Histogram showing the differences in recovery of antidromic 
spike amplitude between pinacidil preconditioned groups and 
controls with either glutamate or ouabain as chemical insults
 ............................................................................................ 151 
Figure 4.29 Pinacidil preconditioning against glutamate in orthodromic 
spikes .................................................................................. 152 15 
 
Figure 4.30 Electrophysiological data from the slices used to generate the 
Western blots for the detection of HSP72 in Figure 4.31  ..... 154 
Figure 4.31 Western blots for the detection of HSP72 from the slices saved 
from the electrophysiological experiments in Figure 4.30  .... 155 
Figure 4.32 Histogram summarising the results of the Western blots in 
Figure 4.31 .......................................................................... 156 
Figure 4.33 Pinacidil preconditioning is prevented by blockade of ATP-
sensitive potassium channels .............................................. 157 
Figure 4.34 Pinacidil preconditioning against ouabain in the presence of a 
NMDA receptor antagonist .................................................. 158 
Figure 4.35 The effects of glutamate preconditioning against ouabain upon 
antidromic population spikes ............................................... 160 
Figure 4.36 The effects of glutamate preconditioning against ouabain upon 
field epsps ........................................................................... 161 
Figure 4.37 Electrophysiology of the slices used in the Western blots in 
Figure 4.36 .......................................................................... 162 
Figure 4.38 Western blots showing the immumodetection of HSP72 and 
actin levels in slices receiving glutamate preconditioning 
treatments followed by ouabain or ouabain only ................. 163 
Figure 4.39 Histogram summarising the changes in HSP72 expression in 
glutamate preconditioned slices and ouabain treated slices  164 
Figure 4.40 Modulation of the effect of ouabain upon the antidromic spike 
by BAPTA-AM ..................................................................... 166 
Figure 4.41 Altered effects of ouabain in the presence of higher and lower 
concentrations of CaCl2 ....................................................... 167 
Figure 4.42 BK+ channel blockade enhances the ouabain-induced 
depression of antidromic spikes .......................................... 168 
Figure 4.43 Possible mechanisms underlying the effects of ouabain on 
orthodromic population spikes during GABAA receptor 
blockade.. ............................................................................ 178 
Figure 4.44 Diagram of possible preconditioning interactions. ................ 200 
  
 
 16 
 
 
 
 
 
 
DECLARATION 
 
I, Alexandra Laura Ferguson, declare that this thesis was composed by myself, and also 
that the experiments described therein were performed by myself, except where referenced.    
 
 
 
 
______________________ 
      Alexandra L Ferguson 
 
 
 
 
 
 
 
 
 
 17 
 
ABBREVIATIONS 
aCSF    Artificial cerebrospinal fluid 
ADP Adenosine  diphosphate 
2-AG    2-arachidonylglycerol 
AIF  Apoptosis inducing factor 
ANCOVA  Analysis of covariance 
AP -5    (R)-2-amino-5-phosphonopentanoic acid 
apaf-1  Apoptotic protease activating factor-1 
ATP Adenosine  5'-triphosphate 
AMP Adenosine  monophosphate 
5’-AMP 5’-adenosine  monophosphate 
AMPA  α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid 
BAPTA-AM   1,2-bis(o-aminophenoxy)ethane- n,n,n',n'-tetraacetic acid-am 
BK
+    Large-conductance calcium activated potassium channels 
CADO   2-chloroadenosine 
cAMP Cyclic  adenosine  monophosphate 
CA1   Cornu ammonis 1 
CA3    Cornu ammonis 3 
CGP 35348  P-(3-aminopropyl)-p-diethoxymethyl-phosphonic acid 
ChTX Charybdotoxin 
CNQX 6-cyano-7-nitroquinoxaline-2,3-dione 
CPA  N
6-cyclopentyladenosine 
D-AP5 D-2-amino-5-phosphonopentanoic  acid 
DAG Diacylglycerol 
DMSO    Dimethyl sulfoxide 
DNA Deoxyribonucleic  acid 
DNQX   6,7-dinitroquinoxaline-2,3-dione 
DPCPX 8-cyclopentyl-1,3-dipropylxanthine 
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E-64  (2S, 3S)-3-(N-{(S)-1-[N-(4-guanidinobutyl) carbamoyl]3-
methylbutyl}carbamoyl)oxirane-2-carboxylic acid 
 
ECL Enhanced  chemiluminescence 
EDTA  Ethylenediamine tetraacetic acid 
EGTA     Ethylene glycol tetraacetic acid 
EPSP     Excitatory post-synaptic potential 
E-S      Epsp-spike 
GABA  Gamma-amino butyric acid 
5-HD 5-hydroxydecanoic  acid 
HPLC     High performance liquid chromatography 
HSP70    Heat shock protein 70 
HSP72     Heat shock protein 72 
i.p.        Intraperitoneal 
IP3  Inositol-1, 4, 5-triphosphate 
IPSP     Inhibitory post-synaptic potential 
i.v. Intravenous 
JNK  C-jun N-terminal kinase 
L-NAME  Nω-nitro-l-arginine methyl ester hydrochloride 
LTD           Long term depression 
LTD-I        Long term depression of inhibition 
LTP          Long term potentiation 
MgATP        Magnesium-bound adenosine 5'-triphosphate 
mGluRs        Metabotropic glutamate receptors 
mIPSC         Miniature inhibitory post-synaptic current 
(+)-MK-801  Dizocilpine / (5s, 10r)-(+)-5-methyl-10,11-dihydro-5h-     
dibenzo[a,d]cyclohepten-5,10-imine maleate 
MOPS     3-morpholinopropane-1-sulfonic acid 
MPTP 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 
NBQX          2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione 19 
 
NMDA  N-methyl-d-aspartate 
nNOS  Neuronal nitric oxide synthase 
NO Nitric  oxide 
NOS  Nitric oxide synthase 
NPPB      5-nitro-2-(3-phenylpropylamino) benzoic acid 
3-NPA 3-nitropropionic  acid 
OGD        Oxygen-glucose deprivation 
PCP         Phencyclidine 
PIP2 Phosphatidylinositol-4,5-biphosphate 
PKA  Protein kinase A 
PKC  Protein kinase C 
PKG  Protein kinase G 
PLA2 Phospholipase  A2 
PLC Phospholipase  C 
PMSF  Phenylmethane sulfonylfluoride 
PVDF                     Polyvinylidene fluoride 
RIPA                 Radioimmuno precipitation assay 
ROS  Reactive oxygen species 
R-PIA                       R-phenyl-isopropyladenosine 
SAH S-adenosylhomocysteine 
SCH 58261        2-(2-Furanyl)-7-(2-phenylethyl)-7H-pyrazolo[4,3-e][1,2, 4]triazolo[1,5
c]pyrimidin-5-amine 
SDS                         Sodium dodecyl sulphate 
SUR                               Sulfonylurea receptor 
TLCK-HCl  Nα-Tosyl-Lys-chloromethylketone·HCl 
TM    Transmembrane 
TMD Transmembrane  domain 
TTBS         Tween Tris-buffered saline 
ZM 241385      4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5]triazo-5-yl-
amino]ethyl)phenol 
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1 - INTRODUCTION 
Preconditioning is a phenomenon whereby tolerance to lethal insults is induced by prior 
sublethal insults. It was first discovered in the canine myocardium (Murry et al., 1986) 
where the tissue became tolerant to a hypoxic state when pretreated with transient, repeated 
episodes of hypoxia. This effect has since been studied in a variety of tissues with many 
investigations focussing on the induction of ischaemic tolerance in neuronal tissues. The 
first of these exhibited hypoxic preconditioning in rat hippocampal slices (Schurr et al., 
1986). Since then, a variety of paradigms have been used to study the mechanisms in 
neuronal tissue employing a number of different experimental systems. This has revealed 
two distinct time windows of tolerance: acute and delayed.  
Acute preconditioning occurs within a time scale of minutes to hours in the brain and 
involves several components which include NMDA receptors (Kato et al., 1992; 
Bandyopadhyay et al., 2002), A1 receptors (Heurteaux et al., 1995; Hiraide et al., 2001; 
Pugliese et al., 2003) and ATP-sensitive K+ channels (Heurteaux et al., 1995; Pérez-
Pinzón & Born, 1999; Garcia de Arriba et al., 1999; Domoki et al., 1999; Blondeau et al., 
2000, Nakagawa et al ,2002; Rajapakse et al., 2002) amongst many others. These features 
also apply to the delayed time window of preconditioning and have been studied to a much 
greater extent than rapid preconditioning. Although they share similar mechanisms, the 
induction of delayed preconditioning involves changes in expression of various proteins 
including inducible heat shock protein 72 (Kirino et al., 1991; Liu et al., 1993) and anti-
apoptotic protein Bcl-2 (Wu et al., 2004) whilst molecular changes during rapid 
preconditioning are unlikely to occur within the time window. Although rapid and delayed 
preconditioning share some common features, the way in which these mechanisms actually 
induce protection may vary between the two time windows. A greater understanding of 
these mechanisms, particularly those of the less studied rapid time window, may lead to the 
discovery of new drug targets which may ultimately mimic the protective effect of 
preconditioning. 
Various experimental systems have been used to outline the events of preconditioning. 
Given the two windows of tolerance, acute preparations such as hippocampal slices have 
been used to study the preconditioning mechanisms within the rapid time window whilst 
neuronal cultures and in vivo models (global and focal ischaemia) are used more 
frequently in studies of delayed protection.  23 
 
There are several pathophysiological and pharmacological stimuli that result in 
preconditioning in neuronal tissue. Among these are ischaemia (Kitagawa et al., 1990; 
Kato et al., 1991; Liu et al., 1992; Miyashita et al., 1994), anoxia (Schurr et al., 1986), 
hypoxia (Schurr et al., 2001), oxygen-glucose deprivation (OGD) (Pugliese et al., 2003),, 
adenosine (Pérez-Pinzón et al., 1996), glutamate (Schurr et al., 2001), NMDA (Schurr et 
al., 2001; Bandyopadhyay et al., 2002), nitric oxide (Centeno et al., 1999), ATP-sensitive 
K+ channel openers (Pérez-Pinzón & Born, 1999; Blondeau et al., 2000, Heurteaux et al., 
1995; Nakagawa et al., 2002; Garcia de Arriba et al., 1999; Domoki et al., 1999; Rajapakse 
et al., 2002) and several others. There are also several models of ischaemia that have been 
used to observe these effects of preconditioning. These can be physiological (blood vessel 
occlusion models, OGD, hypoxia or anoxia) or chemical (glutamate, ouabain, etc). As a 
result, there is a convoluted literature on paradigms and mechanisms of preconditioning. 
 
1.1 - Ischaemia 
 
The pathological processes resulting in reduced brain function arise from a decrease in 
blood supply in vivo or ischaemia (Lipton 1999). When neuronal tissue is deprived of 
oxygen and glucose, ATP production in the mitochondria for which these are required will 
slow down and eventually stop. The extent of ATP depletion determines the pathway of 
damage either by necrosis or apoptosis (Hou & MacManus, 2002).  
ATP-dependent processes fail to function when ATP is depleted during ischaemia. 
Amongst these are the sodium-potassium ATPase pumps which maintain ion homeostasis 
under normal conditions. In excitable tissues, the electrogenic pumps acts to restore ion 
gradients following current generation across cellular membranes. They function by 
exchanging 3 sodium ions from the cytoplasm with 2 potassium ions in a sequential 
manner. As this actively drives the movement of ions against their concentration gradients, 
the process requires hydrolysis of ATP. The pump is composed of an α subunit and a β 
subunit. The α subunit is the site at which the ion transport occurs. The potassium ions 
bind to an extracellular site upon the α subunit. Magnesium-bound ATP (MgATP) also 
binds with low affinity to this subunit and accelerates the transport of potassium into the 
cell. MgATP remains bound with high affinity once the potassium ions have been 
transported across the membrane. This is because ATP and potassium exert antagonism 
against each other as they stabilise the pump in two different conformations. The transition 
between the two conformations is associated with increasing binding energy of ATP to the 24 
 
subunit. It is the increase in binding energy which constitutes the driving force of the 
pump. 
After the potassium ions have been released in the cytoplasm, 3 sodium ions then bind to 
the subunit inducing a release of ADP from ATP hydrolysis. This leaves a magnesium ion 
bound to the phosphorylated subunit with 3 bound sodium ions. The next step involves the 
conformational change in the pump to transport the 3 sodium ions to the extracellular 
surface. Potassium binding to the subunit then displaces and releases magnesium and 
inorganic phosphate leaving the subunit in a conformation available to transport potassium 
ions again (for review, see Jorgensen and Pedersen, 2001). 
The breakdown of the pump during ischaemia is thought to cause the anoxic depolarization 
(propagating electrical silence across neurons); the depolarization itself has been shown to 
mediate damage in neocortical brain slices (Jarvis et al., 2001) by cell swelling of the 
neurons. The resulting membrane depolarisation causes an increase in extracellular 
glutamate concentration. This increase has been largely attributed to a massive release of 
neurotransmitter from pre-synaptic neurons; there is growing evidence that this could be 
mainly due to reversed uptake of glutamate (Madl & Burgesser, 1993; Rossi et al., 2000). 
The glutamate transporters operate by exchanging Na
+ and K
+ ions down their gradients to 
power the transport of glutamate into the neurons and glia. Upon ATP depletion, the 
sodium-potassium ATPase pump stops functioning and the alteration in Na
+ and K
+ 
homeostasis can cause reversal of the transporter; this has been shown in rat hippocampal 
slices (Madl & Burgesser, 1993; Rossi et al., 2000). Excessive extracellular glutamate can 
induce excitotoxicity; this is explained later on in section 1.3.2 Excitotoxicity.  
In vivo, cerebral ischaemia usually occurs in one of two forms; focal or global. Whilst 
global ischaemia is non-selective in terms of oxygen and glucose deprivation to the brain 
tissue, focal ischaemia is confined to a region of the brain and consists of an infarct core 
which shows severe energy depletion and a delayed cell death form such as necrosis and a 
surrounding penumbra region which has low ATP levels and is subject to mainly apoptotic 
delayed cell death mechanisms. The deleterious effects in the larger penumbral region may 
be reversed by therapeutic intervention so it is therefore of interest to examine the 
mechanisms of acute damage and delayed cell death in response to ischaemia (for review, 
see Hou & MacManus, 2002).  
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1.2 - Ischaemic preconditioning – a historical perspective 
 
1.2.1 - Evidence and paradigms  
 
Preconditioning was first identified in the canine heart (Murry et al., 1986) when occlusion 
of the left circumflex coronary artery for a protocol of 5min ischaemia applied four times 
and separated by 5min intervals produced tolerance against a 40min occlusion (p<0.001). 
The infarct size was 25% of that seen in controls. It was soon discovered that this 
phenomenon was not limited to the heart but existed in neural tissue also. Using rat 
hippocampal slices, application of 5min anoxia (by bubbling the perfusing medium with 
95% N2/5% CO2 gas mixture) followed by 13 ± 2 min anoxia 30min later resulted in 
improved recovery of the evoked response of the slice compared to control (p<0.05) 
(Schurr et al., 1986). Other studies have since confirmed these observations in vivo and in 
vitro. 
 
1.2.2 - In vivo preconditioning 
 
Similar to Murry et al. (1986), ischaemic preconditioning of the brain was observed in vivo 
using bilateral occlusion of the carotid arteries in Mongolian gerbils (Kitagawa et al., 
1990). The interval between preconditioning treatment (2min) and ischaemic insult (5min) 
was at least one day, with several hours at least separating each sublethal preconditioning 
ischaemia. The time scale of protection also showed a delayed phase of preconditioning. 
There was also a cumulative effect with multiple sublethal episodes generating greater 
neuroprotection than single ischaemic episodes.  
Another study which implemented bilateral carotid artery occlusion in gerbils showed that 
2min occlusion effectively induced tolerance to 3min occlusion but only if the second 
insult was applied at least 24hrs later (Kato et al., 1991). A 3min occlusion induced an 
observable decrease in surviving hippocampal CA1 neurons whereas 2min showed no such 
difference. Focal ischaemia can also induce preconditioning (Liu et al., 1992). Three 
minutes of focal ischaemia in Wistar rats increased the levels of heat shock protein 72, a 
protein implicated in the preconditioning phenomenon, in CA1 neurons. After 3 days, 
protection against 6 and 8min focal ischaemia was observed. A further study showed that 
focal ischaemia could precondition against global ischaemia (Miyashita et al., 1994). 
Transient focal ischaemia was induced by unilateral middle cerebral artery occlusion as a 
preconditioning stimulus; this was able to protect the tissue against damage induced by a 
further 5min bilateral carotid artery occlusion. There was approximately 40% survival of 26 
 
CA1 neurons in the left hippocampus with no surviving neurons in the right. Protection 
was not as robust in this protocol. 
The preconditioning effect as observed in vivo suggests that it is physiologically relevant 
and therefore study of the underlying mechanisms a worthwhile contribution to the 
scientific literature.  
 
1.2.3 - In vitro preconditioning 
 
There are several experimental paradigms used to illustrate in vitro preconditioning such as 
acute hippocampal slices and cell culture systems. The acute slice system is a good model 
for illustrating rapid preconditioning owing to the time scale over which they work. 
Following on from Schurr et al. (1986), it was shown that brief, 2min oxygen-glucose 
deprivation (OGD) applied to rat hippocampal slices four times preconditioned against a 
7min OGD applied 30min later (p<0.05) (Pugliese et al., 2003). A similar protocol was 
adopted by Centeno et al. (1999) using 1min anoxic insults 3 times separated by 10min 
reperfusion to precondition against anoxia; this was applied until 2min of anoxic 
depolarization occurred. This resulted in over 90% recovery of the evoked responses from 
the CA1 pyramidal cells compared with less than 10% recovery of response in controls 
(p<0.01). 
Studies using cell cultures have also illustrated the effects of preconditioning. Cortical 
cultures were exposed to 90min OGD (Bruer et al., 1997). This sublethal insult did not 
induce changes in lactate dehydrogenase (LDH) release, a measure of the number of 
damaged neurons. When exposed to 180min OGD after 3 days, there was also no release 
of LDH compared to a 70% increase in controls. It was noted that tolerance was not 
observed before 24hrs reperfusion. There are similar observations in hippocampal cell 
cultures (Khaspekov et al., 1998). 60min OGD preconditioned against a 90min insult 
applied at 24 or 48 hrs later (p<0.01). There was approximately 40-60% protection at the 
24 hr time point and complete protection at 48hrs. The time course of protection in cultures 
matches that of in vivo studies. 
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1.3 - Glutamate  
The amino acid, glutamate, is an excitatory neurotransmitter which is ubiquitous 
throughout the central nervous system (Meldrum, 2000). It is synthesized in the nerve 
terminals from glucose as part of the Krebs cycle and by transamination of α-oxoglutarate. 
Glutamate may also be formed via glutamine, another amino acid synthesized in glial cells. 
Glutamine is transported to the nerve terminals where it is converted into glutamate by the 
enzymatic action of glutaminase. Glutamate is then taken up into the vesicles within the 
pre-synaptic neurons. When the propagation of action potentials along the axons of the pre-
synaptic neurons reaches the axon terminal, the resulting depolarization of the terminal 
membrane will open the voltage-gated calcium channels. Upon entry of calcium into the 
pre-synaptic neuron, the calcium ions will interact with vesicle-associated proteins which 
lead to the trafficking of vesicles to the synaptic membrane. The vesicles then fuse with the 
membrane which results in releasing the contents of the vesicles into the synaptic cleft, a 
process termed exocytosis. Once released into the synaptic space, glutamate diffuses 
throughout the cleft, mediating several actions at glial, pre- and post-synaptic sites. One of 
the primary actions is the stimulation of glutamate receptors which are classed into two 
different families, ionotropic and metabotropic. 
 
1.3.1 - Ionotropic glutamate receptors 
The ionotropic receptors are ligand-gated ion channels which are dependent upon the 
binding of glutamate to activate them. Upon activation, the conformation of the receptor is 
altered so as to allow the channel to become permeable to ions. In the nervous system, the 
glutamate ionotropic receptors are located on post-synaptic neurons and consist of 3 
different types: NMDA receptors; AMPA receptors; kainate receptors (for review, see 
Ozawa et al., 1998). 
1.3.1.1 - NMDA receptors 
The NMDA receptors are so named because they are selectively activated by the ligand, N-
methyl D-aspartate (NMDA). They are slowly-activating and require glutamate and 
glycine binding for the channel to open as well as membrane depolarization to relieve the 
voltage-dependent magnesium blockade of the open pore (Mayer et al., 1984). Once 
activated, they become permeable to sodium and calcium ions (Ascher & Nowak, 1988). 
NMDA receptors have a complex pharmacology and function within the brain and mediate 
various forms of synaptic plasticity within the hippocampus. In addition, they contribute to 
the excitotoxic effects which occur when the receptors are overstimulated during an 28 
 
ischaemic event. They have also been shown to mediate some forms of preconditioning in 
the brain.  
1.3.1.1.1 - Molecular biology 
There are several forms of the NMDA receptor which exist on account of the various 
subunits from which a single receptor may be composed. The subunits each contain a large 
extracellular N-terminal domain, 3 transmembrane segments (TM1, 3 and 4), a re-entrant 
loop between TM3 and TM4 (M2) and a cytoplasmic c-terminal domain. There are 3 
different subtypes of NMDA receptor subunits called NR1, NR2 and NR3. Each of these 
subunits has various isoforms which affect the functional properties and pharmacology of 
the NMDA receptor in which it is assembled (for review, see Paoletti & Neyton, 2007). 
Each NMDA receptor is made up of 4 subunits with at least one being of the NR1 subtype 
and one of the NR2 subtype in order for the receptor-channel to function. This is because 
the NMDA receptor requires activation by two agonists, glutamate and glycine (or D-
serine (Mothet et al., 2000)), the binding sites of which are upon the NR2 subunits and the 
NR1 subunits respectively. The NR3 subunit may also bind glycine but its presence in a 
receptor assembly negatively affects the channel conductance, calcium ion permeability 
and voltage-dependent magnesium block.  
The NR1 subunit has 8 different isoforms which result from different combinations of 
alternately spliced cassettes, one in the N-terminal (N1) and two in the C-terminal domain 
(C1,C2). The properties of the NR1 subunit varies according to which cassettes are present. 
The presence of N1 reduces agonist affinity 5 fold and increases current amplitude 3 fold. 
It also reduces polyamine potentiation. C1 enhances the localisation of the NR1 subunit to 
the synapses and C2 reduces protein kinase C (PKC) potentiation 3 fold and tethers the 
receptor to the post-synaptic density. The NR1 subunit has a string of glutamic acid 
residues with negative charges just before M2. This property is considered important for 
the development of the voltage-dependent magnesium block as the positively charged ion 
may be pulled into the pore (Dingledine et al., 1999). 
The NR2 subunit has 4 isoforms (NR2A, NR2B, NR2C, NR2D). Each of these isoforms 
exerts their own properties upon the NMDA receptor. For example, the presence of the 
NR2B subunit increases polyamine potentiation compared with other NR2 subunits. The 
presence of a subunit within the NMDA receptor assembly may be identified by the 
subunit pharmacology which is exerted upon the receptor. 
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1.3.1.1.2 - Pharmacology 
There are several sites on the NMDA receptor upon which drugs and endogenous 
compounds may act (for review, see Stone & Addae, 2002). Glutamate binds to a site 
within the agonist binding domain upon the NR2 subunit whilst its co-agonist, glycine, 
binds to a site upon the NR1 subunit. It is at these sites that competitive agonists and 
antagonists are able to bind, for example, NMDA (glutamate site agonist), AP5 (glutamate 
site antagonist), D-serine (glycine site agonist), kynurenic acid (glycine site antagonist).  
In addition there are binding sites within the channel pore that modulate the activity of the 
receptor in the open state. When the pore opens, the ion current is initially blocked by the 
binding of magnesium ion within the pore (Nowak et al., 1984); this occurs as magnesium 
is attracted to the negative resting membrane potential upon the inside of the cell with 
respect to the outside. The binding site within the channel is also lined with negatively 
charged residues to which the magnesium ion is drawn. Usually, the AMPA and kainate 
receptors will also be stimulated by glutamate and allow the influx of sodium ions which 
depolarizes the membrane. As the ion influx continues, the membrane depolarization 
eventually relieves the magnesium blockade upon the NMDA receptors (Mayer et al., 
1984). There is also a site which binds phencyclidine (PCP) when the channel is open. 
Other channel blockers such as MK-801, ketamine and memantine bind to this site. 
The NMDA receptor also contains binding sites for allosteric modulators. Some of these 
agents show some selectivity for the different subunits, for instance, at the relevant site, 
zinc binds preferentially to NR2A over NR2B subunits to inhibit the receptor activity. 
Ifenprodil is a modulator which binds specifically to NR2B subunit containing receptors. 
There is also a polyamine binding site which promotes the receptor activity when bound by 
endogenous spermine or spermidine. 
1.3.1.2 - AMPA receptors 
Another form of ionotropic receptor is the AMPA receptor. This receptor mediates fast 
excitatory transmission and once activated by glutamate, becomes rapidly desensitized. 
Like NMDA receptors, they are involved in synaptic plasticity within the hippocampus and 
are permeable to sodium ions. 
Each AMPA receptor contains 4 subunits. There are 4 different types of subunit, each 
containing an extracellular N-terminal domain, 4 TM segments and a cytoplasmic C-
terminal domain. The subunits are named GluR1, GluR2, GluR3 and GluR4. There is a 
single residue upon TM2, the subunit segment which lines the channel pore, which 30 
 
influences the ion selectivity of the channel. In GluR2 subunits, the residue is the 
positively charged arginine. Its presence in the lining of the pore prevents the permeability 
of divalent cations such as calcium but allows monvalent sodium ions through the receptor 
channel. In the other subtypes of subunit, a glutamine residue is present instead of arginine. 
In AMPA receptors lacking GluR2 subunits, the channel becomes permeable to divalent 
cations. However, the GluR2 subunit appears to be ubiquitously expressed throughout the 
nervous system and its presence in the AMPA receptor assembly prevents permeability to 
calcium, even if GluR1, 3 and 4 form the other three subunits. AMPA receptors are 
therefore predominantly permeable to sodium ions (Ozawa et al., 1998). 
In terms of binding sites, the glutamate binding site is composed of two segments of the 
subunits; a region of residues between the N-terminal domain and TM1 and another group 
of residues located in the extracellular loop between TM3 and TM4. Together these 
regions form a binding pocket for the neurotransmitter. It is at this site that competitive 
agonists (eg AMPA) and antagonists (eg DNQX) also bind. Within the AMPA receptor, 
there also exists a site which affects the rapid desensitization of the receptor. This is 
affected by compounds such as diazoxide, a mitochondrial ATP-sensitive potassium 
channel opener, which prevents the receptors from desensitizing (Yamada & Rothman, 
1992).  
1.3.1.3 - Kainate receptors 
Kainate receptors are similar in structure, function and pharmacology to AMPA receptors. 
The receptors are composed of subunits of which there are 5 different subtypes, GluR5, 
GluR6, GluR7, KA1 and KA2. These all have the same structure as AMPA receptors and 
may contain either arginine or glutamine at the Q/R site. These subunits have around 40% 
homology to AMPA receptor subunits. The receptor is selectively bound by the agonist, 
kainic acid, but there are few selective drugs which can pharmacologically distinguish 
between AMPA and kainate receptors. They are associated with excitotoxicity as kainic 
acid is able to cause injury to regions which show a high expression of kainate receptors, 
eg CA3 of the hippocampus (Sperk, 1994). 
 
1.3.2 - Excitotoxicity  
Glutamate normally functions to relay chemical messages between neurons at the synaptic 
clefts. It is crucial in mediating the normal processes of transmission that occur within the 
brain as well as changes in synaptic plasticity. The excitatory transmitter is normally 
present in the extracellular space at less than 1µM. If the concentration is elevated to 31 
 
between 2-3µM such as during ischaemia, it becomes neurotoxic or excitotoxic due to 
overactivation of glutamate receptors (Obrenovitch et al., 2000). In particular, it appears 
that excessive calcium influx resulting from overactivation of NMDA receptors induces 
cell-death processes by activating degrading enzymes and generating harmful free radicals 
by excessive calcium sequestration within the mitochondria. In addition, the excessive ion 
influx through all the ionotropic glutamate receptors results in oedematous swelling of the 
neuron and ultimately, damage to the cell. Excitotoxicity can induce delayed cell death 
mechanisms via either necrosis or apoptosis. The hippocampal CA1 area seems to be 
particularly vulnerable to excitotoxcity due to a high quantity of NMDA receptors (Simon 
et al., 1984). 
 
1.3.3 - Glutamate preconditioning 
One of the first studies to demonstrate that glutamate can precondition against further 
glutamate insults was conducted in rat hippocampal slices (Schurr et al., 2001). The 
protocol consisted of applying 20mM glutamate for 5min to precondition. After a washout 
of 30min, the same concentration of glutamate was applied for 20min. Preconditioning was 
observed simply as a return of the evoked responses in the slice as 20mM glutamate is 
toxic to the point of irreversible damage. They observed that approximately 55% of the 
slices showed a return in evoked responses after a preconditioning protocol compared with 
approximately 28% in controls (p<2.56e
-7). This study drew from previous experiments in 
cell cultures showing NMDA exposure to neurons could attenuate the damage mediated by 
glutamate (Chuang et al., 1992; Pringle et al., 1999). Chuang et al. (1992) used cerebellar 
granule cell cultures to show that a 3hr NMDA exposure blocked the damage mediated by 
glutamate. This is in agreement with the study by Schurr et al. (2001) using 5min of 20µM 
NMDA to prevent glutamate toxicity. Similar observations were made by Pringle et al. 
(1999) regarding NMDA induction of tolerance to glutamate toxicity although it was also 
observed that sublethal NMDA exposure did not precondition against a subsequent NMDA 
insult. These studies led onto the supposition that NMDA receptors may mediate 
excitotoxic preconditioning. 
 
1.3.3.1 - NMDA receptors mediate excitotoxic preconditioning 
It has been shown that NMDA receptor stimulation is required for neuronal 
preconditioning (Kato et al., 1992) as blockade by MK-801, an NMDA antagonist, 
attenuated in vivo ischaemic preconditioning in Mongolian gerbils. This evidence has been 32 
 
contradicted in a study using a similar protocol in Wistar rats (Wrang & Diemer, 2004). 
MK-801 did not decrease the neuroprotection offered by preconditioning. There was no 
clear indication why opposing results were obtained although there were slight differences 
in ischaemic insults applied to account for the differential sensitivity of rat and gerbil 
brains to bilateral carotid artery occlusion. NMDA antagonism has been shown to block 
ischaemic tolerance in Mongolian gerbils in vivo in another study (Bond et al., 1999). The 
protocol was almost identical to Kato et al. (1992) using 2min bilateral carotid artery 
occlusion to precondition, 3min occlusion for a test insult and MK-801 to inhibit NMDA 
receptors. It was also shown that AMPA receptor competitive and non-competitive 
antagonism had no significant effect on preconditioning. 
A study in hippocampal slices showed that a protocol of 100µM NMDA for 15sec applied 
every 10min for three applications induced protection against NMDA application for 
10min after 30min washout (Bandyopadhyay et al., 2002). This study showed particularly 
that this protocol decreased cellular swelling in the slices thus attenuating damage caused 
simply by elevated ion permeability and not necessarily that induced by excessive Ca
2+ 
influx. The protocol for NMDA application was adapted from the study of hypoxic 
preconditioning in slices by Centeno et al. (1999). 
 
1.3.3.2 - Mechanism for ischaemic tolerance induced by NMDA receptors 
There is little evidence to explain how NMDA receptor activation may mediate 
preconditioning. Low-level activation is a requirement so as not to induce cell death. A 
study, which elucidated some part of this protection, used 3-nitropropionic acid (3-NPA), 
an inhibitor of succinic dehydrogenase in the mitochondria, to precondition against 15min 
hypoxic insults applied to hippocampal slices (Kasischke et al., 1996). Intraperitoneal 
injection of 3-NPA (20mg/kg) in rats 1hr prior to slice preparation was performed. 
Tolerance was observed as population spikes in the preconditioned slices recovered to 90 ± 
7% compared with 31 ± 9% in controls (p<0.05). This effect was attenuated by 15min 
perfusion of 100µM AP-5 (NMDA antagonist). As the preconditioning was mediated by 
either generation of reactive oxygen species produced by the inhibition of the electron 
transport chain or mild excitotoxicity due to ATP depletion, subsequent membrane 
depolarization and removal of the Mg
2+ block at NMDA receptors, this suggests that 
NMDA receptor activation mediates its own neuroprotection by one or both of these 
mechanisms. NMDA receptors are known to activate nitric oxide synthase (NOS) thus 
generating the gaseous particle, nitric oxide (NO) (Yamada & Nabeshima, 1997a + b; 33 
 
Bredt & Synder, 1989), which has been identified as a mediator of anoxic preconditioning 
in hippocampal slices (Centeno et al., 1999). In that study, anoxia was generated by 
bubbling the perfusion medium with 95%N2/5%CO2 in place of oxygenated gas. 1 min of 
anoxia was applied three times, each separated by 10min, as the preconditioning stimulus. 
After 30min of reoxygenation following the last 1min anoxia applied, 95%N2/5%CO2 was 
bubbled into the medium until anoxic depolarization of the evoked response was generated 
for 2min. This significantly increased the recovery of the evoked response after the anoxic 
depolarization compared with control responses in which anoxic depolarizations alone 
were generated. The authors found that repeating the preconditioning protocol in the 
presence of 7-nitroindazole, a NOS inhibitor, prevented the increase in recovery of the 
evoked response following 2min of anoxic depolarization. They also found that similar 
protection could be induced by perfusing diethylamine/nitric oxide complex for 10min 
onto the slice 30min prior to the generation of anoxic depolarization again. The role of 
nitric oxide has also been shown in delayed preconditioning protocols in vivo (Gidday et 
al., 1999) and in vitro (Gonzalez-Zulueta et al., 2000). As Centeno et al. (1999) have 
observed that NO is involved in anoxic preconditioning, it is very likely that this extends to 
excitotoxic preconditioning as a result of NMDA receptor stimulation.This has been 
demonstrated by Youssef et al. (2006) in rat hippocampal slices where a 10µM NMDA 
application (5min) resulted in preconditioning the population spike against a further 15µM 
NMDA application applied 30min later. The authors showed that the preconditioning 
stimulus also impaired the ability of the slice to produce a spike potentiation in response to 
tetanic stimulation and that this effect was prevented by the NOS inhibitor, L-NAME, 
further suggesting that nitric oxide may also mediate the preconditioning effect of NMDA. 
 
1.4 - Adenosine  
Adenosine is an inhibitory neuromodulator which is normally present at 25-150nM in the 
extracellular medium (for review, see Dunwiddie & Masino, 2001). Its main action in the 
brain is to suppress excitatory transmission by inhibition of transmitter release from the 
pre-synaptic terminals. It does have several interactions in neural tissue during ischaemia 
and preconditioning as well as during synaptic plasticity. 
Adenosine is synthesized in the extracellular medium by the dephosphorylation of adenine 
nucleotides by ecto-nucelotidases, ecto-phosphodiesterases and apyrases. This forms the 
precursor, 5’-AMP which is then converted to adenosine by 5’-nucleotidase. 
Intracellularly, adenosine can also be synthesized from 5’-AMP but it may also be formed 
from S-adenosylhomocysteine (SAH) by the enzyme, SAH hydrolase. 34 
 
1.4.1 - Metabotropic adenosine receptors 
Adenosine exerts its effects by its actions upon four G-protein-coupled receptors: A1; A2a; 
A2b; A3. As metabotropic receptors they have seven transmembrane domains and an N-
terminal and C-terminal domain. They are all coupled to G proteins which act as signalling 
messengers for specific targets to exert their actions upon the cell.  
1.4.1.1 - Adenosine A1 receptors 
Of these receptors, adenosine shows the highest affinity for A1 receptors which is the most 
abundant subtype of adenosine receptor in the hippocampus (for review, see Ralevic & 
Burnstock, 1998). A1 receptors are coupled to inhibitory Gi/o proteins which then act to 
inhibit adenylyl cyclase, hyperpolarize neurons by increasing K
+ conductance and suppress 
neurotransmitter release by inhibiting mainly N-type Ca
2+ channels at the pre-synaptic 
neuron of the CA3-CA1 synapse (Manita et al., 2004). Post-synaptically they appear to 
interact with NMDA receptors and suppress their activity (Canhão et al., 1994; Klishin et 
al., 1995; de Mendonça & Ribeiro, 1993; de Mendonça et al., 1995).  
The A1 receptors activate phospholipase C (PLC) which in turn leads to the production of 
the second messengers, inositol tris-phosphate (IP3) and diacylglycerol (DAG). IP3 can act 
upon receptors of the endoplasmic reticulum to mobilise the calcium stores which can 
affect many calcium dependent processes such as the formation of nitric oxide and 
phospholipase A2 (PLA2) as well as the activity of calcium-dependent potassium channels. 
Increasing intracellular calcium availability can also positively modulate PKC, a signalling 
messenger which is also activated by DAG. PKC can induce the opening of the ATP-
sensitive potassium channels which may affect the resting membrane potential and the 
function of the mitochondria (see section 1.5 - ATP-sensitive potassium channels). 
1.4.1.2 - Adenosine A2a receptors 
Unlike the A1 receptors, A2a receptors are coupled to Gs protein which increases cAMP 
production and overall produces an excitatory effect (for review, see Sebastião & Ribeiro, 
1996). These receptors are mainly present in the striatum although they are also present in 
the hippocampus, co-localized with A1 receptors. They disinhibit the A1 receptors in the 
hippocampus (Cunha et al., 1994) and attenuate the effects of the A1 receptor upon the 
relationship between presynaptic transmitter release and post-synaptic responses in the rat 
hippocampal slice (O’Kane & Stone, 1998). 
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1.4.1.3 - Adenosine A2b receptors 
A2b receptors are also coupled to Gs proteins to increase cAMP production. They have 
been cloned from the human hippocampus (Pierce et al., 1992) and have a much lower 
affinity for adenosine than A2a receptors. They have not been well characterised on 
account of the few pharmacological agents available which selectively bind. 
1.4.1.4 - Adenosine A3 receptors 
A3 receptors are inhibitory in nature. They are coupled to Gi proteins to decrease cAMP 
production and also increase PLC and IP3 intracellularly which in turn increases 
intracellular calcium. In the hippocampus, the adenosine A1 receptor rapidly desensitizes 
in response to agonist exposure within minutes. This desensitization can continue for 
several hours after the initial exposure and is thought to occur as a result of the action of 
A3 receptors upon A1 receptors (Dunwiddie et al., 1997).  
1.4.2 - Adenosine metabolism 
Adenosine is catabolised by adenosine kinase intracellularly. The reaction involves 
dephosphorylation of ATP to produce ADP and AMP. In the extracellular space, adenosine 
is broken down by adenosine deaminase to form inosine. 
 
1.4.3 - Adenosine during ischaemia 
There is a huge elevation in adenosine concentration in the extracellular space during 
ischaemia resulting from ATP breakdown. Adenosine is formed from dephosphorylation of 
5-AMP, a metabolite of ATP. In rat hippocampal slices, a 5min exposure of 95% N2/5% 
CO2 bubbled perfusion medium completely depressed the evoked field epsps from CA1 
neurons. The presence of an A1 receptor antagonist, 8-phenyltheophylline, prevented the 
depression of the evoked response. Measurements of adenosine concentrations indicated 
that it had greatly increased within 10min of the onset of ischaemia (Pedata et al., 1993). A 
5min ischaemic insult in hippocampal slices increased adenosine concentration to 30µM 
from a basal concentration of 240nM (Latini et al., 1999b). It has also been shown that 
adenosine mediates the initial depression of electrophysiological responses in the 
hippocampus during common carotid artery occlusion of rats in vivo (Gervitz et al., 2001). 
Adenosine normally suppresses glutamate release from neurons and thus the concentration 
increase would appear to ameliorate the damaging effects of glutamate. It has been shown, 
however, that at elevated concentrations which occur during ischaemia, adenosine can 
activate A3 receptors which in turn desensitize A1 receptors, most likely through a G-36 
 
protein coupled mechanism (Dunwiddie et al., 1997). As the suppression of glutamate 
release is mediated via A1 receptors, it is possible that adenosine contributes to neuronal 
death by blocking protective mechanisms via A3 receptors.  
 
1.4.4 - Adenosine preconditioning 
Several paradigms in the scientific literature have shown the ability of adenosine to 
precondition against anoxic and hypoxic insults (Heurteaux et al., 1995; Pérez-Pinzón et 
al., 1996; Kitagawa et al., 2002). This was first demonstrated in vivo using bilateral 
common carotid artery occlusion in rats for both preconditioning stimuli and lethal insult 
(Heurteaux et al., 1995). A 3min sublethal occlusion induced tolerance to a 6min occlusion 
3 days later (p<0.05). It was noted that if the second occlusion was performed 1hr later, the 
entire population of CA1 pyramidal cells in the hippocampus were destroyed. The 
beneficial effects observed were cancelled when DPCPX, an adenosine A1 receptor 
antagonist was administered intraperitoneally (1 mg/kg) 15min prior to the sublethal 
ischaemia. Administration of N6-cyclopentyladenosine (CPA), an adenosine A1 agonist, 
when used in the same protocol, also improved recovery after lethal ischaemia. Adenosine 
appears to mediate its preconditioning effects in neuronal tissue through stimulation of A1 
receptors. This was also observed in hippocampal brain slices (Pérez-Pinzón et al., 1996) 
using a perfusion medium bubbled in 95% N2/5% CO2 to generate anoxia. 100µM 
adenosine perfused for 10min prior to anoxia maintained until 2min of anoxic 
depolarization onset induced tolerance (p<0.05). The studies described above show that 
adenosine is involved in acute and delayed preconditioning.  
Further studies have confirmed these observations (Hiraide et al., 2001). In vivo bilateral 
occlusion of common carotid arteries for 2min followed by 5min ischaemia 24hrs later 
showed that damage in the CA1 pyramidal cells was attenuated in preconditioned gerbils. 
This was measured by neuronal density one week later. DPCPX injected intraperitoneally 
3hrs following the preconditioning 2min ischaemia enhanced damage to CA1 neurons. 
Pugliese et al. (2003) also showed similar effects in hippocampal slices with a protocol of 
2min OGD with a reperfusion period of 13min. This was repeated four times before 7min 
OGD was applied 30min later. The preconditioning observed (p<0.05) was abolished by 
perfusion of 100nM DPCPX applied before and during the preconditioning insults 
(p<0.01). It was also noted that an adenosine A3 antagonist (MRS 1523 [100nM]) 
improved recovery when applied as before. This could be related to the desensitization of 
A1 receptors via A3 receptors observed by Dunwiddie et al. (1997). 37 
 
  It has been noted that adenosine A1 receptor agonists and antagonists do not always 
modulate preconditioning (Sorimachi et al., 2004). Using bilateral occlusion of the 
common carotid arteries in Mongolian gerbils, it was shown that DPCPX did not attenuate 
preconditioning or alter the ischaemic depolarisation when administered intraperitoneally 
(1mg/kg) 15min prior to occlusion. There was also no alteration in neuron damage 
assessed histologically 5 days later. Similar results were observed for CPA except that 
severe damage was observed in CA1 neurons after 5 days. 
 
1.4.5 - Mechanism of adenosine preconditioning 
The mechanism by which adenosine induces neuronal tolerance is mediated through a 
signal transduction pathway consisting of A1 receptor activation leading to PKC activation 
followed by ATP-sensitive potassium channel activation (Heurteaux et al., 1995; Reshef et 
al., 2000). In addition to these observations in vivo, the role of ATP-sensitive potassium 
channels and PKC in anoxic preconditioning was observed in rat hippocampal slices 
(Pérez-Pinzón & Born, 1999).  
It is possible that adenosine may modulate the conductance of NMDA receptors in 
preconditioning. In a study using tight seal whole-cell recording from rat neostriatal 
neurons, A2a receptor agonists inhibited the current produced from NMDA receptor 
stimulation when perfused 5min prior to and during a second application of 10µM NMDA 
to the neuron (Nörenberg et al., 1997). There was no impact on NMDA conductance using 
A1 receptor agonists, however, indicating that this may not be a mechanism associated 
with preconditioning. The abundance of A1 receptors may have been a factor; A2a 
receptors are most abundant in the striatum whereas A1 receptors predominate in the 
hippocampus. Adenosine was shown to mediate NMDA preconditioning against glutamate 
via A1 receptors in a cerebellar granule cell culture (Boeck et al., 2005). The 
preconditioning effects of adenosine are also present in the heart (Liu et al., 1991) where 
glutamate presence may be much lower, however, indicating that the mechanism of 
induced tolerance may be common to all cells. 
It has been demonstrated that adenosine delays the onset of anoxic depolarization (Lee & 
Lowenkopf, 1993). Using brain slices, inhibition of endogenous adenosine using A1 
antagonists quickened the onset of depolarization when 99% N2 was bubbled in the 
perfusion medium. The antagonists were applied prior to and during the anoxic insult. 
Jarvis et al. (2001) have observed that anoxic depolarization induced by OGD in 
neocortical slices results in cellular swelling as measured by the intrinsic optical signal 
(changes in light transmittance associated with ischaemia). This occurred in the presence 38 
 
of a non-specific glutamate receptor antagonist, kynurenate, thus excluding a role for 
glutamate in the effect. It has been shown that blockade of the anoxic depolarization 
prevents cellular swelling, damage and loss of evoked responses in the CA1 region of 
slices (Anderson et al., 2005). It is possible that by delaying onset of anoxic depolarization, 
adenosine may reduce the exposure of neuronal tissue to damaging stimuli. Pérez-Pinzón 
et al. (1996) indicated that whilst adenosine preconditioning protects against anoxic insults, 
they observed no significant delay in onset of anoxic depolarization. This suggests that 
preconditioning protection induced by adenosine does not work by delaying the onset of 
damage in tissue. 
 
1.5 - ATP-sensitive potassium channels  
ATP-sensitive potassium channels are present in all cells. They are normally closed when 
ATP is present and open during ATP depletion, an action which decreases the metabolic 
demand to the cell by increasing potassium conductance. These channels are located on the 
mitochondrial inner membrane and at the plasmalemmal membrane. Stimulation of the 
ATP-sensitive potassium channels induces preconditioning protection prompting the 
examination of mechanisms which may mediate these phenomena.  
1.5.1 - Molecular biology 
The ATP-sensitive potassium channels are composed of two different types of subunit; 
these are the Kir6 subunits and the sulfonylurea receptor (SUR) subunits. The Kir6 
subunits are of two types; Kir6.1 and Kir6.2. The SUR subunits are also of two types; 
SUR1 and SUR2. The ATP-sensitive potassium channels in neuronal tissue are composed 
of four Kir6.2 subunits forming the channel pore (Allen & Brown, 2004; Avshalumov & 
Rice, 2003). Each of the Kir6.2 subunits is associated with a corresponding SUR subunit 
(which in neurons is probably SUR1 (Chen et al., 2003)) resulting in four surrounding 
SUR1 subunits around the Kir6.2 pore. The Kir6.2 subunits contain 2 transmembrane 
helices, M1 and M2 which are bridged by an extracellular loop that is responsible for ion 
selectivity of the channel. The SUR subunits contain two transmembrane 6 helix domains 
called TMD1 and TMD2. There is also an N-terminal TMD0 domain in the SUR subunits 
consisting of 5 transmembrane helices; it has a role in trafficking the Kir6.2 subunits to the 
cell membrane and may also control the gating of these subunits. SUR subunits contain 
two nucleotide-binding folds, one of which is located between TMD1 and TMD2 and the 
other which is found after TMD2. 39 
 
1.5.2 - Pharmacology 
ATP interacts with the binding sites on the cytoplasmic domains of all four Kir6.2 subunits 
to maintain the closed state of the channel. There are also binding sites for 
phosphatidylinositol 4-5-bisphosphate (PIP2) which acts to stabilize the channel in an open 
state. Either ATP or PIP2 are bound to a subunit at any one time therefore for the channel 
to be activated by PIP2, all the ATP-binding sites must be unoccupied as the blockade 
results from a hinged motion of the M2 portion of any Kir6.2 subunit which is sufficient to 
maintain the closed state of the channel. 
The SUR subunits provide the binding sites for potassium channel openers (eg SCH 
58261) and sulfonylurea drugs (eg tolbutamide). They also contain binding sites for Mg-
bound ATP or Mg-bound ADP ie the nucleotide binding folds which activate the channel 
when Mg-bound nucleotides are bound, particularly Mg-ADP. When this is the case, it 
seems that this overrides the inhibition induced by ATP binding to the Kir6.2 subunits (for 
review, see Nichols, 2006).  
 
1.5.3 - Subcellular localization and function 
The ATP-sensitive potassium channels are located upon the mitochondrial inner membrane 
and the plasmalemmal membrane. The function of the plasmalemmal channels under 
normal physiological conditions is unclear as there is no apparent effect upon resting 
membrane potential. Under ischaemic conditions or conditions of ATP depletion, the 
plasmalemmal channels may act to reduce the excitability of the neuron by allowing 
potassium efflux to hyperpolarize the membrane. In nerve terminals, this may lead to the 
inhibition of transmitter release such as glutamate (Soundarapandian et al., 2007a) and 
GABA (Matsumoto et al., 2002) within the hippocampus. The plasmalemmal channels are 
also present on post-synaptic sites (Matsumoto et al., 2002, Hosseinzadeh & Stone, 1998) 
where they hyperpolarize the neuronal membrane although in CA1 neurons, the 
distribution of functional ATP-sensitive potassium channels may be limited to the somata 
given that tolbutamide prevents the inhibitory effects of adenosine upon population spikes 
but not upon epsps (Hosseinzadeh & Stone, 1998). It has also been suggested that the 
selective vulnerability of the CA1 pyramidal neurons under conditions of cell stress may 
be due to lower levels of these channels compared with interneurons (Zawar & Neumcke, 
2000). 
The mitochondrial ATP-sensitive potassium channels are present on the inner membrane 
and allow potassium influx into the mitochondrial matrix under conditions when ATP 40 
 
production is decreased. This is thought to protect the mitochondria by preserving the 
mitochondrial membrane potential and inner mitochondrial volume (Busija et al., 2004). 
 
1.5.4 - Role of ATP-sensitive potassium channels in preconditioning 
The ATP-sensitive potassium channels have been well documented as a crucial mediator of 
the preconditioning phenomenon in most tissues. The mitochondrial subtype has been 
studied in particular detail in neuronal tissues and the roles of both subtypes have been 
examined extensively in cardiovascular preconditioning studies. Whilst the protective 
effect of ATP-sensitive potassium channel opening has been studied in neurons mainly 
with the use of diazoxide, a specific opener of mitochondrial ATP-sensitive potassium 
channels, the role of the plasmalemmal ATP-sensitive potassium channels has remained 
unclear. There are conflicting reports regarding the role of the cell surface channels, some 
studies showing the requirement for such channels (Blondeau et al., 2000, Heurteaux et al., 
1995; Pérez-Pinzón & Born, 1999). One study which used knockout mice lacking the 
plasmalemmal channels, however, showed that a preconditioning stimulus (20min of a 
bilateral carotid artery occlusion) protected against 40min ischaemia in the hippocampus 
(Muñoz et al., 2003) indicating that only mitochondrial channels may be required for in 
vivo preconditioning.  
There have been few slice studies in neurons with regard to the effects of ATP-sensitive 
potassium channels and the acute preconditioning phenomenon. The first of these used 
pinacidil, a non-selective ATP-sensitive potassium channel opener as the preconditioning 
stimulus (Pérez-Pinzón & Born, 1999). Hippocampal slices were exposed to three 1min 
periods of anoxia induced by bubbling the perfusion medium with 95% N2/5% CO2. The 
lethal insult was applied 30min later consisting of a longer anoxic period. This 
preconditioning paradigm showed an increase in the recovery of evoked potentials 
following the lethal ischaemic insult compared with slices exposed to lethal ischaemia 
alone. This protection was abolished by the presence of tolbutamide in the perfusion 
medium. It was also shown that 10µM pinacidil, applied for 20min prior to the anoxic 
episode, induced a higher recovery of the evoked potentials also. Other studies have shown 
the effects of diazoxide upon slices. Nakagawa et al. (2002) showed that diazoxide delayed 
the onset of depolarization induced by hypoxia in gerbil hippocampal slices, an effect 
which was blocked by glibenclamide. This may have similar protective effects like the 
delay in anoxic depolarization induced by adenosine (Lee & Lowenkopf, 1993). Garcia de 
Arriba et al., (1999) studied the morphological changes induced by 30min 95% N2/5% CO2 41 
 
in rat neocortical brain slices and found that prior exposure to 300µM diazoxide attenuated 
these effects. They were also partly reversed by tolbutamide. 
The protective effects of diazoxide have been studied in vivo also. Domoki et al. (1999) 
reported that neuronal dysfunction resulting from 10min of global ischaemia induced in 
piglet cortex pial arterioles was attenuated by the prior application of 5-10µM diazoxide. 
The protection was blocked by the presence of 5-hydroxydecanoate (5-HD). It has also 
been shown that i.p. injection of diazoxide into 7 day old rat pups decreased the infarct 
volume in the brain induced by ligation of the common carotid artery for 2.5 hours 
(Rajapakse et al., 2002). This effect was also blocked by 5-HD confirming the specificity 
of diazoxide. The authors also confirmed that diazoxide induced its effects upon the 
mitochondria by using fluoresence studies to show the depolarization of the mitochondria, 
an effect of diazoxide which has also been reported in rat hippocampal homogenates 
(Dębska et al., 2001). Reductions in infarct volumes have also been reported in mice where 
i.v. injection of diazoxide attenuated the effects of a subsequent middle cerebral artery 
occlusion. The effects of diazoxide in vivo have been attributed to an increase in cerebral 
blood flow which appears to be a protective mechanism against ischaemia. However, the 
effects of acute preconditioning in vitro may also be due to the maintenance of the 
mitochondrial matrix volume and the limitation of calcium influx which preserves 
respiration within the tissue and subsequently prevents delayed cell death (for review, see 
Busija et al., 2004). 
In addition to ischaemia, the protective effects of ATP-sensitive potassium channel 
opening have been shown to be effective against chemical insults. This has been studied in 
delayed preconditioning paradigms moreso than acute. These studies have favoured the use 
of exogenous glutamate (Nagy et al., 2004; Kis et al., 2004) or rotenone (Tai et al., 2003) 
as a chemical insult. However, caution must be taken with the interpretation of these 
effects as diazoxide is reported to affect the conductance of glutamate receptors (Crépel et 
al., 1993; Lu & Mattson, 2001). It has been particularly noted that diazoxide blocks the 
rapid desensitization of the AMPA receptors in hippocampal cell cultures (Yamada & 
Rothman, 1992). 
 
1.6 - Heat shock protein 72 
The delayed time window of preconditioning protection (24-48hrs) is associated with 
molecular changes, the most prominent of these being heat shock protein 72 (HSP72) 
(Kirino et al., 1991; Liu et al., 1993) and the anti-apoptotic mitochondrial protein, Bcl-2 42 
 
(Wu et al., 2004). HSP72 belongs to the family of heat shock proteins that function as 
molecular chaperones, maintaining protein structure, synthesis and trafficking. The 
constitutive form of heat shock protein, HSP70, acts in this housekeeping capacity whilst 
the stress-induced form, HSP72, is upregulated to prevent protein denaturation and 
maintain mitochondrial stability in response to cellular stresses such as ischaemia. 
Although HSP72 is found in higher quantities during cell stress, its presence is indicative 
of a repair response in tissues in which the damage may be reversed. It is found in high 
quantities in the ischaemic penumbra of focal ischaemia (Heiss, 2000), the zone of lesser 
damage surrounding the severely impaired tissues at the core. HSP72 is induced in 
response to the denaturation of proteins during ischaemia. Protein denaturation activates 
heat shock factors which phosphorylate and trimerise. This complex then binds to heat 
shock elements upon the heat shock genes which in turn activate HSP72 transcription. 
HSP72 then acts to prevent some forms of cell death (for review, see Sharp et al., 1999). 
HSP72 has been shown to be upregulated in preconditioning protocols and prevent the 
onset of apoptosis and necrosis (for review, see Obrenovitch 2008). In vivo, it has been 
shown that HSP72 expression is elevated in CA1 neurons of male Mongolian gerbils 
following 2min of induced global ischaemia which in turn increases the neuronal survival 
following a subsequent 5min global ischaemia induced at one, two or four days post-
preconditioning (Kirino et al., 1991). Similar in vivo studies have shown the role of HSP72 
in mediating ischaemic tolerance (Liu et al., 1992; Liu et al., 1993; Nishi, 1993; Nishi et 
al., 1993; Chen et al., 1996). 
HSP72 normally stabilises proteins by binding to the hydrophobic regions which become 
exposed when the protein denatures. During preconditioning however, the stress-induced 
protein appears to prevent cell death from the intrinsic apoptotic pathway and caspase-
independent apoptosis in tissues. The extrinsic apoptotic pathway may also be affected by 
HSP72 although to a much lesser extent (for review, see Beere, 2005). The HSP72 
protection of the first two forms of apoptosis mentioned may occur through several 
mechanisms. During ischaemia, the pro-apoptotic protein, Bax, is translocated to the 
mitochondrial membrane where it acts to increase the permeability of the organelle which 
in turn releases reactive oxygen species, and the apoptotic factors, cytochrome c and 
Apoptosis Inducing Factor (AIF). HSP72 acts to suppress the activation of Bax by 
inhibiting c-Jun N-terminal kinases (JNK). It may also enhance the expression of the anti-
apoptotic protein, Bcl-2, which opposes the actions of Bax at the mitochondrial membrane. 
In addition, HSP72 may prevent the effects of cytochrome c and AIF. Cytochrome c 
normally combines with pro-caspase-9 and apoptosis protein activating factor-1 (apaf-1) to 43 
 
form the apoptosome, a complex which activates caspase-9 and subsequently the caspase 
cascade leading to cell degradation. HSP72 binds to apaf-1 and prevents the formation of 
the apoptosome thus preventing caspase-dependent apoptosis. AIF induces a caspase-
independent apoptosis by translocation to the nucleus following its release from the 
mitochondria. It then associates with endonucleases which results in DNA degradation and 
cell death. HSP72 acts to neutralise AIF by sequestering it in the cytosol. HSP72 appears 
to be a highly effective neuroprotective agent on account of its numerous actions in 
preventing apoptotic cell death (for review, see Obrenovitch, 2008). 
The induction of heat shock protein expression has been shown to occur in response to 
adenosine preconditioning or tolerance induced by an ATP-sensitive potassium channel 
openers in the hippocampus (Blondeau et al., 2000). It was observed that preconditioning 
against intraperitoneal injection of kainic acid by a smaller dose of kainic acid 
administered 3 days earlier prevented apoptosis and necrosis in CA1 and CA3 neurons. 
This protection was mimicked when the adenosine agonist, R-phenyl-isopropyladenosine 
(R-PIA), or the ATP-sensitive potassium channel opener, cromakalim, was used as the 
preconditioning stimulus. This proved effective against global ischaemia induced by four-
vessel occlusion as well as kainic acid. It was shown that heat shock protein expression 
increased over the 3 days in response to kainic acid, R-PIA or cromakalim and was 
indicative of protection in the tissue. Whilst this study, like many others, has examined the 
molecular changes in delayed preconditioning, none have assessed the role of HSP72 in 
acute preconditioning. Given that common factors such as A1 receptor stimulation and 
ATP-sensitive potassium channel opening can induce acute and delayed preconditioning, it 
is interesting to see if HSP72 is also common to both. Blondeau et al. (2000) reported that 
after the second kainic acid administration, changes in heat shock protein expression were 
observed within 3 hours. This might form part of the mechanism observed in acute 
preconditioning therefore it may be useful to investigate its role in rapidly induced 
neuroprotection. 
 
1.7 - The hippocampal slice preparation 
The hippocampus is a structure within the mesolimbic system which is involved in the 
processes of memory formation and learning. It has a lamellar structure and receives its 
major input from the entorhinal cortex. It is divided into approximately 4 regions, CA1, 
CA2, CA3 and the dentate gyrus (Figure 1). The neurons in each region project onto the 
next sequentially which forms the trisynaptic pathway. Hence the afferent inputs from the 
entorhinal cortex form the perforant path fibres which terminate onto the dentate gyrus 44 
 
granule cells. These granule cells in turn project their mossy fibres onto the CA3 pyramidal 
cells. The axons of the CA3 neurons, called the Schaffer-collaterals, project onto the CA1 
pyramidal neurons. The axons of the CA1 cells then project through the alveus towards the 
subiculum (Anderson et al., 1971a).  
The CA3-CA1 projection has been widely studied. This is because the terminal projections 
of the Schaffer-collateral axons all synapse onto the CA1 dendrites allowing for easier 
study of events occurring at one synapse. Also, the lamellar structure of the hippocampus 
allows it to be used in vitro in slices whilst keeping the major projections intact. The 
hippocampal slice preparation allows electrophysiological recordings to be made with 
relative ease, particularly extracellular recordings from the CA1 pyramidal cells. Hence it 
is possible to record field epsps from the CA1 dendrites and population spikes from the 
somata. It is also possible to evoke the population spikes which represent the summation of 
action potentials in either an orthodromic direction by stimulating the CA3 Schaffer-
collaterals or in an antidromic direction by stimulating the CA1 axons in the alveus 
(Anderson et al., 1971b).  
 
1.7.1 - Formation of evoked potentials 
1.7.1.1 - Field epsps 
Field epsps are generated by the action of glutamate upon the post-synaptic ionotropic 
receptors. AMPA and kainate receptors are faster to activate and open and thus allow the 
initial influx of sodium ions into the post-synaptic neurons. The slower-activating NMDA 
receptors do not allow any ion influx until the membrane potential has been sufficiently 
depolarized by ion flux through the AMPA and kainate receptors to relieve the voltage-
dependent magnesium block. The AMPA receptors are quick to depolarize so that the 
NMDA receptors are active for much longer. The epsp parameters that are usually 
quantified for analysis are the negative going slope of the waveform and its amplitude. The 
gradient of the slope can serve as an indicator of the strength of the synapse given that it 
represents the rate at which AMPA receptors are opening in response to glutamate to 
produce voltage changes. The amplitude represents the overall change in voltage change in 
the post-synaptic membrane which is indicative of the activity of AMPA and NMDA 
receptors. The recording of epsps can therefore be a useful indicator of events at the 
synapse. 
  
 
 
 
 
 
Figure 1 Diagram of the rat hippocampal slice and electrode positions. Shown 
above are the placements for stimulating and recording electrodes upon the preparation to 
obtain different evoked responses. Examples of the extracellular responses generated by 
the setup are shown (ent. = entorhinal cortex, sc.= Schaffer-collateral, mf.= mossy fibre, 
sep.= septum, comm = commissural). 
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1.7.1.2 - Population spikes 
The population spikes which can be recorded from the CA1 cell bodies represent the sum 
of action potentials which propagate into the soma after the threshold for action potential 
firing has been reached at the axon hillocks. They can be generated by orthodromic current 
stimulation of the pre-synaptic Schaffer-collateral fibres and are thus generated by synaptic 
transmission and subsequent epsp formation. The field epsps in turn alter the membrane 
potential which, if sufficiently depolarized, allows the threshold for action potential firing 
to be reached at the axon hillock. Alternatively, population spikes can be generated by 
antidromic current stimulation of the CA1 axons located within the alveus (Anderson et al., 
1971b). This allows for the study of population spike generation which is independent of 
synaptic transmission. 
 
1.7.2 - Synaptic plasticity 
 
Synaptic plasticity refers to the changes in synaptic strength between neurons which may 
occur as part of the formation of memory in vivo or in response to a chemical or electrical 
stimulus which alters the properties of synaptic transmission in vitro. As changes in 
synaptic plasticity are thought to underly the processes of memory and learning, the 
properties of these phenomena have been extensively examined within the hippocampus. 
The most widely studied forms of synaptic plasticity are long-term potentiation (LTP) and 
long-term depression (LTD). 
1.7.2.1 - LTP 
LTP describes the phenomenon where electrophysiological responses generated from 
neurons shows a marked increase in size following a brief tetanic stimulation. It was first 
discovered by Bliss & Lømo (1973) when the authors stimulated the perforant pathways in 
anesthetized rabbits and recorded the responses from the dentate gyrus granule cells. They 
noted that epsps and population spikes were both elevated following a 100Hz stimulus. 
These results were extended by Schwartzkroin & Wester (1975) to show that a similar 
effect could be obtained from the CA1 neurons of guinea pig hippocampal slices by 
stimulation of the Shaffer-collaterals. The potentiation of responses appears to be due to an 
increase in synaptic strength resulting from increased NMDA receptor stimulation 
(Collingridge et al., 1983) and a potentiation of the epsp-spike relationship where 
population spikes are disproportionately elevated compared to a more modest potentiation 
in epsps (Andersen et al., 1980). 47 
 
1.7.2.1.1 - Synaptic potentiation 
The induction of LTP requires NMDA receptor stimulation. At low frequency stimulation, 
the NMDA receptors retain their voltage-gated magnesium block so that the post-synaptic 
response remains the same for a given electrical pulse. When the synapse is tetanised by 
high frequency stimulation, the post-synaptic neurons become more depolarized to the 
extent that the magnesium blockade is relieved for longer and the NMDA receptors remain 
in the active open state. This results in a greater calcium influx which is required to induce 
LTP (Lynch et al., 1983). The greater depolarization of the post-synaptic neurons is 
observed as a potentiation in the slope and amplitude of the field epsp (Bliss & 
Collingridge, 1993). 
1.7.2.1.2 - E-S potentiation 
E-S potentiation was observed by Bliss & Lømo (1973) when the increase in the 
population spike amplitude in response to tetanisation could not be accounted for by the 
increase in field epsp slope. This was demonstrated further in hippocampal slices by 
Andersen et al. (1980) by showing the changes in the input-output curves for epsp slope 
and population spike amplitude. In dentate granule cells, E-S potentiation has been 
attributed partially to a decrease in GABAergic feedforward inhibition upon dentate 
granule cells (Tomasulo et al., 1991). 
1.7.2.2 - LTD 
LTD describes the effect whereby an evoked potential decreases in size in response to a 
stimulus. The effect was first observed in the hippocampal slice when tetanising one 
pathway to induce LTP also resulted in depressing the response from a non-tetanised 
pathway. This was termed heterosynaptic depression (Lynch et al., 1977). It was 
subsequently shown that homosynaptic depression could be induced by evoking epsps 
from the CA1 neurons with a stimulation protocol of 1-3Hz frequency for 900 pulses 
(Dudek & Bear, 1992).  It has been found that NMDA receptor stimulation is required to 
induce LTD along with a post-synaptic change in calcium (Mulkey & Malenka, 1992). 
LTD may be reversed by applying high frequency stimulation to the pathway (Dudek & 
Bear, 1992; Dudek & Bear, 1993). 48 
 
 
1.7.3 - Using hippocampal slices to study preconditioning 
The hippocampal slice system may provide useful data regarding the effects of 
preconditioning. The CA1 neurons are highly sensitive to ischaemia and are therefore 
useful for studying ischaemia-like changes and the effectiveness of neuroprotective 
strategies. As the slice system retains the lamellar morphology as it exists in vivo to some 
degree, it is possible to evoke electrical responses to assess the function of the tissue. In 
addition to the assessment of electrophysiological changes, it is also possible to examine 
potential molecular changes which may occur as a result of electrophysiological and 
chemical experimental protocol. As the preconditioning phenomenon has been clearly 
demonstrated in hippocampal slices using electrophysiology, it is a suitable choice for 
pursuing further information on the mechanisms and interactions which may occur during 
rapid preconditioning. 
 
1.8 - Aims of the project 
The primary aim of the project was to investigate preconditioning interactions within the 
hippocampal slice preparation. In particular these included: 
•  Investigating the effects of exogenous glutamate and other depolarizing agents in 
the slice preparation and their validity for use as toxic agents  
•  Examining any potential preconditioning neuroprotection induced by adenosine 
against various depolarizing agents (glutamate, NMDA, ouabain) and elucidate the 
underlying mechanisms where relevant 
•  Examining the excitotoxic preconditioning phenomenon and possible underlying 
mechanisms 
•  Looking at the effectiveness of other known preconditioning agents (ATP-sensitive 
K+ channel openers) against depolarizing agents and identify the underlying 
mechanisms of protection 
•  Identifying any molecular changes that may occur during acute models of chemical 
ischemia or acute preconditioning 
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2 - METHODS 
2.1 - Electrophysiology 
2.1.1 - Preparation of rat hippocampal slices 
Adult male Wistar rats (100-200g) between 4 and 6 weeks old were used for hippocampal 
slice preparations. Rats were injected i.p. (1ml/100g) with a solution of 25% urethane in 
distilled water. Once sufficiently anaesthetised, indicated by the loss of limb and corneal 
reflexes, the rat was then killed by cervical dislocation. The brain was removed quickly 
and placed in ice-cold oxygenated artificial cerebrospinal fluid (aCSF) with the following 
composition (mM): KH2PO4 (2.2); KCl (2.0); NaHCO3 (25); NaCl (115); CaCl2 (2.5); 
MgSO4 (1.2); glucose 10; distilled water. Both hippocampi were dissected from the 
hemispheres, placed on a McIlwain tissue chopper and sliced transversely to a thickness of 
450µM. The slices were then immersed in cold aCSF and separated out in a petri dish. The 
aCSF was then removed until the slices were still sufficiently immersed whilst allowing 
sufficient oxygen diffusion across the aCSF to reach the tissue. The slices were then placed 
in a closed incubation chamber continuously gassed with 95% O2/5% CO2. 
 
2.1.2 - Extracellular recording 
Slices were allowed to incubate for at least 1 hour at room temperature before recording. 
Slices were placed in a recording chamber that was continuously perfused with oxygenated 
(95% O2/5% CO2) aCSF at a rate of 3-4ml/min. The slices were held in place within the 
perfused chamber by placing them on a wire mesh within the chamber and placing small 
silver bars on top of the slice to hold it in place against the mesh. The temperature was 
maintained between 28 and 30
0C. A concentric, bipolar stimulating electrode was placed 
using micromanipulators under manual control on the stratum radiatum in the CA2 area for 
orthodromically evoked responses and on the CA1 axons in the stratum oriens for 
antidromically evoked population spikes. Using a NeuroLog period generator (NL303) and 
delay-width (NL403), the slice was stimulated via a NeuroLog stimulus isolator (NL800) 
through the bipolar electrode with 330µs square wave pulses at a frequency of 0.1Hz.  
Recording electrodes were made from borosilicate glass capillaries in a Kopf vertical 
pipette puller. The capillaries were pulled to a fine tip of 1µm. The tip was broken under 
microscopic control to a diameter of approximately 2µm and the micropipette was then 
filled with 0.9% NaCl solution with a fine 36 gauge needle. The micropipette was then set 50 
 
up near the recording chamber for manual manipulation. A Ag/AgCl wire electrode was 
inserted within the open end of the micropipette. This electrode was connected to the 
NeuroLog pre-amplifier (NL104) via a headstage. To record a population spike, the 
recording electrode was placed in the CA1 pyramidal cell layer; for a field excitatory post-
synaptic potential (epsp), the electrode was placed in the stratum radiatum to record the 
apical dendrites of the CA1 pyramidal neurons just above the stratum lacunosum. The 
evoked response was amplified using the NeuroLog pre-amplifier (NL104) and amplifier 
(NL106) and filtered before being captured via the Cambridge Electronic Design 
microplus1401 interface onto the computer-based Signal software. The waveform was 
captured with a sampling frequency of 10000Hz. The population spike was quantified as 
the difference between the negative and positive peak potentials. The fepsp negative slope 
was quantified as the gradient of the line of best fit of all the sampled points taken from 
between two points determined approximately from after the first quarter and before the 
last quarter of where the slope formed. The fepsp amplitude was quantified as the 
difference between the negative peak and the returning baseline. The stimulus amplitude 
was adjusted by the NeuroLog pulse buffer (NL510) to evoke the maximum response from 
the slice. In all experiments, a 10min stable baseline of the measured parameter 
(population spike amplitude; epsp slope; epsp amplitude) was evoked prior to perfusion of 
any drugs. 
As some compounds such as glutamate, NMDA and ouabain, once applied, were shown in 
initial experiments to induce changes in the maximal response from the slice which lasted 
beyond one hour, it was determined that at least two slices should be taken from one rat 
each day to compare the drug treatments on the responses (e.g. slice 1: preconditioning + 
glutamate; slice 2: glutamate alone). Responses were obtained from the slices at the same 
time in two different rigs to take account of any time-dependent degradation in the tissue; 
this was to ensure that results indicating any differences between treatments were not due 
to a difference in sensitivity or vulnerability of the slice.  
Recovery was taken as the mean of the recorded values between 50 and 60 minutes after 
application of glutamate, NMDA or ouabain for each experiment except where stated 
otherwise. Percentage values in the text are derived from a 10min stable baseline of the 
response which is taken as 100%. Time course graphs show the average of the normalized 
data of several experiments except where a sample time course graph of one experiment is 
shown. The data from experiments were normalised using the GraphPad Prism software. 
Tests for linear regression were performed in GraphPad Prism. Where a linear regression 
test resulted in p<0.05, a residual plot showing the deviation of the y values from their 51 
 
predicted value is shown also.  With the exception of ANCOVA, GraphPad Instat software 
was used for all other statistical analysis. ANCOVA was performed to assess the difference 
between drug treatments when the size of the response parameter was shown to be a 
continuous variable affecting the outcome and when all assumptions were met. ANCOVA 
was performed using the NCSS 97 statistical software. Students t test was used for 
comparison between 2 groups except where otherwise stated. ANOVA was used for 
comparisons between multiple groups. Post-tests used are indicated where relevant. All 
data are presented as mean ± standard error. 
Drugs and chemicals were obtained from the Sigma Chemical Company and Tocris Ltd. 
 
2.2 - Molecular methods 
2.2.1 - Protein extraction and Bradford assay 
Following electrophysiological experiments, pre-selected slices were placed in an 
eppendorf tube which was placed in dry ice and kept at -80 degrees Celsius until further 
use. The protein was extracted from the slices in preparation for Western blotting. 150µl 
RIPA buffer (composition: 50mM Tris; 150mM NaCl; 1% Igepoal; 0.5% Tritonx100; 
0.1% sodium dodecyl sulphate [SDS]; complete Mini EDTA-free protease inhibitor 
cocktail tablet {composition: aprotinin; bestatin; calpain inhibitor I; calpain inhibitor II; 
chymostatin; E-64; leupeptin; α2-macroglobulin; petabloc SC; pepstatin; PMSF; TLCK-
HCL; trypsin inhibitor (chicken, egg white); trypsin inhibitor (soybean)}) was added to the 
tissue in the eppendorf tubes and the mixture was ground down with a pestle. The tubes 
were then placed in a centrifuge and spun at 13,000 rpm at 4 degrees Celsius for 5min. 
Afterwards, the tubes were carefully removed from the centrifuge so as to not disturb the 
pellet and the supernatant containing the protein was pipetted out into a new eppendorf 
tube. The tissue and protein solutions were kept on ice as much as possible during this 
procedure to minimise degradation of the samples.  
The protein concentration was measured for each sample using a Bradford assay. To do 
this, standard concentrations of Bovine Serum Albumin were prepared in eppendorf tubes 
at 0, 0.25, 0.5, 1.0, 1.5 and 2.0mg/ml. For the samples, 4µl of protein sample solution was 
added to 396µl of distilled water. Biorad reageant was diluted with distilled water in a 1:1 
ratio and 200µl was added to each tube (standard and protein sample solutions) and mixed 
thoroughly. 200µl of each solution was then pipetted into a 96 well plate which was then 
read using fluorometry at 595nm on a plate reader. Once the protein concentration in each 52 
 
sample was known, all the samples were normalised to the lowest concentrated sample by 
adding the appropriate amount of RIPA buffer unless the lowest was below 20mg/ml 
concentration (the minimum concentration recommended by NuPage for use in the mini-
gel).  
 
2.2.2 - Western blotting 
After normalisation, 65µl of each sample was prepared for Western blotting by addition to 
25µl of 4 x sample buffer and 10µl of 10 x reducing agent in eppendorf tubes. The solution 
was mixed thoroughly and heated to 70 degrees Celsius for 10min immediately before 
loading onto a NuPage 4-12% Bis-tris gel. The gel cassette was cut out of the pack and 
rinsed with distilled water. The comb was removed from the loading wells and and the 
wells were then rinsed with NuPage MOPS running buffer mixture with distilled water 
(buffer 50ml; distilled water 950ml). On the third rinse, the buffer was left in the wells to 
prevent bubble formation. The gel cassette was set up in the gel tank for electrophoresis. 
0.5ml of NuPage antioxidant was added to 200ml of the MOPS running buffer. This was 
then mixed and added to the central reservoir in the tank. The rest of the buffer was added 
to the rest of the tank to keep the gel cool while it was running. 10µl of Amersham Full-
Range Rainbow Molecular Weight Marker (RPN800V) and 20µl of each heated protein 
sample were each loaded onto a well. Once loading was complete, gel electrophoresis was 
run for 45min at 200V. During this time the solutions and equipment for the protein 
transfer from gel to the Invitrogen PVDF membrane were prepared. 50ml of NuPage 
transfer buffer was added to 100ml of methanol, 850ml of distilled water and 1ml 
antioxidant. 200ml of this solution was held back for use in the central reservoir in the gel 
tank. The rest was used to soak equipment, filter papers, the PVDF membrane and sponges 
ensuring particularly that the sponges were fully saturated with the solution. Prior to 
soaking in the transfer buffer mixture, the hydrophobic PVDF membrane (Invitrogen) was 
soaked for 1min in methanol to enable it to soak in the transfer buffer mixture. At the end 
of the electrophoresis, the gel cassette was removed from the tank and rinsed in distilled 
water. The gel cassette was cracked open around the rim with a blade and the top was 
removed carefully so as not to break up the gel. The equipment for protein transfer was 
then set up. 3 soaked sponges were placed in a cassette; on top of these was placed a piece 
of soaked filter paper and then the soaked PVDF membrane. The gel was then released 
from the rest of the cassette onto the PVDF membrane. Another soaked piece of filter 
paper was placed on top of the gel. A small roller was used to flatten the stack of sponges, 
filter paper, gel and membrane in order to remove any remaining bubbles. Another 3 53 
 
soaked sponges were then placed on top of the stack followed by the cassette cover. This 
arrangement was carefully placed in the gel tank and secured. The clean transfer buffer 
was added to the reservoir inside the cassette whilst the rest that was used to soak the 
equipment, sponges, filter paper and membranes was poured into the rest of the gel tank. 
Current was applied across the gel and membrane to enable transfer of proteins; this was 
run for 1 hour at 30V. 
At the end of the protein transfer, the PVDF membrane was removed and immersed in 
Ponceau staining solution for 5min to check if the transfer had worked. This was then 
rinsed with distilled water and the membrane was checked for protein bands. A digital 
photographic record was kept of the Ponceau staining to also show the variation in loading 
of the samples. The membrane was then rapidly immersed in 0.1M NaOH solution for 10-
30sec until the bands disappeared. The membrane was then thoroughly rinsed with distilled 
water. 
Prior to blocking, the membrane was cut to separate the protein of interest (HSP72) and the 
housekeeping protein (actin). This was possible as the two proteins were separated by a 
distance of more than 2 bands of the rainbow marker. The membranes were then each 
immersed in 10ml of blocking solution composed of 0.3g dried milk powder and 10ml 
Tween Tris-buffered saline (0.05% Tween; Tris base 20mM; NaCl 137mM adjusted to pH 
7.6 with HCl) (TTBS) in a petri dish and agitated on a shaker for 2.5hours. Following 
blocking, the membranes were then each placed in 10ml TTBS  in 1% milk with a 1:2000 
dilution of the primary antibody (mouse anti-HSP72 monoclonal antibody, product no 
SPA-810 from StressGen) for the membrane containing HSP72 and a 1:200 dilution of the 
primary antibody (goat anti-actin polyclonal antibody, product no SC1615 from Santa-
Cruz) for the membrane containing actin. This was agitated on a shaker overnight at 4 
degrees Celsius. Following binding of the primary antibody, the membranes were given 3 
separate 10min washes in TTBS on a shaker.  
 After rinsing with TTBS, the membranes were incubated for 1hour on a shaker with the 
secondary antibody for the anti-HSP72 antibody (peroxidise-conjugated AffiniPure goat 
anti-mouse IgG from Jackson ImmunoResearch Laboratories, code 115-035-168) at a 
dilution of 1:2000 in 1% milk TTBS and the secondary antibody for the anti-actin antibody 
(donkey anti-goat IgG horse radish peroxidase, product no SC2020 from Santa Cruz) at a 
dilution of 1:10000 in 5% milk TTBS. Following secondary antibody binding, the 
membranes were again given 3 separate 10min washes with TTBS. They were then rinsed 
with distilled water. The membranes were agitated on the shaker with the developing 
solution from the Amersham enhanced chemiluminescence (ECL) kit. Following agitation, 54 
 
the excess solution was blotted off of the membranes with filter paper then placed in the 
developing cassette. The cassette was taken to a dark room where the developing film was 
then placed into the cassette for an initial exposure time of 30sec under the safelight. This 
film was developed and based on the outcome, further exposure times were gauged to 
produce a suitable film for analysis. 
The Western blot was analysed for optical density and size of blot using the NIH Image 
software.  The measurements for area and optical density were captured 3 times as well as 
3 background measurements of optical density for each band. The corresponding actin 
band for each HSP72 band was taken as 100% to provide a measurement of HSP72 levels 
for each sample. The values for HSP72 were used for statistical analysis. One way 
ANOVA or unpaired t tests were performed to test for differences in HSP72 expression 
between different groups of slices.  
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3 –STUDIES REGARDING THE EFFECTS OF GLUTAMATE 
UPON EVOKED RESPONSES AND THEIR MODULATION 
BY PURINE ANTAGONISTS 
 
3.1 – Introduction 
As exogenous glutamate has been identified as a chemical mediator of preconditioning, it 
was of interest to develop a protocol in which glutamate preconditioning could be readily 
induced during the acute time window of protection. This would enable further study into 
the mechanisms and interactions with other known mediators of preconditioning e.g. 
adenosine. To study this in hippocampal slices, exogenous glutamate was included in the 
perfusion medium and the effects upon the evoked responses were examined. As the 
results below show, glutamate induced a diverse range of effects upon different responses 
and potential roles for adenosine receptors in mediating or modulating these effects were 
observed. 
 
3.2 – Results 
3.2.1 - The effects of glutamate on evoked responses 
In order to examine the effect of glutamate as a preconditioning or excitotoxic stimulus, 
various exposure times and concentrations of glutamate were tested on the slices and the 
resulting changes in orthodromic population spikes were examined. It was determined that 
a 10min exposure to 5mM or 10mM glutamate resulted in a depolarization leading to a 
complete loss of response lasting between 10 and 30min following glutamate perfusion 
(Fig 3.1a). The response would then return until it reached a stable plateau which was 
lower than the initial spike size prior to glutamate treatment (Fig 3.1a & b). This effect was 
concentration dependent with 10mM glutamate producing a more pronounced depression 
in response size than 5mM. It was also noted that the extent of post-glutamate depression 
in spike size was to some degree dependent on the initial orthodromic spike amplitude with 
smaller spikes producing a greater % depression (Fig 3.2). For further experiments, the 
average size of population spike amplitudes between treatment groups were compared 
statistically to ensure that the outcomes were not influenced by this covariate.  56 
 
A preconditioning paradigm was developed using repeated 5min exposures of 5mM 
glutamate on orthodromic population spikes (Fig 3.3). A 5min exposure allowed a 
complete recovery of the response before further glutamate treatment. There was no 
significant difference in the rate of depolarization, the maximal response to glutamate or ∆t 
as indicated in Figure 3.3. It was noted however, that by the third treatment the rate of 
recovery of the response following glutamate perfusion was significantly faster than after 
the first treatment and remained so for the fourth treatment (Fig 3.4). The rate of recovery 
was taken as the gradient of the line of best fit; the median value between the maximum 
amplitude depression and the following recovery and the five values above and below the 
median were used to calculate the equation of the line. It was therefore determined that 
5mM glutamate was an adequate concentration for examining excitotoxic preconditioning 
interactions. 
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Figure 3.1a Time course graph showing the effect of glutamate on the 
amplitude of orthodromic population spikes. A sample response in the time course 
changes are shown for each concentration of glutamate. The arrows (a and b) indicate the 
time points at which the sample waveforms shown in Figure 3.1b are taken. 
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Figure 3.1b Sample traces of orthodromic population spikes taken from the 
time points as indicated in figure 3.1a.  
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Figure 3.2 Scatterplot showing the relationship between orthodromic spike 
size and the % recovery of the response following treatment with 5mM and 
10mM glutamate. Recovery of response is taken as the average % spike size of a stable 
10min plateau recovery following glutamate treatment in a). There is a significant 
difference in recovery between 5mM (74.3 ± 4.2, n = 16) and 10mM (23.2 ± 3.9, n = 18) 
(p<0.0001, ANCOVA) glutamate concentrations. b) shows the residual plots obtained from 
the regression analy. Note there is a random scatter in both residual plots. 
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Figure 3.3 Repeated glutamate application increases the rate of 
repolarization of the response. The graph shows the time course of changes in 
orthodromic spike amplitude. The lines show when 5mM glutamate was perfused onto the 
slices. ∆t is the time taken to return to 50% of the baseline after glutamate application. 
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Figure 3.4 Histogram outlining the changes in the rate of repolarization of 
the response following glutamate after each application as shown in Figure 
3.3.  (ns = not significant *p<0.05 Dunnett multiple comparisons test). 
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3.2.2 - Adenosine antagonists modify recovery from glutamate 
Since adenosine is known to be present in the extracellular space of tissue slices and its 
release can be increased by the activation of glutamate receptors (Manzoni et al., 1994; 
Hoehn & White, 1990), the effects of adenosine receptor-selective antagonists were 
examined on responses to glutamate. The A1 receptor antagonist DPCPX, at a 
concentration of 30nM, was perfused for 10min prior to and during the application of 5mM 
glutamate. The blockade of A1 receptors did not produce any change in the maximal 
amplitude of the response to glutamate, but it did result in an improvement in recovery of 
the population spike amplitude compared with controls, with a larger potential size 
recorded at the recovery plateau (p<0.01; Fig. 3.5a & b).  
A similar protocol was adopted using the A2a receptor selective antagonist ZM241385 
(50nM) which also produced a significant improvement in recovery of the population spike 
amplitude after glutamate application (p<0.01; Fig.3.5a & b). 
Since the effects of DPCPX and ZM241385 were so similar, and it has been reported that 
the latter compound can block A1 receptors in the hippocampus (Lopes et al., 1999), we 
tested this possibility by examining the effects of the antagonists on the depression of 
population spikes induced by adenosine. Adenosine was initially perfused alone for 10min 
at a concentration of 10μM, after which a recovery period of 30 min was allowed before 
DPCPX (30nM) or ZM241385 (50nM) was perfused for 10min prior to and then during the 
application of  a further pulse of 10μM adenosine for 10min. Both DPCPX and ZM241385 
blocked completely the inhibitory response of adenosine, strongly supporting the 
suggestion that ZM241385 has an antagonist action at A1 receptors (p<0.05 paired t test; 
Fig. 3.6). To examine any potential role of A2a receptors, we therefore used another A2a 
receptor antagonist, SCH 58261 (1µM) which has no reported specificity for A1 receptors 
in the hippocampus. Use of this antagonist resulted again in a significantly greater recovery 
of spike amplitude following 5mM glutamate compared with controls (Fig 3.7a & b). This 
result was even more marked by the fact that perfusion of SCH 58261 alone resulted in a 
significant depression of the response to 85 ± 2.2% (n = 5) (p<0.005 one sample t test) (Fig 
3.7a & b) suggesting that A2a receptors are indeed a component of post-glutamate 
recovery of spike amplitude.  
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Figure 3.5a The effects of adenosine antagonists on the recovery of post-
glutamate responses. Blockade of adenosine receptors with 30nM DPCPX (n = 11) or 
50nM ZM 241385 (n = 9) significantly increases spike amplitude following 5mM 
glutamate perfusion compared with 5mM glutamate controls without antagonist (n = 9) 
(DPCPX, 95.0 ± 5.4%; ZM 241385, 96.0 ± 7.4%; glutamate control, 64.5 ± 3.1%) (p<0.01 
Bonferroni multiple comparisons test). Perfusion with 0.05% DMSO vehicle alone showed 
no significant difference compared to glutamate controls (76.0 ± 8.9%, n = 5). Note that 
the spike amplitude significantly decreases in the presence of 50nM ZM 241385 prior to 
glutamate perfusion (85.6 ± 7.2%) (p<0.05, Wilcoxon rank sum test). The arrows (a, b and 
c) indicate the time points from which the sample waveforms in Figure 3.5b are taken. 
0
50
100
150
ZM 241385 (0.05% DMSO) + glutamate
DPCPX (0.05% DMSO) + glutamate
0.05% DMSO vehicle + glutamate
glutamate
5mM glutamate
antagonist
time (min)64 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5b Sample traces taken from time points as indicated in 3.5a. 
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Figure 3.6 50nM ZM241385 antagonises the inhibitory response of 10µM 
adenosine. a) 10µM adenosine caused a 43.6 ± 4.7% depression in orthodromic spike 
amplitude compared to adenosine perfusion with 50nM ZM241385 which resulted in an 
18.0 ± 6.9% depression (p < 0.05, n = 4). b) 10µM adenosine induced a 47.1 ±  19.1% 
depression in spike size compared to 3.8 ± 10% with adenosine perfusion with 30nM 
DPCPX (p<0.05, n =5).  Depression is taken as the mean value of the 2min period 
preceding adenosine removal from the perfusion medium. 
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Figure 3.7a The effect of SCH58261 upon the post-glutamate recovery of the 
orthodromic population spike amplitude. 1µM SCH58261 is perfused prior to, 
during and following 5mM glutamate perfusion (n = 9) or for the same period without 
glutamate (n = 5). Controls have only glutamate applied (n = 7). There is a significant 
difference in the recovery of spike amplitude following glutamate with and without SCH 
58261 (SCH 58261 + glutamate: 101.7 ± 8.5%; glutamate: 71.7 ± 9.3%) (p<0.05). Note 
that perfusion of SCH 58261 alone resulted in a significant depression of the spike 
amplitude between 90 and 100min (p<0.005 one sample t test). The arrows (a, b and c) 
indicate the time points from which the sample waveforms shown in Figure 3.7b are taken. 
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Figure 3.7b Sample traces taken from time points as indicated in Figure 3.7a. 
 
 
 
 
67 
 68 
 
 
 
3.2.3 - ATP-sensitive potassium channels mediate the effect of SCH 58261 on 
the response to glutamate 
The possibility that disinhibition of A1 receptors by an A2a receptor antagonist might 
result in opening of ATP-sensitive potassium channels and in turn modify the response of 
orthodromic spikes to glutamate was considered. We repeated the experiment with SCH 
58261 described above in the presence of glibenclamide, an ATP-sensitive potassium 
channel blocker. Glibenclamide suppressed the effect of SCH 58261 on glutamate induced 
depression (Fig 3.8a & b) suggesting that this effect was mediated by stimulation of ATP-
sensitive potassium channels. 
 
3.2.4 - Adenosine A1 receptor blockade does not modify the response to 
NMDA 
Having determined that A2a receptor blockade modifies the responses to glutamate and 
that this is likely due to disinhibition of A1 receptors, the mechanism by which A1 receptor 
blockade induces a similar effect was still unclear. As A1 receptors are known to interact 
with NMDA receptors (de Mendonça & Ribeiro, 1993; de Mendonça et al., 1995; Canhao  
et al., 1994), DPCPX (30nM) was perfused 10min prior to and during applications of 
NMDA (25μM) for 5min (Fig 3.9a & b). The recovery of potential size was measured as 
the average of the evoked responses from 50 to 60min after the removal of NMDA, but 
there was no significant difference observed between responses to NMDA with or without 
the perfusion of DPCPX (control recovery 12.2 ± 7.2%, treated recovery 13.2 ± 10.6%). It 
was interesting to note, however, that the resulting recovery of response to NMDA showed 
a significant linear relationship with spike size (Fig 3.10), suggesting that levels of NMDA 
receptor stimulation are a factor in determining the % recovery of the response following 
glutamate perfusion as well as NMDA perfusion. 
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Figure 3.8a Blockade of ATP-sensitive potassium channels attenuates the 
modulatory effect of SCH 58261 on glutamate-induced depression of 
orthodromic population spikes. 30µM glibenclamide is perfused prior to and during 
perfusion of 1µM SCH 58261. There was no significant difference in response to 
glutamate between slices treated with inhibitors (n = 5) and those with glutamate alone (n 
= 6) (p = 0.83). The arrows (a, b, c and d) indicate the time points from which the sample 
waveforms shown in Figure 3.8b are taken. 
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Figure 3.8b Sample traces taken from the time points as indicated in 3.8a. 
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Figure 3.9 The adenosine A1 receptor antagonist DPCPX does not attenuate 
the reduced recovery of orthodromic population spikes following 
depolarization of the response with NMDA. a) shows the time course of the entire 
experimental protocol and the changes in orthodromic spike size throughout (DPCPX + 
NMDA  n = 8,  NMDA  n = 5). b) shows extrapolated data from a) normalised 5min prior 
to perfusion of 25µM NMDA.          
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Figure 3.10 Scatterplot showing the inverse relationship between 
orthodromic spike size and % recovery of spike size following treatment with 
25µM NMDA for 5min. There is a significant linear relationship (r
2 = 0.69, p<0.0005). 
The lower scatterplot shows the residuals obtained from the regression analysis. 
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3.2.5 - Antidromic population spikes and epsps are unaffected in their 
response to glutamate by A1 receptor blockade 
The effect of DPCPX on glutamate was examined further using antidromic population 
spikes.  The antidromic responses depolarized partially in response to 5mM glutamate and 
recovered fully once glutamate was removed. 10mM glutamate induced a complete loss of 
antidromic spike amplitude which returned in a similar manner to that observed in 
orthodromic spikes. There was no correlation observed here between spike size and % 
recovery following glutamate. When DPCPX was perfused prior to and during 5mM 
glutamate, there was no observable difference in the observed changes in antidromic spike 
amplitude (Fig 3.11). It was therefore decided to examine possible changes in epsp slope 
size and amplitude. 5mM glutamate induced a complete depolarization of the response 
which lasted between 10 and 20min after glutamate was removed (Fig 3.12). The epsp then 
recovered but unlike orthodromic spikes, it did not always show a reduced response size 
compared with pre-glutamate treatment. In some cases, the slope and amplitude of the epsp 
exceeded that prior to glutamate treatment. A scatterplot of epsp slope or amplitude and % 
recovery of either parameter showed a trend whereby smaller epsps generally recovered to 
a greater extent than larger epsps although a statistical correlation for this effect could not 
be found (Fig 3.13). When glutamate was perfused in the presence of DPCPX, there was 
no significant difference in either epsp slope or amplitude detected between glutamate only 
treated responses and glutamate + DPCPX (Fig 3.12). The scatterplots of epsp slope or 
amplitude versus % recovery of either parameter show that treatment groups were within 
the same response size range and t-tests showed no significant difference (Fig 3.13) 
(GLUTAMATE: slope -0.56 ± 0.15 (mV/ms) amplitude 1.3 ± 1.0 (mV)(n = 12); DPCPX + 
GLUTAMATE: slope -0.92 ± 0.29 (mV/ms) amplitude 1.8 ±  0.5 (mV) (n = 8)). 
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Figure 3.11 DPCPX does not attenuate the effects of 5mM glutamate on 
antidromic population spikes. Antidromic population spikes show a recovery 
following glutamate-induced depolarization that does not differ significantly from the 
baseline (50-60min post-glutamate 90.3 ± 8.5%, n = 4). Co-perfusion with DPCPX does 
not alter the changes in spike size following treatment with glutamate (50-60min post-
glutamate 85.7 ± 7.5, n = 4). 
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Figure 3.12 DPCPX does not attenuate the effects of 5mM glutamate on field 
epsps. Graphs show the time course changes in a) epsp slope and b) amplitude for slices 
treated with glutamate alone (n = 12) or in combination with DPCPX (n = 8). 
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b) 
Figure 3.13 Scatterplots showing the size of epsp parameters against the % 
recovery of each parameter following treatment with glutamate alone or in the 
presence of DPCPX. a) shows the amplitudes and b) shows the slopes. 
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3.2.6 - The effects of NMDA receptor blockade on the response to glutamate 
in epsps 
Given that orthodromic population spikes appear to show a correlation between the 
outcome following NMDA treatment and the initial spike amplitude and that epsps show a 
similar trend with glutamate, the effects of NMDA receptor blockade during glutamate 
perfusion on epsps were examined. The use-dependent NMDA channel blocker, MK-801 
(10µM) was perfused prior to, during and after 5mM glutamate exposure (Fig 3.14). The 
ranges of response sizes versus the % recoveries following glutamate are shown in the 
scatterplots in Figure 3.15. It was noted that before glutamate perfusion, MK-801 induced 
either a potentiation or depression in epsp slope and amplitude so the baseline was taken as 
5min prior to glutamate perfusion. The majority of responses showed a depolarization 
upon glutamate perfusion which lasted for approximately 10min post-glutamate. For these 
responses, the post-glutamate recovery significantly exceeded the initial epsp slope size 
(137.3 ± 11.1%, p<0.01 one-sample t-test) and amplitude (143.7 ± 9.7%, p< 0.005 one-
sample t-test) and also the post-glutamate recoveries of control responses without MK-801 
co-perfusion (SLOPE: 88.2 ± 12.8%, p<0.05; AMPLITUDE: 85.1 ± 9.5%, p<0.0005). Two 
of the responses, however, showed a depolarization in response to glutamate followed by 
an immediate repolarization. This was transient as the response depolarized again in the 
continued presence of glutamate. The recoveries of these two responses were markedly 
depressed compared with glutamate treated controls. These responses also showed a 
marked depression in response size during MK-801 perfusion alone. When the effect of 
MK-801 on response size was correlated with the outcome following glutamate treatment, 
it was shown that the % MK-801-induced changes in epsp slope and amplitude were 
inversely related to the % recovery of epsp parameters post-glutamate (Fig 3.16). This 
suggested that the extent of NMDA receptor modulation determines the degree of recovery 
following glutamate. 
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Figure 3.14 Time course graphs showing the effect of glutamate on epsp a) 
slope and b) amplitude alone (n = 13) or in the presence of MK-801 (n = 12). 
Note that treatment with MK-801 + glutamate is split into two groups based on the 
response to the protocol (potentiation n = 10, depression n =2).  
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Figure 3.15 Scatterplots showing the size of epsp slopes or amplitudes 
against the % recovery of either parameter following treatment with 
glutamate alone or glutamate in combination with MK-801. a) shows the gradient 
of the slope versus the % recovery of the slope after glutamate application. b) shows the 
size of the epsp amplitude versus the % recovery of the amplitude. 
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Figure 3.16 The relationship between the effect of MK-801 on epsps and the 
resulting post-glutamate recovery. The scatterplots show the relationship between 
the effect of MK-801 on a) epsp slope and b) amplitude and the % recovery of each 
parameter following perfusion with glutamate. Note that there is a significant linear 
relationship between the effect of MK-801 on epsp amplitude and the % recovery 
following glutamate (r
2 = 0.44, p<0.05) and also a significant correlation between the 
effect on epsp slope and % recovery (Spearman r = -0.7343, p<0.01). c) shows the 
scatterplot of the residuals generated from linear regression analysis for b). 
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3.2.7 - The effects of adenosine A1 receptor blockade on NMDA receptor 
mediated epsps 
To investigate the implications of the above result on the interaction between A1 receptor 
blockade and the effects of glutamate, the DPCPX-glutamate protocol was repeated in 
epsps with the NMDA receptor mediated component isolated by perfusing the slice with 
DNQX and removing Mg2+ from the aCSF. DPCPX was perfused for 10min prior to 5mM 
glutamate as before (Fig 3.17). NMDA receptor mediated epsps exposed to glutamate 
alone showed a change in slope and amplitude similar to that observed in composite epsps. 
The same trend in post-glutamate % recovery compared with epsp slope or amplitude was 
present although again not significantly correlated (Fig 3.18). Recovery for each 
experiment was measured as the average of a 10min plateau recovery following glutamate 
perfusion as soon as such a recovery was obtained. Control responses were selected to 
match the range of response sizes in the DPCPX + glutamate treated slices (Fig 3.18). It 
was observed that DPCPX significantly attenuated the depression of NMDA receptor 
mediated epsp amplitude (Fig 3.19) by glutamate thus confirming that A1 receptor 
blockade modifies the response to glutamate by interaction with the NMDA receptor. 
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Figure 3.17 A1 receptor antagonist DPCPX attenuates the depression in 
NMDA receptor mediated epsp amplitude following depolarization of the 
response with glutamate. The graphs show the time course of changes in epsp 
amplitude for a single experiment for glutamate only and glutamate in combination with 
DPCPX. The sample traces shown below are taken from the time points as indicated by the 
letters in the time course graphs. Note that a shows a full epsp whilst b shows an NMDA-
receptor mediated epsp derived from that obtained in a.  
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Figure 3.18 Scatterplot showing the amplitude of NMDA receptor-mediated 
epsps versus the corresponding percentage recovery following perfusion of 
glutamate. Responses were treated with either glutamate alone or in combination with 
DPCPX as shown in Figure 3.17. The dashed lines enclose the range of values used for 
comparison between groups as shown in Figure 3.19. Epsps treated with glutamate only 
and with amplitudes below 0.8mV were excluded. 
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Figure 3.19 Histogram showing the difference in outcome between glutamate 
treatment alone (n = 7) and in combination with DPCPX (n = 6) on NMDA 
receptor-mediated epsp parameters. A1 receptor blockade significantly attenuates 
the depressed recovery in epsp amplitude following glutamate (p<0.05) but not in the epsp 
slope. Values for the statistical comparison are those indicated in the scatterplot in Figure 
3.18. 
 
 
84 
 85 
 
 
3.2.8 - Varying the stimulus intensity induces a potentiation of the post-5mM 
glutamate orthodromic spike 
In order to clarify the effects of 5mM glutamate upon the orthodromic population spike, it 
was decided to vary the stimulus intensity to produce half-maximal and 25% maximal 
baselines instead of evoking the maximal population spike. After establishing a stable 
baseline, it was observed that 5mM glutamate applied onto the slices for 10min abolished 
the response regardless of the stimulus intensity used. During the washout, the response 
recovered but in slices which used a half-maximal baseline, the recovery of the response 
was significantly greater than the initial baseline evoked prior to glutamate application (Fig 
3.20). It was also observed that the recovery of the responses evoked at the 25% maximal 
baseline was either increased (n = 3) or significantly decreased (n = 8) (p = 0.001, one 
sample t test) indicating that some kind of threshold existed using this stimulus intensity. 
To examine further the threshold phenomenon observed using a 25% maximal baseline, 
the same protocol was repeated for the 25% baseline applying 5mM glutamate and 
observing the outcome. The maximal response was evoked three times prior to the 
application of glutamate to ensure that the response was stable. At one hour post-
glutamate, a 100Hz/1sec stimulus was applied to the slice to see if the effects of glutamate 
were reversed (Fig 3.21). It was observed that the post-glutamate responses, regardless of 
whether they were higher or lower than the 25% maximally evoked baseline, produced a 
significant potentiation in response to the tetanising stimulus (Fig3.21a, b & c). This 
indicated that the effects of 5mM glutamate upon the orthodromic population spike were a 
form of long-term depression as characterised by its reversibility by a tetanising stimulus. 
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Figure 3.20 The effects of different stimulus strengths on the response to 
glutamate in orthodromic population spikes. The stimulus strength was adjusted to 
produce population spike amplitudes that were either approximately 50% or 25% of the 
maximum. At 50% of the maximal response, post-glutamate recovery was significantly 
greater than the spike amplitude 10min prior to 5mM glutamate perfusion (140.9 ± 16.3%, 
n = 8, p<0.05 one sample t test) unlike the effect of glutamate on the maximally evoked 
population spike (73.9 ± 7.4%, n = 4, p<0.05 one sample t test). At the 25% maximal 
baseline, post-glutamate recovery showed either an increase from the initial baseline or a 
depression. This could not be accounted for by differences in absolute maximal baseline 
(mV), the exact % baseline of the maximum or the absolute baseline when stimulated at 
25% of the maximum. 
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Figure 3.21a,b (c, overleaf). The effect of glutamate on synaptic plasticity in 
orthodromic population spikes. The time course graphs show the changes in 
orthodromic spike amplitude before during and after 5mM glutamate exposure and after 
receiving a 100Hz/1sec stimulus. The experiments were separated into two groups based 
on outcome following glutamate exposure: a) recovery above pre-glutamate baseline (n = 
3); b) recovery below pre-glutamate baseline (n = 4)). The responses showing a post-
glutamate recovery lower than the pre-glutamate baseline produced a significant LTP in 
response to 100Hz/1sec stimulation (p<0.05 one sample t test). Post-glutamate recoveries 
were not significantly elevated or depressed unlike the initial experiments above. 
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Figure 3.21c Time course graph showing pooled data from the experiments 
above. Overall a significant LTP is induced in response to 100Hz/1sec stimulation 
following glutamate exposure (239.2 ± 31.2%, n = 7, p<0.005 one sample t-test).  
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3.3 - Discussion 
 
3.3.1–The effects of exogenous glutamate upon evoked responses from the 
CA1 neurons 
 
3.3.1.1 – The use of exogenous glutamate as an excitotoxin in the hippocampus 
Many studies have attempted to induce excitotoxicity in the hippocampal slice preparation 
with the use of exogenously applied glutamate (Wallis et al., 1994; Alici et al., 1996; 
Virgili et al., 1997; Schurr et al., 2001; Larsen et al., 2006) or other excitotoxins (NMDA 
(Bandyopadhyay et al., 2002); kainic acid (Andrew & MacVicar, 1994; Andrew et al., 
1996), quinolinic acid (Stone, 1985), domoic acid (Polischuk & Andrew, 1996; Polischuk 
et al., 1998; Kerr et al., 1999)). In several cases, the changes that are produced in evoked 
field potentials from slice preparations have been used to quantify the degree of damage 
induced by application of such agents. The rationale for this can be derived from a prior 
study in vivo which showed that the extent of evoked field potential changes in the 
hippocampus induced by glutamate and metabolic inhibitors correlated with histologically 
assessed cell death four days later (Lees & Sandberg, 1991); thus evoked responses may 
serve as an indicator of tissue function in response to stressful stimuli. It was noted by Lees 
& Sandberg (1991), however, that the observed correlation disappeared when potential size 
was greatly decreased (70% depression or greater). At this level of depression, it is 
possible that changes in synaptic plasticity dictated the size of the potential rather than 
toxic effects. Response sizes below 70% may have indicated lower levels of transmission 
as opposed to reduced cell function; by reducing synaptic transmission excitotoxicity may 
have been reduced in the hippocampus to a certain extent. This observation was 
unexplained by Lees & Sandberg (1991) but it does indicate that limitations may exist by 
assessing tissue injury with the sole use of recorded field potentials. A more recent study 
has found a correlation between the degree of histologically assessed cell death induced by 
bilateral common carotid artery occlusion and the degree of depression in the input/output 
curve of field epsps in the CA1 area of the hippocampus measured at 2 days and 7 days 
post-ischaemia (Henrich-Noack et al., 2007). Both of these studies suggest that changes in 
measured field potentials are a reflection of cell damage that occurs in tissue in vivo. These 
in vivo studies back up many others conducted in vitro, including those examining 
preconditioning phenomena, which have made assumptions regarding the loss of evoked 
field potential in relation to toxicity rather than considering changes in transmitter release 
or synaptic plasticity.  90 
 
The difficulty in determining tissue toxicity in slice preparations arises from the acute 
nature of in vitro electrophysiological protocols whereby sufficient time to induce 
morphological or molecular indicators of cell death is restricted. Some studies have 
attempted to assess the toxic effects of glutamate in acute hippocampal slices. An early 
study by Vornov & Coyle (1991) assessed the rate of protein synthesis by autoradiography 
in hippocampal slices. They noted that, whilst NMDA and glutamate both inhibited protein 
synthesis, the effects of NMDA were prevented by MK-801 and ketamine whereas the 
toxic effect of glutamate was not inhibited by glutamate receptor antagonists for any given 
concentration, exposure duration or by the presence of magnesium in the medium. These 
results were confirmed and extended in later studies which indicated that 10mM glutamate 
exposure in hippocampal slices transiently decreased protein synthesis to 50% and ATP 
levels to 30% (Djuricic et al., 1994a). Unlike a 15min OGD exposure however, the effects 
of glutamate were reversed within two hours. The same group also showed that the 
presence of glutamate, quinolinic acid or kynurenic acid did not affect the changes in 
protein synthesis at 24hours following a 15min exposure to ischaemic conditions in acute 
slices (Djuricic et al., 1994b). These studies suggest that high glutamate concentrations 
may have an initial role in decreasing protein synthesis and energy metabolism which is 
receptor-independent. As the in vivo study by Lees & Sandberg (1991) suggests that cell 
death is induced a few days following glutamate exposure, exogenous glutamate may be 
considered a useful tool to inflict acute and delayed damage upon hippocampal tissue.  
As a starting point in the present study, exogenous glutamate was applied to hippocampal 
slices whilst evoking orthodromic population spikes. The results presented here with 
glutamate showed a complete depolarization of the evoked response that persisted for a 
while during the washout of glutamate; this was followed by a recovery of the response 
which showed inconsistencies between epsps, orthodromic population spikes and 
antidromic population spikes which are discussed below.  
 
3.3.1.2 -The effects of exogenous glutamate on orthodromic population spikes 
The initial experiments using orthodromic population spikes showed a complete loss of the 
response in the presence of glutamate; this may have occurred in a few ways. An 
overdepolarization of the neurons may have occurred via a massive influx of positive ions 
through the glutamate ionotropic receptors (Choi, 1987). Depolarization of the membrane 
potential would effectively prevent the formation of action potentials and thus the 
orthodromic population spike. It may also be possible that exposure of high levels of 91 
 
exogenous glutamate to the pre-synaptic neurons may have somehow decreased the release 
of excitatory transmitters. Alternatively, the exposure of the tissue to glutamate may have 
induced a release of inhibitory neurotransmitters which may have caused the orthodromic 
population spike to disappear. The recovery of the responses following glutamate removal 
could also have a few explanations. When the orthodromic population spikes started to 
reappear, they recovered to a stable plateau level which was significantly less than the 
spike amplitude measured prior to the application of glutamate. This reduced amplitude 
could be the result of a toxic effect, glutamate-mediated long-term depression or increased 
inhibitory neurotransmission.  
As previous studies have shown that short glutamate exposure preconditions against a 
more prolonged glutamate exposure (Schurr et al., 2001), the use of 5mM glutamate in 
preconditioning paradigms was determined by repeated exposures on the orthodromic 
population spike. It was observed that the rate of recovery following later exposures were 
higher than those previously seen. This established that some degree of preconditioning 
effects were present with this glutamate concentration and was therefore used initially to 
probe the mechanisms mediating the effect of exogenous glutamate on the evoked 
responses. 
 
3.3.1.3 - The effect of exogenous glutamate on antidromic population spikes 
The effects of glutamate were examined further in the hippocampal slice by observing the 
responses of antidromically evoked population spikes. It was observed that exposure to 
5mM glutamate caused a reduction in the amplitude of antidromic population spikes but 
unlike orthodromic population spikes, the response did not completely disappear. This was 
followed by a return of the spikes to baseline values during washout. 10mM glutamate 
reduced the spike amplitude until it disappeared and the post-glutamate recovery was 
significantly lower than pre-glutamate spike size. This indicated that the depressed post-
5mM glutamate recovery which occurs in orthodromic population spikes may reflect a 
change in synaptic transmission but glutamate at 5mM concentration only exerts a transient 
effect upon the formation of action potentials directly. 10mM glutamate appears to have 
longer lasting effects upon the cell body as the lack of an orthodromic current pulse did not 
prevent a long-lasting decrease in action potential formation as observed using antidromic 
spikes.  92 
 
Other studies have examined the pathophysiological effects of applying high 
concentrations of exogenous glutamate. The findings of Larsen et al. (2006) indicated that 
in isolated CA1 neurons, a 15min exposure of 1mM glutamate in the presence of 10µM 
glycine and magnesium free aCSF induced an elevation in intracellular calcium that did 
not return to baseline levels upon washout. In addition, observation of the mitochondrial 
membrane potential showed an increase of Rhodamine 123 fluorescence (indicating 
mitochondrial membrane depolarization) in 25% of tested neurons. Whilst the lower 
glutamate concentration used may not be as potent as that used in the hippocampal slices, 
the presence of glycine and absence of magnesium would enhance glutamate stimulation of 
NMDA receptors. Several other studies have shown that mitochondrial depolarization is a 
consequence of excitotoxicity (Budd & Nicholls, 1996; White & Reynolds, 1997; Ward et 
al., 2005) although few aside from Larsen et al., have examined this in acute preparations. 
It is possible that some cellular dysfunction may occur using 5mM glutamate 
concentrations as Virgili et al. (1997) have reported reduced rates of protein synthesis in 
rat hippocampal slices although any specific toxic effect is unclear from that study. Any 
resulting damage induced by such molecular changes may not necessarily be reflected by 
changes in the extracellular recordings of antidromic spikes. Whilst 5mM glutamate does 
not exert a long-lasting electrophysiological change upon antidromic population spikes, the 
reduced recovery in orthodromic responses might have reflected a degree of damage 
induced at the synapse as opposed to the cell body. To investigate this further, the effects 
of exogenous glutamate upon the orthodromically evoked field epsps were examined.  
 
3.3.1.4 - The effects of exogenous glutamate upon field epsps 
The effects of glutamate on field epsps showed inconsistencies with those observed in 
orthodromic spikes. Both 5 and 10mM concentrations of glutamate again induced a rapid 
reduction in the slope and size of the field epsps until the response disappeared. The post-
10mM glutamate recoveries were consistently lower than the initial baseline levels. 
Recovery following 5mM glutamate however showed predominantly a return to baseline 
levels in most responses with a few small epsps showing a recovery that was markedly 
higher than the initial baseline levels. As the orthodromic population spikes recovered to a 
lower level than initial baseline values following 5mM glutamate, the discrepancy in effect 
between field epsps and orthodromic population spikes might be indicative of a glutamate-
induced dissociation in the epsp-spike relationship. The small epsps which exhibited a 
recovery higher than the initial baseline may have been AMPA receptor-mediated, no 
NMDA receptor component existing on account of their size (Davies and Collingridge, 93 
 
1989). To examine the effect of the NMDA receptors upon the post-glutamate recovery of 
the field epsps, the slices were again exposed to glutamate in the presence of MK-801. By 
dividing the experiments into groups depending on the effect of NMDA receptor blockade 
in combination with glutamate exposure, it could be seen that either a potentiated or 
depressed post-glutamate recovery was induced compared with glutamate alone, although 
only two slices out of the twelve tested exhibited a depressed recovery which limited a 
statistical analysis; the results were used for correlation analysis later on (this is discussed 
further in section 4.5.3). The different effects of NMDA receptor blockade might be 
accounted for by variations in the numbers and/or subtypes of NMDA receptors at the 
recording site in each slice. Both factors are varied throughout the hippocampus (Martens 
et al., 1998; Pandis et al., 2006) and within the slice preparation (Dahl et al., 1990). These 
results suggest that NMDA receptors determine the post-glutamate outcome in field epsps 
and mainly prevent the occurrence of a glutamate-induced NMDA receptor-independent 
form of LTP. The two responses which showed the opposite effect may reflect a role for 
NMDA receptors in preventing a glutamate-induced NMDA receptor-independent form of 
LTD. Future experiments into this phenomenon may include quantifying and subtyping 
receptors from the slice preparation and epsp-spike coupling experiments to further 
understand these occurring differences in response to glutamate.  
 
3.3.2 - Interaction of adenosine antagonists with post-glutamate recovery: 
orthodromic population spikes 
3.3.2.1 - A1 receptor blockade and glutamate 
Having observed that 5mM glutamate reduced the size of the orthodromic population spike 
until it disappeared and that once glutamate was removed, a partial recovery of the 
response followed, further experiments were conducted to examine the possibility of these 
effects resulting from the release of inhibitory neurotransmitters. Adenosine was examined 
as it is known to be released at high concentrations during ischaemia (Latini et al., 1999b) 
and is a known preconditioning agent (Liu et al., 1991; Pérez-Pinzón et al., 1996). It was 
found that blockade of adenosine A1 receptors attenuated the depressed post-glutamate 
recovery. This indicated that endogenous adenosine may be released in the slice during 
glutamate perfusion which appears consistent with reported observations that NMDA 
exposure to neuronal tissues increases adenosine levels (Hoehn & White, 1990; Manzoni et 
al., 1994). As adenosine binding to A1 receptors will decrease in the presence of DPCPX, 
it is possible that any glutamate-induced increase in extracellular adenosine will increase 
adenosine binding to the A2a receptor population which in turn may induce a greater 94 
 
inhibition of A1 receptors (Cunha et al., 1994; O’Kane & Stone, 1999). A2a receptor 
agonists have been shown to induce protection in the hippocampus in rats against systemic 
administration of the excitoxin, kainate, (Jones et al., 1998) which seems consistent with 
the interaction observed between DPCPX and glutamate upon orthodromic spikes here. 
The possible role of A2a receptors was studied further by observing the effect of glutamate 
upon the orthodromic population spikes in the presence of an A2a receptor antagonist. 
 
3.3.2.2 - A2a receptor blockade and glutamate 
A similar protocol to the experiments examining A1 receptor blockade in the presence of 
glutamate upon orthodromic spikes was adopted with the A2a receptor antagonist, SCH 
58261, used in place of DPCPX before, during and after 5mM glutamate perfusion. As the 
mechanism underlying the enhanced post-glutamate recovery induced by DPCPX upon 
orthodromic population spikes was hypothesized to be partly due to an increase in A2a 
receptor stimulation by endogenous adenosine, it was surprising that a similar result was 
yielded when the experiment was repeated with A2a receptor blockade instead of A1. 
Also, SCH 58261 alone caused a significant depression of the orthodromic population 
spike: this may have been due to a suppression of any disinhibitory effect of A2a receptors 
upon A1 receptors (Cunha et al., 1994; O’Kane & Stone, 1999) resulting in increasing 
basal A1 receptor stimulation; it is also consistent with the enhancement of field epsps 
(Cunha et al., 1994) and population spikes (Sebastião & Ribeiro, 1992) in the hippocampus 
observed upon exposure to CGS21680, an A2a agonist.  
Regarding the effects of A2a receptor antagonism upon the post-glutamate recovery in 
orthodromic population spikes, it is conceivable that the effects of glutamate upon the 
orthodromic population spike may represent some form of long-term depression; it is 
therefore possible that the A2a receptor population acts to mediate such an effect. This is 
inconsistent, however, with the studies examining the effects of A2a receptor interactions 
with synaptic plasticity in hippocampal slice preparations. A2a receptor antagonists have 
been shown to have no effect upon the induction of LTP in population spikes although they 
can prevent the occurrence of LTP in epsps (Sekino et al., 1991; Fujii et al., 1992; 
Forghani & Krnjević, 1995; Fujii et al., 1999). A2a receptor antagonists also seem to 
prevent depotentiation from occurring in population spikes (Fujii et al., 1992; Fujii et al., 
1999) although the reasons for this are not understood. It is possible that the 5mM 
glutamate exposure in this system has a similar physiological mechanism to the 95 
 
depotentiation phenomenon which could explain why the presence of an A2a receptor 
antagonist affected the post-glutamate recovery. 
 It is possible that during glutamate perfusion, sufficient adenosine is released to stimulate 
A2b or A3 receptors, particularly if higher affinity receptors are blocked by SCH58261 or 
DPCPX. According to Latini et al. (1999), extracellular adenosine concentrations during 
ischaemia can reach as high as 23µM in hippocampal slices compared with 240nM under 
basal conditions. Whilst the exact concentration of adenosine has not been determined 
during glutamate perfusion in this study, it is possible that adenosine may be increased 
sufficiently to stimulate A2b or A3 receptors, both of which require an extracellular 
adenosine concentration over 1µM for binding to occur (Fredholm et al., 1994). As the A3 
receptor is known to desensitize the A1 receptor under ischaemic conditions (Dunwiddie et 
al., 1997), this might explain why A2a receptor blockade produces the same result as A1 
receptor blockade.  
It is also possible that the effect of SCH 58261 upon post-glutamate recovery is simply 
mediated by increasing A1 receptor stimulation through suppressing their disinhibition by 
A2a receptors. As the levels of adenosine were not measured during and after glutamate 
perfusion, it is possible that they do not change at all; if this were the case, the depression 
of the post-glutamate recovery is more likely related to glutamate receptor stimulation. 
This would also mean that A3 receptors are not stimulated as normal levels of adenosine 
are too low for binding to occur. As this was the simplest interpretation of the results, 
downstream mechanisms of A1 receptor stimulation were examined as potential mediators 
of the effects of A2a receptor antagonism upon glutamate-induced changes in orthodromic 
population spikes. 
 
3.3.3.3 - The role of ATP-sensitive potassium channels in the effect of A2a 
receptor blockade upon post-glutamate recovery 
To further investigate why A2a receptor antagonists were able to prevent the post-
glutamate induced depression in spike recovery, the possible role of ATP-sensitive 
potassium channels was considered as they are known to be activated by A1 receptor 
stimulation (Heurteaux et al., 1995; Reshef et al., 2000).  Using glibenclamide to block the 
ATP-sensitive potassium channels, it was observed that the post-glutamate recovery of 
orthodromic population spikes remained significantly depressed below initial baseline 
levels, despite the presence of SCH 58261. This was consistent with studies showing that 96 
 
stimulation of ATP-sensitive potassium channels protects against excitotoxicity (Nagy et 
al., 2004; Kis et al., 2004) although the mechanism for this is unclear. As ATP-sensitive 
potassium channels are most likely stimulated by A1 receptors, the previously discussed 
possibility that A3 receptors may act to desensitize A1 receptors during A2a receptor 
blockade throughout the perfusion of glutamate would now appear unlikely. 
 
3.3.3.4 - Selectivity of ZM241385 
The experiments initially conducted to examine the effect of A2a receptor blockade upon 
the glutamate-induced depression in spike recovery used the A2a antagonist, ZM 241385, 
in place of DPCPX. Using ZM 241385 enhanced the recovery of the orthodromic 
population spike following glutamate perfusion in a similar manner to DPCPX. This was 
consistent with the fact that ZM 241385 has been shown to reduce hippocampal cell death 
induced by kainate in vivo (Jones et al., 1998) suggesting that ZM 241385 can attenuate 
the effects of excitoxins.  
The selectivity of ZM241385 for A2a receptors became a pressing issue, however, as 
another study had revealed that ZM 241385, at the same concentration used in this study, 
prevented the inhibitory effects of the A1 receptor agonists, N
6-cyclopentyladenosine 
(CPA) and R(-)-N
6-phenylisopropyladenosine (R-PIA) upon the population spikes evoked 
from rat hippocampal slices (Lopes et al., 1999). To investigate this further in the present 
study, the effect of ZM 241385 on the inhibition of orthodromic population spikes induced 
by adenosine was examined. It was shown that ZM 241385 attenuated the inhibition of the 
response induced by 10µM adenosine, which was consistent with a blockade of A1 
receptors. This experiment was repeated using DPCPX in place of ZM 241385 to confirm 
the selectivity of DPCPX as an A1 receptor antagonist. While the results obtained using 
ZM 241385 were consistent with those using DPCPX and SCH58261, they do highlight 
problems that can arise regarding the known selectivity of available drugs and subsequent 
interpretation of data. 
 
3.3.3.5 - Interactions between adenosine receptor subtypes 
As later experiments using SCH58261 confirmed that blockade of A2a receptors has a 
similar effect to blockade of A1 upon the post-glutamate recovery of orthodromic 
population spikes, the possibility of an effect of A1 receptors upon A2a receptors in 97 
 
mediating these effects seemed unlikely given that ZM 241385 produced a similar result 
with its non-selective blockade of A1 and A2a receptors. It remains possible that A2a 
receptors do mediate their effects upon post-glutamate recoveries of orthodromic 
population spikes by enhancing A1 receptor stimulation in view of the results that show a 
role for ATP-sensitive potassium channels in mediating their effects. It therefore appears 
that ZM 241385 may have mediated its effects primarily by A1 receptor inhibition without 
requiring an interaction with A2a receptors.  
This leaves the possibility that endogenous adenosine acts at other receptor subtypes, A2b 
or A3. It has been recently shown that A3 receptors are indeed present in the hippocampus 
(Lopes et al., 2003) and may affect synaptic plasticity (Costenla et al., 2001). A2b 
receptors are present in the hippocampus although their functional characterization is still 
lacking due to a limited selection of pharmacological agents (Volpini et al., 2003). The role 
of A2b and A3 receptors cannot be excluded from the data presented here and their role in 
mediating these effects may warrant future investigation. 
 
3.3.4 - The effects of NMDA upon orthodromic population spikes and 
interactions with A1 receptors 
Having established that the effects of A2a receptor antagonists upon the post-glutamate 
recovery of orthodromic population spikes were most likely mediated by enhancing A1 
receptor stimulation, the question still remained regarding the reason for the similar effect 
induced by A1 receptor antagonism. As the use of a non-selective antagonist of A1 and 
A2a receptors, ZM 241385, yielded a similar result also, it seemed unlikely that DPCPX 
mediated this effect through enhanced A2a receptor stimulation as initially thought. The 
underlying mechanism behind A1 receptor blockade was initially sought by replacing 
exogenous glutamate with exogenous NMDA. NMDA produced a similar effect to 
glutamate; initially a complete depolarization which continued for a while after NMDA 
was removed from the perfusion medium followed by a recovery of the response below its 
initial size. The presence of DPCPX in the perfusion medium did not affect this response 
suggesting that it was due to LTD or excitotoxicity, either without release of adenosine. 
This seems to contradict the findings of Manzoni et al. (1994) and Hoehn & White (1990). 
Both these studies suggest that NMDA receptor stimulation releases adenosine in cortical 
and hippocampal slices. Manzoni et al. showed that 10µM NMDA applied for 3min 
induced a depression which was successfully blocked with 8-cyclopentyltheophylline (8-
CPT). Hoehn & White applied 500µM NMDA to cortical slices for 10min and measured 98 
 
the adenosine content throughout application and washout. Whilst both studies provide 
clear evidence of adenosine release in response to NMDA, it is critical to note that the 
effects induced by NMDA in both studies were abolished within minutes of the washout 
period; there was therefore no post-NMDA recovery which differed from initial baseline 
values. 
 
3.3.5 - Interactions between exogenous glutamate and DPCPX 
3.3.5.1 - Effects on antidromic population spikes 
As replacing glutamate with NMDA had failed to yield any information on the nature of 
the interaction between DPCPX and glutamate, the protocol previously used for 
orthodromic population spikes was repeated using antidromic population spikes. It was 
initially observed that 5mM glutamate lowered the antidromic spike amplitude but it did 
not disappear; it then continued to recover to initial baseline values after glutamate was 
removed. This suggested that the effects of 5mM glutamate upon orthodromic population 
spikes were not mediated solely by the actions of glutamate at the cell body but must be 
derived from effects at the synapse also. The presence of DPCPX had no impact upon the 
response of the antidromic population spike to 5mM glutamate therefore the effect of A1 
receptor blockade was examined upon field epsps. 
 
3.3.5.2 - Effect on composite epsps 
The field epsps, as previously discussed in the section 4.1.4, showed a full recovery in both 
slope and amplitude following treatment with 5mM glutamate. When glutamate perfusion 
was repeated in the presence of DPCPX, there was no impact of A1 receptor blockade 
upon the post-glutamate recovery of the response. Given that there were differences in the 
post-glutamate recovery between orthodromic population spikes and field epsps, it was 
thought that 5mM glutamate may have induced dissociations between the epsps and the 
population spikes. This may explain why DPCPX has no effect upon the post-glutamate 
recovery of the epsps as adenosine receptors are known to affect epsp-spike coupling in 
hippocampal slice experiments (O’Kane & Stone, 1998). Also, studies examining the 
effect of adenosine receptors upon synaptic plasticity have reported differential effects 
between the epsp and the orthodromic population spike in E-S coupling experiments (Fujii 
et al., 1992: Fujii et al., 1999). These studies have reported that the induction of long-term 99 
 
potentiation and depotentiation are increased and decreased respectively in epsps when A2 
receptors are activated whereas the induction of these forms of plasticity in population 
spikes are unaffected by the A2 receptors. It should be noted that Fujii et al. (1999) also 
reported that the presence of the A1 receptor antagonist, 8-CPT, increased the size of both 
population spikes and epsps in response to a tetanising stimulus (3 bursts each consisting 
of 5 current pulses at 100Hz, delivered at 20min intervals) without affecting the E-S 
relationship. These observations seemed to disagree with the apparent lack of interaction 
between A1 receptor blockade and glutamate observed here with composite field epsps. It 
was hypothesized that the interaction between DPCPX and exogenous glutamate may be 
better observed using pharmacologically isolated NMDA receptor-mediated epsps given 
that there are reported interactions between the NMDA receptors and A1 receptors in the 
hippocampus (de Mendonça & Ribeiro, 1993; Schubert et al., 1993; Canhão et al., 1994; 
de Mendonça et al., 1995; Klishin et al., 1995; Nikbakht & Stone 2001). The effects of 
glutamate and A1 receptor blockade were therefore examined on NMDA receptor-
mediated epsps.  
 
3.3.5.3 - Effects on isolated NMDA receptor-mediated epsps 
The NMDA receptor-mediated component of the field epsp was isolated by inhibiting 
AMPA receptors and removing magnesium from the perfusion medium to allow the 
NMDA receptors to activate in response to glutamate alone without requiring membrane 
depolarization. The NMDA receptor-mediated epsp was smaller and slower in response 
compared to the composite epsps. Once the response was stable, the protocol for DPCPX 
and 5mM glutamate was applied in the same manner as before. The NMDA receptor-
mediated epsps decreased in size until they disappeared in response to glutamate alone, as 
was previously observed for orthodromic population spikes and composite epsps. When 
glutamate was removed, the responses reappeared and recovered to a stable level that was 
usually below the initial baseline values for slope and amplitude. The smallest NMDA-
receptor mediated epsp recorded, however, showed a recovery that was markedly higher 
than its initial size. This was similar to the small composite epsps that showed a potentiated 
recovery following glutamate treatment which strengthened the possibility that the 
occurrence of higher recoveries may be due to increasing NMDA receptor stimulation.  
When DPCPX was applied in the presence of glutamate during the recordings of NMDA 
receptor mediated epsps, it was observed that the depressed post-glutamate recovery was 
partially attenuated. The effects of A1 receptor antagonism upon NMDA receptor currents 100 
 
have been previously studied in the hippocampus and have shown that a consensus that A1 
receptor antagonism results in enhancing the effects of NMDA receptors. In particular, it 
has been observed that DPCPX both facilitates the NMDA receptor-mediated component 
of epsps in the rat hippocampal slice (Canhão et al., 1994) and suppresses the high-
frequency stimulation induced reduction in extracellular calcium, an effect which is 
dependent on NMDA receptor activation (Schubert et al., 1993).  The A1 receptor 
antagonist, 8-CPT, has also been shown to increase the NMDA receptor component to 
epsp currents recorded in hippocampal neurons (Klishin et al., 1995). The modulation of 
NMDA receptors by A1 receptor stimulation is also supported by studies which have 
observed that the A1 receptor agonist, 2-chloroadenosine (CADO), suppresses the NMDA 
receptor-mediated epsps in slices (de Mendonça & Ribeiro, 1993) and NMDA-induced 
currents in isolated hippocampal neurons (de Mendonça et al., 1995). From this evidence it 
is possible that the increase in post-glutamate recovery observed in orthodromic population 
spikes and NMDA receptor-mediated epsps when DPCPX is present may be due to a direct 
effect of A1 receptors upon NMDA receptors. Without glutamate in the perfusion medium, 
it is possible that the evoked responses would simply increase to higher levels than the 
post-glutamate recovery observed in the presence of the antagonist. Alternatively, 
exogenous glutamate may induce adenosine release similarly to NMDA (Hoehn & White, 
1990; Manzoni et al., 1994) (see Figure 3.22), the effects of which may be alleviated by 
DPCPX although the lack of post-glutamate-induced depression in composite epsps 
suggests that adenosine is not released in response to glutamate. In addition, the results 
suggest that the NMDA receptor-mediated epsps may modulate the orthodromic 
population spikes without producing slope or amplitude changes in the composite epsps. 
The importance of the NMDA receptors involved in epsp formation in the generation of 
population spikes may be a very interesting avenue of further research. 
 
 
 
 
 
 
  
 
 
 
 
 
Figure 3.22 Diagram showing possible interactions between adenosine 
receptor antagonists and glutamate. Bulleted points indicate references or results 
from the present study which support particular interactions. 
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3.3.6 - Relationships between response sizes and their percentage post-
glutamate/NMDA recovery 
3.3.6.1 -  Glutamate and population spikes 
Throughout the experiments performed using glutamate or NMDA, correlations emerged 
regarding the initial size of a given response and the % recovery of the response following 
glutamate or NMDA perfusion. This was first noted when examining the effects of 
exogenous glutamate upon orthodromic population spikes where a positive correlation was 
discovered between the spike size and the degree of recovery of the response. This was 
initially thought to be due to a probable relationship between the health of the tissue used 
and the size of the subsequently evoked response. As healthy tissue would have a greater 
number of functioning mitochondria, a greater capacity to withstand insults or stressful 
stimuli may exist. Similar correlations between resting membrane potential and total 
voltage change have been noted for other toxic compounds including cyanide (Englund et 
al., 2001), a cytochrome oxidase inhibitor that disrupts the electron transport chain within 
mitochondria. This observation with cyanide was slightly different in that the size of the 
voltage change depended on how far the initial resting potential was from a fixed potential. 
The authors observed that cyanide seemed to always return the membrane potential to a 
fixed point therefore the size of the voltage change would depend on the initial resting 
potential. It could be interesting to examine the effects of glutamate more thoroughly with 
intracellular experiments to see if a similar mechanism is responsible for the relationship 
between initial spike amplitude and percentage recovery following glutamate. However, no 
correlation was found for antidromic spike size and subsequent % recovery in response to 
glutamate. If this phenomenon were related to membrane potential, then a similar 
observation would be expected from antidromic spikes as that found in orthodromic spikes.  
3.3.6.2 - NMDA and orthodromic population spikes 
It was also noted that a correlation existed between orthodromic population spike 
amplitude and % post-NMDA recovery. This was unlike glutamate however, in that small 
spike amplitudes produced larger post-NMDA recoveries whilst larger potentials did not 
recover well. This might have been due to fewer active NMDA receptors in the smaller 
responses making NMDA less potent. In light of these data, it became unlikely that the 
correlation between post-glutamate recovery and spike size was due to fewer functioning 
mitochondria as initially suggested but instead, it was somehow dependent on NMDA 
receptor modulation. 103 
 
 
3.3.6.3 -  Glutamate and composite field epsps 
As antidromic population spikes showed no correlation between spike amplitude and post-
glutamate recovery, this suggested that the relationship observed between orthodromic 
spike amplitude and post-glutamate % recovery might result from the effects of glutamate 
upon the epsps. Field epsps showed a negative trend regarding post-glutamate %recovery 
and initial slope gradient and response amplitude although no correlation could be found 
for this effect. Nonetheless, it contrasted with the small recovery for small population 
spikes observed earlier. It was however, consistent with the negative relationship that 
appeared between orthodromic spike amplitude and post-NMDA % recovery of the 
response. It seemed possible therefore, that glutamate may act on NMDA receptors to 
cause dissociations between the epsp and the orthodromic population spike. The effect of 
the NMDA receptors upon the epsp response to 5mM glutamate was highlighted when co-
application of the NMDA receptor blocker, MK-801, induced elevations in the recovery of 
the majority of epsp responses.  It was observed that during the perfusion of MK-801 alone 
prior to co-perfusion with glutamate, the epsp slope and amplitude became elevated or 
depressed. The resulting post-glutamate recovery of the response would be 
correspondingly elevated or depressed compared to the initial baseline value. These data 
suggested that the degree to which NMDA receptors contributed to the composite epsp 
formation strongly influenced the size of the recovery of the response during glutamate 
washout. The overall suppressant effect that NMDA receptors appear to exert upon the 
recovery  of the epsp following 5mM glutamate application is consistent with the idea that 
the small epsps, which had shown a potentiated recovery to glutamate alone, had little if 
any NMDA receptor component to them. As the smaller NMDA receptor component of the 
epsp waveform is much slower to emerge than the AMPA/kainate receptor component of 
the field epsp (Davies & Collingridge, 1989), the influence of the NMDA receptors upon 
the recovery of responses during washout from 5mM glutamate application was studied 
further using pharmacologically isolated NMDA receptor-mediated epsps. 
 
3.3.6.4 - Glutamate and NMDA receptor-mediated epsps 
Consistent effects were observed when isolated NMDA receptor-mediated epsps, similarly 
to composite epsps, showed a negative trend between epsp size and post-glutamate % 
recovery. NMDA receptors are associated with various forms of synaptic plasticity such as 
LTP (Bliss & Collingridge, 1993) and LTD (Mulkey & Malenka, 1992) and the induction 104 
 
of LTP and LTD has been observed in intracellular recordings from CA1 neurons with 
pharmacologically isolated NMDA receptor-mediated synaptic transmission (Xie et al., 
1992). As post-glutamate recovery was to some extent dependent on the size of the NMDA 
receptor mediated epsp, it is likely the correlation between composite epsp size and post-
glutamate recovery depends on the degree of NMDA receptor involvement in the evoked 
response. This is entirely consistent with the effects observed between MK-801 and 
glutamate upon epsps. It would appear that NMDA receptor stimulation may also induce 
dissociations in the epsp-spike relationship given that small composite field epsps tended 
to show a high post-glutamate recovery whilst smaller population spikes had a small 
recovery. Epsp-spike relationships are known to be affected by NMDA receptors (Daoudal 
et al., 2002). The apparent epsp-spike dissociation in the present study requires verification 
with E-S coupling experiments as differences in stimulation strength between separate 
groups of experiments alone may account for the discrepancy in effect between 
orthodromic population spikes and epsps. The present experiments were all conducted 
using the minimum possible stimulation to evoke a maximal response. Epsps and 
orthodromic population spikes are known to have a non-linear relationship (Andersen et 
al., 1980; O’Kane & Stone, 1998) therefore a maximally evoked epsp requires a higher 
degree of stimulation than a maximally evoked population spike.  
It is interesting to note that the effects of NMDA on the orthodromic population spikes 
produced a similar trend in recovery to the NMDA receptor-mediated epsps. It has been 
shown that a form of inhibitory interaction exists between AMPA receptors and NMDA 
receptors at CA1 dendrites (Bazhenov & Kleshchevnikov, 1999) whereby antagonism of 
one receptor-mediated component of the epsp will induce a potentiation of the other. 
NMDA-induced LTD has also been shown to dephosphorylate GluR1 subunits of AMPA 
receptors (Lee et al., 1998). These studies suggest that NMDA receptor stimulation 
depresses the AMPA receptor component of the epsp which is consistent with the effects 
of MK-801 in potentiating the post-glutamate recovery in epsps. This may relate to the 
formation of the population spike in one of two ways:- 
 
1.  Stimulation of AMPA receptors by glutamate may inhibit NMDA receptor modulation 
producing a depression in the orthodromic spike 
2.  Stimulation of NMDA receptors by glutamate inhibits AMPA receptors therefore 
producing a depression in the orthodromic spike 105 
 
 
Given that small population spikes show a low post-glutamate recovery and a high post-
NMDA recovery it seems likely that it is the first possibility that is the cause of 
orthodromic population spike depression of post-glutamate recovery. As the NMDA 
receptor component increases, AMPA receptors become inhibited therefore the larger 
population spikes show a higher post-glutamate recovery. The opposite appears to be true 
for epsps. Small epsps may have no NMDA-receptor component; glutamate stimulation 
may therefore induce a change in the AMPA/NMDA receptor ratio meaning that the 
potentiated recovery is NMDA receptor mediated. This is consistent with the behaviour of 
small NMDA-receptor mediated epsps. NMDA receptor stimulation is required for the 
induction of LTP (Bliss & Collingridge, 1993). Changes in ionotropic receptor ratios have 
been previously shown in response to LTP (Isaac et al., 1995; Liao et al., 1995) and LTD 
(Beattie et al., 2000). As epsps increase in size, the NMDA receptor component may 
increase until the receptor ratio changes where depression is favoured instead of 
potentiation. This may also reflect changes in the subunit composition of the NMDA 
receptors which mediate larger synaptic responses as NR2A subunit containing receptors 
are associated with LTP induction whereas LTD is associated with the NR2B subunit (Liu 
et al., 2004). The NMDA receptor is also known to increase the linearity of spatial 
summation of epsps (Cash & Yuste, 1999).  A point to note is that the trends observed with 
all epsps were in relation to amplitude and not slope. Earlier studies have indicated that 
NMDA receptor blockade induced a decrease in amplitude but not the negative slope of 
epsps in the hippocampal slice (Dahl et al., 1990) which indicated that epsp amplitude 
changes alone are likely to reflect NMDA receptor mediated changes. 
 
3.3.7 - Examining the toxicity of glutamate 
Experiments were performed to assess the nature of the effects of 5mM glutamate upon the 
evoked responses from the hippocampal slice.  The results of these experiments suggested 
that the use of 5mM glutamate was non-toxic. The observations that support this 
conclusion are listed below (1, 2, 3 and 4) and are discussed further in this section. 
1.  Whilst orthodromic population spikes showed a post-glutamate recovery below 
initial baseline values, epsps and antidromic spikes showed a complete recovery 
following glutamate perfusion 
2.  Lowering the stimulus intensity to obtain 50% maximal orthodromic spikes 
produced elevations in post-glutamate recovery above the initial 50% baseline 106 
 
3.  Using 25% maximal orthodromic spikes, either elevated or depressed post-
glutamate recoveries were observed against the initial 25% baseline 
4.  Using 25% maximal orthodromic spikes, a tetanic stimulus applied during the post-
glutamate recovery produced significant potentiations of the orthodromic 
population spikes 
The first results indicated that 5mM glutamate did not induce membrane dysfunction as 
antidromic population spikes recorded from the CA1 soma recovered fully. There was no 
suggestion of damage at the synapse either as epsps showed no significant post-glutamate 
depression. The effect in maximal orthodromic spikes was therefore interpreted as some 
form of post-synaptic change in epsp-spike coupling. As post-glutamate depression 
changed to potentiation using lower stimulation intensity, 5mM glutamate was considered 
non-toxic. Reversing the depressant effects of glutamate using a 100Hz/1sec stimulus in 
orthodromic spikes strongly suggests that 5mM glutamate induced changes in synaptic 
plasticity which was consistent with the elevated post-glutamate recoveries observed in 
small epsps. The exact nature of the influence of 5mM glutamate on the responses is still 
unclear as it is impossible to accurately understand the effect on the epsp-spike relationship 
without E-S coupling experiments which detect the changes in epsps and orthodromic 
population spikes at the same time in a single slice. Also, the elevated post-glutamate 
recoveries using small epsps cannot be clearly interpreted as pre-synaptic or post-synaptic 
effects without paired pulse experiments or measurements of quantal transmission to 
examine the behaviour of pre-synaptic neurons. It is also important to note that lowering 
stimulus intensity may be sufficient to change the metabolic demand of the neurons thus 
better enabling them to withstand stress. It is known that lowering stimulus intensity 
produces larger potentiations in population spikes in response to theta-frequency patterned 
primed-bursts (4 trains of 100Hz stimulation applied for 0.1msec and repeated at 200msec 
intervals) (Leung & Au, 1994). It has also been observed that hippocampal slices show 
changes in mitochondrial membrane potential which were consistent with theta frequency 
stimulation in the tissue and which also correlated with the intensity of electrical activity 
and spatial changes of intracellular calcium induced by the stimulation (Bindokas et al., 
1998). 
Long-term depression of inhibition (LTD-i) may also explain why lower stimulus 
intensities produce an elevated post-glutamate recovery. LTD-i is a phenomenon whereby 
GABA transmission is reduced. The mechanism involves stimulation of post-synaptic 
group1 mGluRs which generate DAG via phospholipase C (PLC). DAG is then converted 
to the endocannabinoid, 2-arachidonylglycerol (2-AG) via DAG-lipase. 2-AG is then 107 
 
thought to stimulate cannabinoid CB1 receptors on GABAergic neurons via retrograde 
transmission from the post-synaptic neurons which in turn appears to inhibit GABA release 
(for review, see Freund & Hájos, 2003). The time-course of LTD-i is consistent with the 
changes observed here (approximately 40min). It is possible that the lower stimulus 
intensity prevents saturation of the response allowing this effect to emerge. From the 
mechanism outlined above, this could be shown using a mGluR Group 1 antagonist or a 
CB1 antagonist and examining the effect on the post-glutamate recovery.  
 
3.3.8 – General Discussion  
The results presented above have examined the effects of glutamate upon the evoked 
potentials from the CA1 pyramidal cells and the modulation of these effects by adenosine 
receptor antagonists. It was observed that 5mM glutamate applied to hippocampal slices 
induced a complete loss of response size. During the post-glutamate washout, the 
responses returned to below baseline values in orthodromic populaton spikes and isolated 
NMDA receptor-mediated epsps. The response recovery using composite epsps and 
antidromic population spikes was not signficantly different from pre-glutamate baseline 
values. The A1 receptor antagonist, DPCPX, blocked the effect of glutamate upon the 
response recovery using orthodromic population spikes and NMDA-receptor mediated 
epsps whilst no interaction was observed for antidromic population spikes or composite 
field epsps. From these observations, it would appear that 5mM glutamate applied to 
hippocampal slices can induce dissociations between the field epsp and the orthodromic 
population spike. The change in the E-S relationship induced by glutamate can also be 
modulated by blockade of A1 receptor antagonists, an effect which seems to depend upon 
interactions with NMDA receptors. Further experiments using E-S coupling are required to 
verify these results. 
 
It was also observed that blockade of A2a receptors by SCH58261 could enhance the 
resposne recovery of orthodromic population spikes following application of glutamate. 
Further experiments revealed that this was due to ATP-sensitive potassium channel 
stimulation which most likely occurred as a result of removing the inhibitory effect of A2a 
receptors upon A1 receptors. This may have implications for the use of A2a receptor 
antagonists as a preconditioning mimetic as ATP-sensitive potassium channels are a 
central mediator of this phenomenon. 
 
Experiments were conducted to examine the nature of the effects of glutamate upon the 
orthodromic population spikes. It was revealed that the reduction of response size 108 
 
following glutamate application could be reversed by a tetanic stimulation. This indicated 
that the effect of 5mM glutamate upon the slice was induced by a synaptic change and 
unlikely to be due to a toxic effect. As a consequence of these results, 10mM glutamate 
was used as toxic insult in further preconditioning experiments. 
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4 – THE EFFECTS OF ADENOSINE 
PRECONDITIONING AGAINST EXOGENOUS 
GLUTAMATE AND OUABAIN 
 
4.1 – Introduction 
 
Having established that using 5mM glutamate was probably not a concentration sufficient 
to induce an excitotoxic effect in hippocampal slices, the effects of using a 10mM 
glutamate pulse were examined in the slice. This could enable the study of any potential 
protection induced by adenosine preconditioning against excitotoxicity. It was also of 
interest to examine the effects of a different chemical model of ischaemia, namely the 
sodium-potassium ATPase inhibitor, ouabain. This allowed for a comparison of the effects 
of adenosine and other preconditioning stimuli against different mechanisms by which 
tissue damage may be induced. The results presented below outline the observed effects of 
glutamate, ouabain and adenosine preconditioning upon the evoked responses in the 
hippocampal slice. 
 
4.2 – Results 
4.2.1 - The effects of 10mM glutamate upon hippocampal slices 
Preliminary experiments established that perfusing slices with 10mM glutamate for 10min 
yielded the best and most reproducible depressions of electrophysiological activity. When 
recording orthodromic population spikes, glutamate at 10mM initially induced multiple 
population spikes, but this period of increased excitability was superceded by a decline of 
potential size as the pyramidal cells became over-depolarised. Following the removal of 
glutamate from the superfusion medium evoked potentials gradually returned to a plateau 
level within 30 to 60 minutes of washout. There was a significant depression in the size of 
all evoked responses (Fig 4.1a & b). 
To investigate if 10mM glutamate induced a form of long-term depression upon the 
orthodromic responses, the stimulus intensity was reduced to evoke the half-maximal 
response. Once a stable baseline was established, 10mM glutamate was applied to the slice 
for 10min. The orthodromic population spike was abolished during glutamate application 
and throughout the entire washout period. At one hour post-glutamate, a tetanising 110 
 
stimulus was applied to the slice (100Hz/1sec). There was no reappearance of the spike in 
response to the stimulus unlike the control LTP responses which were obtained from slices 
taken from the same hippocampi (Fig 4.2). This indicated that 10mM glutamate exerted an 
effect other than long-term depression upon the slices.  
Western blotting was carried out on slices treated with 10mM glutamate for 10min to 
detect possible changes in heat shock protein expression (Fig 4.3 & 4.4). There were no 
significant changes detected between glutamate-treated slices and untreated slices (Fig 
4.5). 
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Figure 4.1a The effects of glutamate on evoked responses from CA1 neurons 
a) Epsp slopes (n = 11), orthodromic spikes (n = 18) and antidromic pop spikes (n = 7) all 
show a significant depression in response size following 10mM glutamate after 50 to 
60min (* p<0.05 ** p=0.0001 ***p<0.0001 one sample t- test).  
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Figure 4.1b Sample traces showing the effects of 10mM glutamate at various 
time points on the evoked responses from the rat hippocampal slices. Time 
points are in relation to the application of 10mM glutamate. 
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Figure 4.2 The effect of 10mM glutamate exposure on synaptic plasticity in 
orthodromic population spikes. The time course graph above shows the changes in 
orthodromic population spike amplitude in response to different stimulation intensities and 
10mM glutamate perfusion. The responses perfused with 10mM glutamate for 10min show 
no perceptible recovery after one hour (n = 5). A 100Hz/1sec stimulus at the one hour 
time-point post-glutamate does not reverse the depression. Control responses show a 
significant LTP in response to 100Hz/1sec stimulation (140.6 ± 9.4%, n = 5, p<0.05 one 
sample t-test. 
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Figure 4.3 Electrophysiological data from the slices used to generate the 
Western blots for the detection of HSP72 in Figure 4.4. A graph of the time 
course of changes in antidromic population spike amplitude when either treated with 
10mM glutamate for 10min or stimulated in the recording chamber for the same length of 
time is shown.  
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Figure 4.4 Western blots showing the immumodetection of HSP72 and actin 
levels in slices receiving glutamate treatments. The blots for the naive tissue show 
the detection of HSP72 and actin levels in slices stimulated for the same length of time as 
the chemically treated slices as shown in Figure 4.3. The corresponding Ponceau stains are 
shown (in colour). 
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Figure 4.5 Histogram summarising the changes in HSP72 expression in 
glutamate treated slices from the Western blot in Figure 4.4. There are no 
significant changes in HSP72 expression between glutamate treated groups and naive 
slices (ns = not significant).  
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4.2.2 - Adenosine does not precondition against glutamate  
To investigate preconditioning, a protocol was used similar to that devised by previous 
groups, in which several mild exposures are given to the preconditioning agent, followed 
by the application of a stimulus which, when given alone, would induce some degree of 
irreversible tissue function or damage. To examine the effects of adenosine on glutamate 
toxicity, the purine was superfused at concentrations of 10µM, 50µM or 100µM for 3 min 
every 15 mins. Three such applications were made after which a further period of 15min 
was allowed before a pulse of 10mM glutamate was applied for 10min. A comparison of 
control responses to glutamate applied alone, with responses obtained after adenosine 
preconditioning (n = 3 for each concentration) revealed no statistically significant 
differences between them, either in the amplitude of depression, the extent of recovery 
measured at the plateau phase, or the rate of recovery measured as the time taken from the 
end of maximal depression to the attainment of half the plateau recovery (Fig 4.6). A 
10min application of 100µM adenosine, shown by Pérez-Pinzón et al., (1996) to protect 
against anoxia in slices, was employed to examine any protective effect against glutamate. 
This also failed to protect against 10mM glutamate when treated on orthodromic responses 
(preconditioned group n = 6; control group n = 9) (Fig 4.7) or antidromic responses 
(preconditioned group n = 5; control group n = 5) (Fig 4.8). 
 
Using the former protocol it was also found that adenosine did not induce any difference in 
the depression of potentials produced by 25μM NMDA. 
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Figure 4.6 Adenosine does not precondition against glutamate. Various 
concentrations of brief adenosine applications failed to precondition against 10mM 
glutamate (aden = adenosine). 
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Figure 4.7 A sustained application of 100µM adenosine failed to precondition 
against the effects of 10mM glutamate upon orthodromic responses. 
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Figure 4.8 A sustained application of 100µM adenosine failed to precondition 
against 10mM glutamate in antidromic responses. 
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4.2.3 - Effects of ouabain, a Na
+/K
+ ATPase inhibitor, on evoked responses 
In view of the failure of adenosine applications to modify responses to glutamate, we 
tested an unrelated agent which has, like adenosine, been reported to produce 
preconditioning against ischaemia (Pierre et al., 2007; Pasdois et al., 2007). In preliminary 
experiments it was found that a narrow window existed between ouabain applications that 
produced only a minimal effect on the slices, and applications that generated a complete 
and irreversible loss of electrical activity. The application of 100μM ouabain for 2 min 
resulted in an initial increase of neuronal excitability reflected in the recording of multiple 
population spikes on orthodromic stimulation (Fig 4.10). This was followed by a marked 
reduction in the size of the evoked potential (Fig 4.9 & 4.10) which did not return to 
baseline level within 1 hour of washout. 
Antidromically evoked population spikes were normally decreased in amplitude by 
ouabain, though significantly less than orthodromic spikes (see Fig 4.9 & 4.10). 
Since ouabain can induce the release of neuroactive compounds (Basarsky et al., 1999; Li 
& Stys, 2001) and it has been shown to precondition tissues against hypoxic damage, the 
possibility was considered that the effects of ouabain were due to the release of glutamate 
or adenosine. When slices were superfused with the non-selective glutamate antagonist, 
kynurenic acid (Perkins and Stone, 1982; Stone & Darlington, 2002), the potentials that 
were recorded after orthodromic and antidromic stimulation behaved differently. The 
depressant effect of ouabain on antidromic evoked potentials was unchanged after 
perfusion with kynurenic acid at a concentration of 1mM, applied for 10min before, during 
and for 1h following the inclusion of ouabain (Fig 4.11). Orthodromic potentials, however, 
exhibited a much greater recovery after the presence of kynurenic acid, compared with 
control slices in which ouabain was present without any blockade of glutamate receptors 
(Fig 4.12). These results indicate that glutamate is released by ouabain, but the effects of 
glutamate are only observed when stimulation involves synapse activation by orthodromic 
stimulation. It may be that the releasing effect of ouabain is limited to synaptic terminals 
and not to cell somata or glial cells. 
In contrast, adenosine does not seem to contribute to the effects of ouabain. Slices were 
superfused with DPCPX (30nM) prior to and during the application of ouabain (Fig 4.13). 
This blockade of A1 adenosine receptors had no effect on the loss of response induced by 
ouabain (69.4 ± 5.1%, n = 5) compared with control (68.6% ± 5.2%, n = 7). GABA also 
appears to have no role as blockade of GABAA and GABAB receptors did not attenuate the 122 
 
depression of orthodromic population spikes (Fig 4.14). Indeed blockade of GABAA 
receptors enhanced the ouabain-induced decrease in spike size which was significant at the 
50min time point of the experimental protocol.         
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Figure 4.9 The effects of ouabain on evoked responses from CA1 neurons. A 
long lasting decrease in response size after 100µM ouabain perfusion for 2 min is observed 
for epsps, orthodromically and antidromically evoked population spikes (field epsp 58.59% 
± 7.06, n = 7; orthodromic population spike 55.49% ± 7.97, n = 8; antidromic population 
spike 82.04% ± 1.80, n = 5). The reduction in antidromic spike size is significantly less 
than that observed for epsp slope and orthodromic spike size (ns = not significant *p<0.05  
Kruskal-Wallis test).  
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Figure 4.10 Sample traces showing the effects of ouabain at various time 
points on the evoked responses from the hippocampal slice. Times indicated 
are in relation to application of ouabain. 
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Figure 4.11 Reduction in antidromic spike amplitude in response to ouabain 
is independent of glutamate-receptor mediated damage. The time course graph 
of antidromic spike amplitude show no difference in response to 100µM ouabain when 
perfused with (79.8 ± 2.1%, n = 4) or without (79.9 ± 2.7%, n = 6) 1mM kynurenic acid.  
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Figure 4.12 The effect of ouabain upon orthodromic spikes in the presence 
of kynurenic acid. Orthodromic spikes show a clear attenuation of the ouabain-induced 
depression in the presence of kynurenic acid (96.3 ± 5.9%, n = 4) compared with ouabain 
only controls (39.9 ± 13.1%, n = 4) (p<0.05). 
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Figure 4.13 The effect of ouabain upon orthodromic spikes in the presence 
of DPCPX.  Blockade of A1 receptors does not modulate the response to ouabain in 
orthodromic spikes (DPCPX + ouabain 69.4 ± 5.1%, n = 5; ouabain only 68.6 ± 5.2%, n = 
7). 
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Figure 4.14 Blockade of GABA receptors does not attenuate the ouabain-
induced depression in orthodromic spikes a) GABAA receptor blockade during 
ouabain perfusion with 100nM bicuculline (n = 5) and ouabain only controls (n = 5). Note 
that GABAA blockade significantly enhances the effects of ouabain at the 50min time point 
(31.7 ± 12.9%, n = 5) compared with ouabain-only controls (75.7 ± 7.0%, n = 5) (p<0.05). 
b) GABAB receptor blockade during ouabain perfusion. (CGP35348 + ouabain 44.0 ± 
18.7%, n = 6; ouabain only 56.9 ± 11.4%. n = 10). 
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4.2.4 - The effects of ouabain on synaptic plasticity 
Having determined that the post-ouabain induced depression in orthodromic population 
spikes was due to glutamate receptor stimulation, the nature of this effect on synaptic 
plasticity was examined. The extent of glutamate receptor stimulation can determine if 
LTP, LTD or excitotoxicity is induced. Orthodromic population spikes were evoked to 
obtain the maximum response. When a stable baseline was established, the stimulus was 
reduced to produce 50% of the maximum response (Fig 4.15a). The maximum stimulus 
was induced at three time points to determine the exact maximum response during the 
evocation of the 50% baseline. After establishing a stable baseline at the reduced stimulus, 
100µM ouabain was perfused onto the slice for 2min. It was observed that following 
ouabain treatment, the population spikes showed an initial increase in size followed by a 
drop. The orthodromic population spikes did not show a significant decrease in size at 50 
to 60min post-ouabain (75.2 ± 16.5%, n = 5) compared to the 100% baseline or a 
significant difference from the half-maximal baseline (50.6 ± 3.2%). The maximum 
responses were evoked at approximately 45min, 50min and 55min post-ouabain; the 
average value of the three time points showed no difference in size compared with the 
average value of those evoked prior to ouabain application (pre-ouabain 114.6 ± 4.8%; 
post-ouabain 111.1 ± 11.9%) (p=0.72, paired t test) (n = 5). 
A 100Hz stimulus was applied for 1 second at 1hour post-ouabain. The 100% baseline was 
taken as the 10min period prior to stimulation for calculating the size of LTP induced. 
There was a significant potentiation observed which lasted for at least 30min (140.7 ± 
11.3%) (p<0.05, one sample t test)(n = 5) (Fig 4.15b). This was compared to control LTP 
responses which were obtained from slices taken from the same hippocampus as those 
treated with ouabain. The orthodromic population spikes obtained from control slices were 
stimulated to produce the maximal response followed by establishing a half-maximal 
baseline. Once a stable baseline was established, a 100Hz stimulus was applied for 
1second to these slices. The control responses showed a significant potentiation in 
response to the tetanizing stimulation (207.6 ± 26.8%, n = 4)(p<0.05, one sample t test) 
which were significantly greater than those obtained from ouabain treated responses 
(p<0.05) (Fig 4.15b). It was noted that the half-maximal baselines obtained for ouabain-
treated slices and control slices did not vary significantly (ouabain-treated response 
baseline 50.6 ± 3.2%, n = 5; control response baseline 42.3 ± 3.6%, n = 4) nor did the 
values of the ouabain treated slices at the 10min period prior to LTP stimulation (75.18 ± 
16.5%, n = 5). It can therefore be concluded that ouabain does not prevent the induction of 
LTP in the hippocampus but it does appear to attenuate the extent of LTP induced. 130 
 
 
 
 
 
 
 
 
Figure 4.15 Ouabain impairs but does not prevent the induction of LTP in the 
rat hippocampal slice. a) shows the time course of changes in orthodromic population 
spike amplitude induced in response to altered stimulation and ouabain exposure. The three 
diagonal lines at approximately the 10min time point indicate the time elapsed before a 
stable baseline with a half-maximal response was obtained. The times at which ouabain 
and a 100Hz/1sec stimulus are applied are indicated. b) shows extrapolated data from a) 
taken 10min prior to the application of a 100Hz stimulus and normalised. The data are 
normalised from the 10min period prior to LTP. 
time (min)
0 3 06 09 0 1 2 0
%
 
o
r
t
h
o
d
r
o
m
i
c
 
p
o
p
 
s
p
i
k
e
 
a
m
p
l
i
t
u
d
e
0
50
100
150
100Hz/1sec
100µM ouabain
b) 
a) 
time (min)
03 0 6 0 9 0 1 2 0
%
 
o
r
t
h
o
d
r
o
m
i
c
 
p
o
p
 
s
p
i
k
e
 
a
m
p
l
i
t
u
d
e
0
100
200
300
ouabain + 100Hz/1sec stimulus
100Hz/1sec stimulus 
4.2.5 - Adenosine can precondition against ouabain but not glutamate 
Since the results presented above indicate that adenosine, although known to produce 
preconditioning in vivo, did not precondition against exogenously applied glutamate, it 
was of interest to examine its ability to precondition against the release of glutamate 
released endogenously by ouabain. A preconditioning stimulus of 100µM adenosine was 
applied to the slices for 10min, causing a complete loss of the orthodromic population 
spike which returned within 10min of ending the adenosine perfusion. Indeed, several 
slices during the return of response showed a recovery of potential size to levels greater 
than the initial baseline size (Fig 4.16a), an effect of adenosine that has been reported 
elsewhere and has been attributed to opening of ATP-sensitive potassium channels (Li & 
Henry, 1992). Recovery from adenosine was followed 30 min later by an application of 
ouabain (100µM) or glutamate (10mM) applied for 2min and 10min respectively as in the 
previous experiments (Fig 4.16a & b).  
Adenosine applications did not produce any change of the subsequent glutamate response, 
as reported above, but it did produce a clear modification of the response to ouabain. With 
a preceding application of adenosine, orthodromic responses recovered after superfusion 
with ouabain, to a significantly higher level that they did after applications of ouabain 
alone (Fig 4.16a & b). 
The protocol for adenosine preconditioning against ouabain was repeated for recordings of 
the field epsps (Fig 4.17) using, in separate experimental groups, a stimulus strength to 
achieve the maximum response (Fig 4.17a) or a reduced stimulus strength to produce a 
potential size that was 50% of the maximum (Fig 4.17b). At maximum stimulus strength 
both adenosine and ouabain induced a clear decrease in the amplitude and slope of epsps. 
The loss of epsp slope size and amplitude induced by ouabain was not attenuated by the 
preceding application of adenosine, suggesting that the modifications of the ouabain effect 
on orthodromic somatic spikes was not attributable to changes of synaptic transmission, 
but probably to changes of postsynaptic excitability. It was noted that post-adenosine 
treatment, a significant decrease was observed in epsp amplitude (97.8 ± 0.8%, n = 7) (p 
<0.05 one sample t test), the opposite effect to population spikes. This is consistent to 
some extent with adenosine’s reported effects on epsp-spike coupling (O’Kane & Stone, 
1998). 
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This view was supported when adenosine was applied before ouabain while recording 
antidromically-induced spikes. After adenosine application, which produced no significant 
change of antidromic spike size during its perfusion, a significant increase of spike 
amplitude was observed upon adenosine washout, similar to that seen when using 
orthodromic spikes (p < 0.05) (Fig 4.18a & c). After ouabain was perfused, a similar onset 
of reduced response size was observed compared with non-preconditioned controls but the 
response recovered to a level that was significantly greater than control potentials (control 
recovery to 82.3% ± 2.0, n = 11; preconditioned recovery to 95.2% ± 4.8, n = 8, p < 0.05) 
(Fig 4.18b & c). If slices were perfused with 30nM DPCPX prior to, during and 15min 
after adenosine applications, the greater recovery from a subsequent application of ouabain 
was prevented (p = 0.93, n = 4) (Fig 4.19).  
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Figure 4.16a. Adenosine preconditioning attenuates ouabain-induced 
changes in orthodromic spike size. a) Preconditioned slices recovered to 94.8 ± 
5.5% (n =7) compared to 82.3 ± 2.0% in control slices (n = 11) (p < 0.05) when normalised 
prior to ouabain application. The arrows (a, b and c) indicate the time points from which 
the sample waveforms shown in Figure 3.37b are taken. 
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Figure 4.16b. Sample traces of preconditioning experiments and controls 
taken from the time points as indicated in Figure 4.16a. 
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Figure 4.17 Adenosine preconditioning effects against ouabain are absent in 
epsp responses. a) shows experimental protocol using stimulation to evoke maximal 
epsps. b) shows the same protocol using stimulation to evoke half-maximal epsps.  
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Figure 4.18a,b/ Protection against ouabain is induced by adenosine 
preconditioning in antidromic spikes. a) Time course changes in antidromic spike 
amplitude in response to adenosine preconditioning and subsequent ouabain application. A 
significant elevation of response is observable following adenosine. b)  Preconditioned 
responses (n = 8) and controls (n = 11) in antidromics spikes normalised prior to 
superfusion of ouabain. The arrows (a, b and c) show the time points from which the 
sample waveform shown in Figure 3.39c are taken. 
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Figure 4.18c Sample traces taken from time points as indicated in Figure 
4.18a. 
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Figure 4.19 Adenosine preconditioning is suppressed by A1 receptor 
blockade using 30nM DPCPX. a) Time course changes in antidromic population spike 
amplitude during A1 receptor blockade of the adenosine preconditioning protocol. Note 
that the elevation in spike amplitude following removal of DPCPX (108.1 ± 2.9%) is not 
statistically significant (p = 0.07 one sample t-test). b) The same data from the top graph 
normalised prior to ouabain application (DPCPX + adenosine preconditioning + ouabain 
77.9 ± 8.0%, n = 4; ouabain 78.7 ± 4.1%, n = 4).  
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4.2.6 - Adenosine preconditioning against ouabain requires activation of 
NMDA receptors 
To assess any possible role of glutamate in adenosine’s modification of ouabain responses, 
kynurenic acid (1mM) was perfused throughout the complete experimental protocol, 10 
min prior to adenosine and then throughout the adenosine washout and subsequent ouabain 
perfusion. The sequence was tested using antidromically-evoked spikes. The presence of 
the glutamate receptor antagonist resulted in a complete suppression of adenosine 
protection (control recovery to 78.0% ± 3.2, n = 12; preconditioned recovery to 78.3% ± 
3.9, n = 9; p = 0.9614) (Fig 4.20). This result suggests that glutamate receptor activation is 
involved in adenosine’s protective effect on ouabain responses. This was further confirmed 
by blocking adenosine preconditioning using 50µM AP-5 and 10µM DNQX in separate 
experiments in the same manner as 30nM DPCPX. Adenosine protection against ouabain 
was still observed during blockade of AMPA receptors with DNQX but was completely 
suppressed when AP-5 was used to block NMDA receptors (Fig 4.21 & 4.22). It is 
therefore likely that the role of glutamate in adenosine preconditioning is via NMDA 
receptor activation. 
             
To probe the mechanism by which NMDA receptor stimulation induces protection against 
ouabain, we inhibited nitric oxide production with the nitric oxide synthase inhibitor, L-
NAME. 100µM L-NAME was perfused 20min prior to, during and 15min after adenosine 
application (n = 4). This resulted in a complete suppression again of adenosine’s 
preconditioning against ouabain (Fig. 4.23).  
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Figure 4.20 Modulation of adenosine preconditioning by kynurenic acid. 
There is no significant difference between preconditioned slices (78.3 ± 3.9%, n = 9) and 
controls (78.0 ± 3.2%, n = 12) (p = 0.96). All data are normalised 10min prior to ouabain 
superfusion. Solid lines indicate application of drugs in preconditioning experiments. 
Dashed lines indicate application of drugs in control experiments.  
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Figure 4.21 Blockade of NMDA receptors during adenosine preconditioning 
against ouabain. a) Perfusion of 100µM DL-AP-5 prior to, during and after superfusion 
of 100µM adenosine. Note that a significant elevation of antidromic spike amplitude 
occurs following removal of AP-5 from the perfusion medium (p<0.05). b) The same data 
as above normalised prior to 100µM ouabain perfusion. There is no significant difference 
between preconditioned responses in the presence of DL-AP5 (n = 5) and control 
responses (n = 8). c) Perfusion of 10µM DNQX prior to, during and after superfusion of 
100µM adenosine. d) The same data as above normalised prior to 100µM ouabain. There is 
an elevated recovery of preconditioned slices (n = 7) which is significant between 40 and 
50min post-ouabain treatment (88.581 ± 1.513%, p<0.05 unpaired t-test with Welch 
correction) compared with controls (81.585 ± 2.614%, n = 10). 
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Figure 4.22 Histogram summarising the results outlined in Figure 4.21. 
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Figure 4.23 Adenosine preconditioning in the presence of 100µM L-NAME 
attenuates any modulation of the response to ouabain. a) Perfusion of 100µM 
L-NAME during adenosine preconditioning. b) The same data as above normalised prior 
to superfusion of 100µM ouabain. There is no significant difference between 
preconditioned slices (n = 6) and controls (n = 7).  
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4.2.7 - Adenosine preconditioning against ouabain is suppressed by 
blocking ATP-sensitive K+ channels 
A similar protocol to that for A1 receptor blockade was used to examine the role of ATP-
sensitive K+ channels in mediating the effects of adenosine. The ATP-sensitive K+ 
channel blocker glibenclamide was perfused before, during and after adenosine 
application. This resulted in an almost complete attenuation of adenosine protection against 
the effects of ouabain (86.6 ± 4.7%, n = 7) compared with controls (82.5 ± 2.5%, n = 10) 
(p = 0.4226) (Fig 4.24) implicating ATP-sensitive K+ channels in mediating this effect. 
This was examined further by using a selective mitochondrial ATP-sensitive potassium 
channel blocker, 5-HD (50µM). This attenuated the effects of adenosine confirming the 
action of glibenclamide (Fig 4.25) and suggesting that adenosine’s mechanism involves 
mitochondrial ATP-sensitive potassium channels. 
   
4.2.8 - Pinacidil, an ATP-sensitive K+ channel opener, preconditions against 
glutamate and ouabain 
Having established a role for ATP-sensitive K+ channels which is consistent with reports 
of adenosine preconditioning (Heurteaux et al., 1995; Reshef et al., 2000) and given that 
direct modulation of these channels can precondition against hypoxia (Pérez-Pinzón & 
Born, 1999), we examined the effects of such a modulator, namely pinacidil in this 
protocol.  We perfused 30µM pinacidil for 20min as a preconditioning stimulus followed 
by either 10min of glutamate (10mM) (Fig 4.27a) or 2min of ouabain (100µM) (Fig 4.26a) 
at 30min post-pinacidil treatment. Experiments in which there was no perceptible recovery 
of the antidromic population spike were excluded from analysis.  We observed a 
significant attenuation of the ouabain- and glutamate-induced depressions in antidromic 
spike amplitude (p<0.05) (Fig 4.26b, 4.26c, 4.27b, 4.27c & 4.28) indicating that these 
channels serve as a common mechanism of protection against Na+/K+ ATPase inhibition 
and excessive glutamate. The pinacidil preconditioning protocol against glutamate was 
also repeated using orthodromic spikes. It was observed that the recovery of the responses 
post-glutamate did not vary between preconditioned and control slices (Fig 4.29). 
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Figure 4.24 The role of ATP-sensitive potassium channels in mediating the 
preconditioning effects of adenosine against ouabain. a) Perfusion of 30µM 
glibenclamide prior to, during and after superfusion of 100µM adenosine. b) The same data 
as above taken from and normalised 10min prior to superfusion with ouabain. There is no 
significant difference between preconditioned responses in the presence of glibenclamide 
(86.6 ± 4.7%, n = 7) and controls (82.5 ± 2.5%, n = 10). 
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Figure 4.25 Blockade of mitochondrial ATP-sensitive potassium channels 
during adenosine preconditioning. a) Perfusion of 50µM 5-HD prior to, during and 
after adenosine preconditioning. b) The same data as above taken from and normalised 
10min prior to superfusion with ouabain. There is no significant difference between 
preconditioned responses in the presence of 5-HD (75.6 ± 2.1%, n = 4) and controls (72.4 
± 4.8%, n = 4).  
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Figure 4.26a,b. Time course graphs showing the changes in antidromic 
spike amplitude during the preconditioning protocol with 30µM pinacidil 
against glutamate. a) shows the full experimental time course for preconditioned and 
control slices. b) shows the same data as above normalised prior to addition of ouabain in 
treated slices (preconditioned group 88.6 ± 2.3% (n = 6); control group 78.3 ± 3.2% (n = 9) 
(p<0.05)). The arrows (a. b, c and d) indicate the time points from which the sample 
waveforms shown in Figure 4.26c are taken. 
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Figure 4.26c Sample traces of antidromic population spikes taken from the 
time points as indicated Figure 4.26a. 
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Figure 4.27a,b. Pinacidil can precondition against the effects of glutamate 
upon orthodromic population spikes. a) Time course graph showing the changes in 
orthodromic spike amplitude during pinacidil preconditioning. b) The same data as a) 
extrapolated and normalized from 10min prior to the application of 10mM glutamate. 
Preconditioned slices show a significant elevation in response compared with glutamate 
only treated controls (preconditioned group 73.3 ± 12.317% (n = 5); control group 36.3 ± 
7.1% (n = 6) (p<0.05)). The arrows (a, b, c and d) indicate the time points from which the 
sample waveforms shown in Figure 4.27c are taken.  
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Figure 4.27c Sample traces of antidromic population spikes taken from the 
time points inidicated in Figure 4.27a. 
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Figure 4.28 Histogram showing the differences in recovery of antidromic 
spike amplitude between pinacidil preconditioned groups and controls with 
either glutamate or ouabain as chemical insults (GLUTAMATE: preconditioned 
group 73.3 ± 12.317% (n = 5); control group 36.3 ± 7.1% (n = 6); OUABAIN: 
preconditioned group 88.6 ± 2.3% (n = 6); control group 78.3 ± 3.2% (n = 9)) (*p<0.05). 
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Figure 4.29 Pinacidil preconditioning against glutamate in orthodromic 
spikes. a) Time course changes in orthodromic spike amplitude during 30µMpinacidil 
preconditioning against 10mM glutamate. b) The same data as the top graph normalised 
prior to glutamate perfusion. There is no significant difference in post-glutamate recovery 
between preconditioned (n = 3) and control (n = 3) slices. 
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4.2.9 - Studies on HSP72 changes in response to pinacidil preconditioning 
against ouabain 
Having observed a successful preconditioning outcome with pinacidil against ouabain, 
some of the slices from these experiments were saved to analyze any molecular changes 
later on. Naive tissue that was stimulated for the protocol duration for both pinacidil 
preconditioned and ouabain alone slices were saved for use in Western blotting to account 
for differences in stimulation times that might induce molecular changes. The 
electrophysiological data for these slices is shown in Figure 4.30. All these slices were 
analysed for changes in HSP72 expression. It was shown that there were no differences in 
expression between preconditioned slices and the corresponding naive slices or control 
slices and the corresponding naive slices. There were also no changes between ouabain 
only treated slices compared with pinacidil preconditioned slices (Fig 4.31 & 4.32). HSP72 
expression appears to be unaffected by either ouabain treatment alone or preconditioning 
with pinacidil. 
 
4.2.10 - The role of ATP-sensitive potassium channels and NMDA receptors 
in the pinacidil preconditioning effect against ouabain 
To confirm that the preconditioning effects of pinacidil against ouabain observed in 
antidromic spikes were in fact, due to the opening of ATP-sensitive potassium channels, 
the protocol was repeated with 30µM glibenclamide, an ATP-sensitive potassium channel 
blocker, present before, during and after 30µM pinacidil was applied. It was observed the 
the elevated post-ouabain recovery of the antidromic population spike, previously observed 
in response to pinacidil preconditioning, was attenuated by the presence of glibenclamide 
in the perfusion medium (Fig 4.33). This confirmed that the effects were mediated by 
ATP-sensitive potassium channels. 
Having established that NMDA receptors mediated the preconditioning effect of adenosine 
against ouabain in antidromic population spikes, it was interesting to see NMDA receptors 
also mediated pinacidil preconditioning. The pinacidil preconditioning protocol was 
repeated in the presence of the NMDA receptor antagonist, DL-AP5 (Fig 4.34). It was 
observed that the preconditioning effect was attenuated by the presence of the antagonist 
indicating that NMDA receptors are involved in the pinacidil preconditioning effect. 154 
 
 
 
 
 
 
 
 
Figure 4.30 Electrophysiological data from the slices used to generate the 
Western blots for the detection of HSP72 in Figure 4.31. Note that these data 
show no statistical differences between groups; the complete data for this experiment is 
shown in Figure 4.26. Included also are the electrophysiological time course changes for 
naïve slices which were used to account for potential molecular changes induced by 
different stimulation times in the recording chamber. (PC = preconditioning). 
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Figure 4.31 Western blots for the detection of HSP72 from the slices saved 
from the electrophysiological experiments in Figure 4.30. The Western blots 
show detection of HSP72 and actin with different treatments of slices indicated above. 
Shown below are Ponceau stains for each blot.  
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Figure 4.32 Histogram summarising the results of the Western blots in 
Figure 4.31. There are no significant changes in HSP72 between either treated slices and 
naïve slices or preconditioned slices and ouabain controls. 
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Figure 4.33 Pinacidil preconditioning is prevented by blockade of ATP-
sensitive potassium channels. a) Perfusion of 30µM glibenclamide during 30µM 
pinacidil preconditioning against 100µM ouabain. Note that the elevation in antidromic 
spike size during and after glibenclamide perfusion is significant (114.6 ± 3.6%, p<0.05 
one sample t test). b) the same data as in a) normalised prior to ouabain perfusion. There is 
no significant difference between preconditioned slices (n = 4) and controls (n = 4). 
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Figure 4.34 Pinacidil preconditioning against ouabain in the presence of a 
NMDA receptor antagonist.  a)  Perfusion of 100µM DL-AP5 during pinacidil 
preconditioning. b) The same data as above normalised prior to superfusion of 100µM 
ouabain. There is no significant difference between preconditioned slices (n = 3) and 
controls (n = 5).  
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4.2.11 - Stimulation with brief applications of glutamate causes a reduction 
in the size of evoked responses following ouabain 
Since there is previous evidence that low concentrations of glutamate can precondition 
against a toxic application of glutamate (Schurr et al., 2000), it was decided to determine 
whether glutamate could also precondition responses to ouabain. Glutamate was applied 3 
times at a concentration of 10mM for 2min. After the third glutamate application, ouabain 
(100μM) was applied for 2min resulting in a dramatic reduction of antidromic (Fig 4.35) 
and orthodromic (Fig 4.36) responses. The depression of potential size (epsps or 
antidromic) was significantly different from control responses to ouabain applied without 
preceding compounds (antidromic potentials: glutamate-treated n = 3; ouabain only n = 4, 
p<0.05; epsps: glutamate-treated n = 5; ouabain only n = 3; p<0.05 unpaired t-test with 
Welch correction). 
 
As the interaction of glutamate upon the post-ouabain recovery of the responses was so 
profound, some of the slices were saved for later analysis of molecular changes. Naive 
tissue which was stimulated in the recording chamber for the corresponding length of time 
of the preconditioning protocol and the control slice protocol was also obtained to account 
for any differences that may occur on account of variable stimulation times. The 
electrophysiology for these slices is shown in Figure 4.37. Western blotting was used to 
detect any changes in HSP72 expression in the slices (Fig 4.38). The results showed that 
there were no discernable changes in HSP72 between naive slices and the corresponding 
treated slices or between preconditioned and control slices (Fig 4.39). This indicated that 
the glutamate-ouabain protocol did not induce any changes in HSP72. 
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Figure 4.35 The effects of glutamate preconditioning against ouabain upon 
antidromic population spikes. 10mM glutamate preconditioning prior to application 
of ouabain in antidromic responses results in a significantly greater loss in spike size (26.2 
± 5.4%, n = 3) compared with ouabain only treated responses (68.1 ± 11.0%, n = 4) 
(p<0.05). 
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Figure 4.36 The effects of glutamate preconditioning against ouabain upon 
field epsps. 10mM glutamate preconditioning prior to application of ouabain in epsp 
responses results in a significantly greater loss in slope size (1.4 ± 2.2%, n = 5) compared 
with ouabain only treated responses (77.3 ± 9.7%, n = 4) (p<0.005) unpaired t test with 
Welch correction *(glut = glutamate). Note that percentage values in the legend are derived 
by taking the average epsp slope size in the 10min period prior to ouabain application as 
100%. The figure shows 100% baseline as the 10min period prior to the first application of 
glutamate for the preconditioned responses. 
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Figure 4.37 Electrophysiology of the slices used in the Western blots in 
Figure 4.36. The time course graph shows in the changes in epsp slope in response to 
10mM glutamate preconditioning prior to application of ouabain. Preconditioned epsp 
responses show a significantly greater loss in slope size in response to ouabain (2.0 ± 
5.6%, n = 4) compared with ouabain only treated responses (77.3 ± 9.7%, n = 4) (p = 0.005 
unpaired t test with Welch correction). Also shown are the time course changes in epsp 
slope recorded from slices which were stimulated for the same length of time as each 
treatment protocol, referred to as naive slices. *(glut = glutamate) (PC = preconditioning). 
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Figure 4.38 Western blots showing the immumodetection of HSP72 and actin 
levels in slices receiving glutamate preconditioning treatments followed by 
ouabain or ouabain only. The blots for the naive tissue show the detection of HSP72 
and actin levels in slices stimulated for the same length of time as the chemically treated 
slices as shown in Figure 4.37. The corresponding Ponceau stains are shown (in colour). 
(PC = preconditioning). 
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Figure 4.39 Histogram summarising the changes in HSP72 expression in 
glutamate preconditioned slices and ouabain treated slices. There are no 
significant changes between treatment groups (PC = preconditioning) (ns = not significant 
Bonferroni multiple comparisons test). 
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4.2.12 - Modulation of the effects of ouabain in antidromic spikes by calcium 
manipulation 
It was decided to examine the role, if any, of calcium in the effects of ouabain upon 
hippocampal responses as changes in calcium dynamics may alter to preconditioning 
(Bickler & Fahlman, 2004; Pérez-Pinzón et al., 1999).  The intracellular calcium chelator, 
BAPTA-AM (10µM) was perfused for 20min and had no effect on the antidromic 
population spike (p = 0.6885) (Fig 4.40). 100µM ouabain was then perfused for 2min in 
the presence of BAPTA-AM resulting in a dramatic loss in antidromic spike amplitude (2.4 
± 1.9%, n = 4) compared to ouabain only (83.5 ± 2.5%, n = 4) (p<0.001) (Fig 4.40) 
indicating that intracellular calcium is needed for recovery. To determine the exact nature 
of the role of calcium, we altered the concentration of CaCl2 in normal aCSF (2.5mM 
CaCl2) to 0.5mM or 5mM. Changes in [CaCl2] alone did not significant alter the 
antidromic spike amplitude after 30min (Fig 4.41) as expected from the absence of 
synaptic involvement in the antidromic potential. When 100µM ouabain was perfused onto 
the slice after 30min of altered [CaCl2], O.5mM CaCl2 produced dramatic reductions in 
response size similar to that seen for BAPTA-AM whilst 5mM CaCl2  prevented any 
significant change in the size of the response (107.9 ± 12.8%, p = 0.5568 one-sample t-
test). Given that BAPTA-AM or low extracellular calcium appear to enhance the 
depressant effect of ouabain and that the effect of ouabain can be attenuated by raising 
extracellular calcium concentration, it seems that ouabain induces its reduction in 
antidromic spike amplitude by decreasing intracellular calcium. 
To investigate further the possibility that intracellular calcium reduction is an effect of 
ouabain, potential downstream consequences on calcium-activated K+ channels were 
examined. The large conductance calcium-activated K+ channels (BK+ channels) were 
selected in particular as they have a reported role in preconditioning in cardiovascular 
tissue (Shintani et al., 2004; Feng et al., 2006). Charybdotoxin (ChTX), a selective channel 
blocker for BK+ channels was used at a concentration (25nM) that is reported not to 
induce changes in population spike amplitude although it may cause some spike 
broadening (Shao et al., 1999). We perfused ChTX for 1min prior to perfusion of ouabain 
and then for 3min after ouabain removal from the medium (Fig 4.42). The ChTX + 
ouabain group showed an enhanced depression of antidromic spike amplitude which 
continued until the end of the experiment (58.4 ± 7.0%, n = 4) compared to ouabain alone 
(74.9 ± 3.5%, n = 6)(p<0.05). This suggests further that intracellular calcium concentration 
is decreased upon ouabain application resulting in an inhibition of BK+ channels.  
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Figure 4.40 Modulation of the effect of ouabain upon the antidromic spike by 
BAPTA-AM a) Chelation of intracellular calcium using BAPTA-AM induces a dramatic 
loss in spike amplitude in response to ouabain perfusion. Note that BAPTA-AM alone does 
not affect antidromic spike amplitude. 
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Figure 4.41 Altered effects of ouabain in the presence of higher and lower 
concentrations of CaCl2. 0.5mM CaCl2 enhances the depression of antidromic spikes 
by ouabain (n = 3) compared to normal aCSF (n = 5) (p<0.0001). Ouabain is unable to 
produce a significant change in spike amplitude in the presence of 5mM CaCl2 (107.9 ± 
12.8%, p = 0.5568 one-sample t-test). Note that spike amplitude is unaffected by changes 
in [CaCl2] alone. 
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Figure 4.42 BK+ channel blockade enhances the ouabain-induced 
depression of antidromic spikes (ChTX = charybdotoxin).  
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4.3 – Discussion  
 
4.3.1 –The effects of 10mM glutamate upon the hippocampal slice 
 
4.3.1.1 - 10mM glutamate: effects on evoked responses 
Unlike 5mM glutamate, 10mM glutamate induced a significant depression in antidromic 
responses. The reduced action potential firing cannot be due to a glutamate-induced change 
in synaptic plasticity but probably some membrane dysfunction resulting from the likely 
entry of sodium and calcium ions through the glutamate ionotropic receptors. This would 
result in a change in resting membrane potential and subsequent interference with the 
opening of voltage-gated ion channels. Although the sodium-potassium pump should 
restore the ion equilibrium after membrane depolarization, the lasting depression in post-
glutamate recovery in the antidromic spikes may indicate that excessive ion influx has 
resulted in a cell swelling and subsequent damage to the structural integrity of the neuron. 
Bandyopadhyay et al. (2002) demonstrated cell swelling in slices in response to 100µM 
NMDA by using optical image scattering. The reduced potential size in the orthodromic 
responses following glutamate may be indicative of a similar effect or it could be due to a 
change in synaptic plasticity. This might include glutamate-induced long-term depression 
or increased inhibitory neurotransmission.  
The effects of glutamate itself on the evoked responses from the hippocampal slice are 
consistent with those reported in the literature (Wallis et al., 1994; Alici et al., 1996; 
Obrenovitch et al., 1997). Some studies confirm a loss of electrophysiological 
responsiveness that is highly comparable to that reported here, mainly a complete loss of 
evoked responses upon application of millimolar concentrations of glutamate for several 
minutes which returns during washout to a reduced level (Wallis et al., 1994; Alici et al., 
1996). Wallis et al. (1994) observed these effects using 9mM glutamate for 8min; this 
resulted in approximately 25% recoveries for antidromic and orthodromic population 
spikes at 1hour post-glutamate. They concluded that the reduced recovery for antidromic 
population spike amplitude was evidence of excitotoxicity. The epsp slope showed no 
recovery using the same protocol. The authors also noted that 5mM glutamate for 8min 
exposure did not induce a significant depression in the recovery of antidromic and 
orthodromic population spikes and concluded that 5mM glutamate was not a toxic 
concentration. Alici et al. (1996) applied 5mM and 10mM glutamate to hippocampal slices 
for 20min and measured the extracellular calcium concentration using calcium-sensitive 
electrodes. They observed that extracellular calcium concentration decreased from 1.2mM 
to approximately 0.83mM and 0.79mM for 5 and 10mM glutamate respectively. They 170 
 
noted that the calcium concentration returned to baseline levels within 15-20min of the 
washout period, an effect which is consistent with the return of the evoked responses in the 
results presented in this thesis. Alici et al. (1996) also observed that antidromic and 
orthodromic responses recovered to baseline levels following treatment with 10mM 
glutamate whilst higher concentrations (20mM and 50mM) induced an irreversible loss of 
response. The effects of glutamate on evoked responses presented in the results appear to 
agree with those of Wallis et al. (1994) and disagree with Alici et al. (1996). This might be 
on account of the calcium concentrations used in each study.  Alici et al., (1996) used 
1.6mM CaCl2 in the aCSF whilst Wallis et al. (1994) used 2.4mM CaCl2 which is closer to 
the concentration used in the present study (2.5mM CaCl2). This could explain the 
difference in sensitivity of evoked responses to glutamate shown in each study as calcium 
influx has been shown to mediate glutamate-induced extended neuronal depolarization in 
hippocampal neuronal cultures (Limbrick et al., 2003).   
The effects of exogenously applied glutamate have also been examined in other neuronal 
preparations. Obrenovitch et al. (1997) have observed a concentration-dependent 
depolarization of the intracellular potential upon intracerebral application of 5 or 20mM 
glutamate for 2min to striatal tissue. Sombati et al. (1991), Coulter et al. (1992) and 
Limbrick et al. (2003) have observed similar changes in membrane potential in 
hippocampal neuronal cultures using 500µM glutamate in the presence of 10µM glycine. 
In these studies glutamate exposure produced burst firing followed by a depolarization of 
the membrane potential. During glutamate washout, the membrane potential remained 
depolarized to approximately -5mV for hours post-treatment; this effect is termed 
“extended neuronal depolarization” by the authors. Coulter et al. (1992) demonstrated that 
there was no change in responsiveness to glutamate or cell morphology at 4hours post-
glutamate but that cytotoxicity occurred at 24hrs post glutamate. It was also shown that 
calcium influx is required for the induction (Coulter et al., 1992) and maintenance 
(Limbrick et al., 2003) of extended neuronal depolarization. Hippocampal neuronal 
cultures are more sensitive to glutamate than acute slice preparations and die from 
exposure to micromolar concentrations. This increased sensitivity is presumably due to the 
lack of glia and their glutamate transporters to reduce extracellular glutamate 
accumulation. In spite of the difference in glutamate concentration used, the time course 
and nature of changes in membrane potential in hippocampal cultures are similar to those 
in the evoked responses presented here. It is possible that extended neuronal depolarization 
underlies some of the effects observed in hippocampal slices in relation to low post-
glutamate recovery of evoked responses. 171 
 
4.3.1.2  - 10mM glutamate: effects on LTP 
The post-glutamate response to a 100Hz/1sec stimulus again differed greatly between 
5mM and 10mM glutamate concentrations. The depression in post-10mM glutamate 
responses was not reversed using a 50% baseline. The effects of stimulus intensity on the 
degree of LTP induced by theta frequency stimulation as reported by Leung & Au (1994) 
may explain the discrepancy between 5mM and 10mM glutamate concentrations which 
used 25% maximal and 50% maximal baselines respectively in the present study. Leung & 
Au reported that larger potentiations were obtained using smaller baselines therefore the 
use of a 25% maximal baseline for 5mM glutamate may have induced LTP whereas 50% 
maximal baselines for 10mM glutamate may not. However, control LTP responses were 
obtained in slices taken from the same hippocampus as those which received 10mM 
glutamate stimulation; as a 100Hz/1sec stimulus would be expected to reverse the effects 
of LTD (Dudek & Bear, 1992; Dudek & Bear, 1993), the failure of such a stimulus to 
reverse the effects of 10mM glutamate indicates that this concentration does not induce 
LTD. Taken together with the reduction of antidromic spike amplitudes following 
treatment with 10mM glutamate, it can be suggested that 10mM glutamate exerts a toxic 
effect upon the tissue. 
 
4.3.1.3 - 10mM glutamate: effects on heat shock protein expression 
Potential changes in heat shock protein expression were also examined in response to 
10mM glutamate exposure in hippocampal tissue. No statistically significant difference in 
heat shock protein 72 expression between naive tissue and glutamate-exposed tissue. 
Changes in heat shock protein expression have been noted in hippocampal tissue in 
response to excitotoxicity in vivo (Ayala & Tapia, 2003). In the study by Ayala & Tapia 
(2003), rats were treated with 4-AP (a potassium channel blocker) via microdialysis in the 
hippocampus. Electroencephalogram recording showed seizure activity in response to 4-
AP which was inhibited by the glutamate antagonists, MK-801 and NBQX. It was also 
noted that extracellular glutamate concentration was increased in 4-AP exposed tissue. 
However, they were unable to detect changes in heat shock protein 72 until at least 6 hours 
post-treatment had elapsed.  A different study has shown dectection of  changes in heat 
shock protein expression  within 30min within the hippocampus in vivo (Galli et al., 2006) 
although it has also been reported that HSP72 expression in the CA1 region does not 
appear until 16hours after 5min ischaemia induced by a four-vessel occlusion (Nishi et al., 
1993). The 1hour time point post-glutamate at which the slices were frozen may explain 172 
 
why no significant changes were detected in protein expression in the results presented 
here.  
 
4.3.1.4  - Assessing toxicity to acute injury 
Direct assessment of glutamate toxicity in hippocampal slices has been difficult in this 
study and others. Lozovaya et al. (2004) have indicated that exogenously applied glutamate 
only reaches the cell body in hippocampal slices as the synapses are protected by the 
uptake mechanisms of the glutamate transporters; that study however used micromolar 
concentrations of glutamate which are much lower than the millimolar concentrations used 
in the present study. Virgili et al. (1997) have detected reduced rates of protein synthesis 
following exposure to 5mM glutamate in hippocampal slices. Studies examining positive 
indicators of cell death such as morphological changes or molecular markers in response to 
such exogenous chemical insults are lacking in slice systems, mainly because of the acute 
nature of electrophysiological responsiveness compared with the time scale taken to induce 
such changes which may extend from several hours to days. It has been noted in 
hippocampal neuronal cultures that exposure to 500µM glutamate shows a neuronal 
survival of 70-80% in the short-term; at 24hours it was observed that more neurons then 
died highlighting the difficulty in assessing short-term changes with long-term (Coulter et 
al., 1992). Lees and Sandberg (1991) conducted electrophysiology in vivo to obtain 
histological changes several days after a glutamate insult although they were able to 
correlate changes in evoked responses with delayed cell death. For in vitro systems, slice 
cultures may prove a more suitable tool for assessing electrophysiology with delayed cell 
death. For acute changes in evoked responses however, visual analysis may be better to 
confirm tissue injury using agents such as propidium iodide or Rhodamine 123, both of 
which require confocal microscopy. Optical image scattering may also be used to assess 
cell swelling rather than molecular markers or changes in morphology of hippocampal 
slices. 
 
4.3.2 - Adenosine preconditioning: interaction with exogenous glutamate 
No interaction was found between adenosine preconditioning and exogenous glutamate 
using various concentrations of adenosine and different preconditioning protocols. This 
was a surprising result as adenosine has been shown to precondition against hypoxia 
(Pérez-Pinzón et al. (1996) using 100µM adenosine for 10min, a protocol which was 173 
 
attempted against glutamate in the present study. Adenosine is released during hypoxia 
(Pedata et al., 1993) and also during NMDA receptor stimulation (Manzoni et al., 1994; 
Hoehn & White, 1990) so that a potential interaction seemed likely. In addition adenosine 
may trigger glutamate release (Okada et al., 1992) in some circumstances leading one to 
hypothesize that an indirect excitotoxic preconditioning effect might occur. No interaction 
was observed in orthodromic or antidromic population spikes here suggesting that any 
potential glutamate release is not sufficient to precondition against 10mM glutamate or that 
adenosine release during hypoxia or NMDA receptor stimulation is unaffected by 
adenosine preconditioning. 
Adenosine might be expected to precondition against excitotoxicity by inhibiting glutamate 
release pre-synaptically via A1 receptor stimulation. This may explain the discrepancy 
between anoxia used by Pérez-Pinzón et al. (1996) and glutamate used in the present study. 
 
4.3.3  -  Effects of ouabain on evoked responses: excitatory transmission 
The sodium-potassium ATPase inhibitor ouabain produced multiple spikes in evoked field 
potentials followed by a depression in response size. Ouabain-induced multiple spiking of 
evoked responses has been attributed to calcium influx (McCarren & Alger, 1987). The 
depression in potential size was the parameter examined in the present study. It was first 
noted that antidromic population spikes showed a significantly smaller depression in 
response size than orthodromic spikes and field epsps. The discrepancy in effect seems to 
be due to differences in glutamate receptor stimulation at the cell body and dendrites in 
response to ouabain exposure. The broad spectrum glutamate receptor antagonist, 
kynurenic acid (Perkins & Stone, 1982; Stone & Darlington, 2002), was able to prevent the 
ouabain-induced depression in orthodromic population spikes which are driven by synaptic 
transmission whilst the significantly smaller depression in antidromic population spikes 
was unaffected by glutamate receptor blockade. These results are consistent with those of 
Jarvis et al. (2001) who showed that neocortical brain slices showed a decrease in light 
transmittance in response to ouabain which is consistent with water uptake into the cell. 
The authors also showed that this effect occurred in the presence of kynurenic acid. As the 
protocol for ouabain application to the tissue was exactly the same as that used in the 
present study (100µM ouabain applied for 2min), it seems likely that the results presented 
here using antidromic spikes in the presence of ouabain reflect a degree of cell swelling in 
the hippocampal slice that occurs independently of glutamate. This is also consistent with a 
reported observation that exogenously applied glutamate only reaches the cell body in 174 
 
hippocampal slices as the synapses are protected by the uptake mechanisms of the 
glutamate transporters (Lozovaya et al., 2004). It can therefore be assumed that 
synaptically released glutamate would not reach the cell body as a result of the same 
uptake mechanisms. This may be considered as a useful model of ischaemia in the rat 
hippocampal slice as 10min OGD exposure in this experimental system has yielded cell 
swelling and loss of electrophysiological responsiveness in CA1 neurons that was not 
mediated by glutamate (Obeidat et al., 2000); these effects were attributed to damage that 
occurred from spreading depression, a phenomenon that induces a wave of electrical 
silence over neuronal tissue and which occurs independently of glutamate. Ouabain has 
been considered to be a useful model of spreading depression in other studies which utilize 
hippocampal slice systems (Barsarksy et al., 1998; Obeidat & Andrew, 1999; Basarsky et 
al., 1999; Balestrino et al., 1999).   
Whilst the antidromic spike depression occurs without glutamate receptor stimulation, it is 
apparent that the depression in orthodromic responses occurs in response to glutamate 
accumulation at the synapse leading to enhanced glutamate receptor stimulation. 
Glutamate may accumulate in the extracellular space in a few ways: 
 
1.  Sodium-potassium ATPase inhibition may depolarise the pre-synaptic neuron 
allowing calcium entry and therefore exocytotic release of glutamate (Drejer et al., 
1985) 
2.  Sodium-potassium ATPase inhibition may result in cell swelling leading to 
activation of glutamate-permeable volume-sensitive anion channels, therefore 
increasing efflux and extracellular accumulation of glutamate (Basarsky et al., 
1999). 
3.  Glutamate uptake in the pre-synaptic nerve terminals and glia is driven by the 
gradient of sodium (for binding glutamate) and potassium (for net transport) ions at 
the glutamate transporter (for review see Tzingounis & Wadiche, 2007). This 
process is therefore dependent on the ability of the sodium-potassium ATPase to 
maintain the ion equilibrium across the membrane. Inhibition of the pump results in 
accumulation of extracellular glutamate due to reduced uptake at the transporters 
(Madl & Burgesser, 1993; Roettger & Lipton, 1996; Rossi et al., 2000). 
The effects of ouabain on orthodromic responses are consistent with the report of Basarsky 
et al. (1999) which showed that 100µM ouabain perfused for 90seconds onto hippocampal 175 
 
slices produced cell swelling detected by intrinsic optical imaging and glutamate efflux 
measured by high performance liquid chromatography. The glutamate efflux was 
prevented by blocking glutamate permeable volume-sensitive organic anion channels with 
5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB) in the presence of zero calcium and 
EGTA. In the present study, adenosine only preconditioned against ouabain-induced 
depressions in the antidromic and orthodromic population spikes and not the field epsps, 
therefore the mechanism of glutamate accumulation at the synapse was not investigated 
further as it seemed unlikely that adenosine exerted its effects by modulating synaptic 
glutamate levels. The source of glutamate accumulation could be investigated by co-
perfusing adenosine with ouabain in a similar manner to the experiments conducted with 
kynurenic acid and ouabain in orthodromic potentials. Adenosine inhibits exocytotic 
release of glutamate therefore if the ouabain-induced depression was blocked in the 
presence of adenosine, this would suggest that glutamate is pre-synaptically released by 
exocytosis. Alternatively the pre-synaptic release of glutamate could be directly measured 
by examining potential changes in the frequency of spontaneous mepsps by quantal 
analysis. If the result suggested that glutamate accumulation resulted from blockade of 
transporters, one could selectively block glial or neuronal transporters. Madl & Burgesser 
(1993) used high performance liquid chromatography (HPLC) to directly measure ATP 
content and the uptake and release of excitatory amino acids in hippocampal slices. Using 
D, L-threo-β-hydroxyaspartate, a substrate for the transporters, it was determined that ATP 
depletion decreased uptake into neurons and glia. Decreased glutamate immunoreactivity 
also occurred primarily at axonal terminals suggesting that extracellular glutamate 
accumulation was mainly due to pre-synaptic reversal of transporters. Calcium was 
removed from the medium to exclude an exocytotic mechanism. The authors also showed 
that 1µM ouabain acted in synergy with ATP depletion to increase extracellular glutamate. 
Similar observations have been made in rat spinal dorsal white matter showing that 
reduction in compound action potentials in response to ouabain exposure were attenuated 
by blockade of glutamate receptors and sodium-dependent glutamate transporters (Li & 
Stys, 2001). Voltage-sensitive dyes have been used to examine glutamate transporter 
activity in rat hippocampal slices showing a role for glia in glutamate removal from the 
extracellular space (Nakamura et al., 2003).  
Rossi et al. (2000) showed that current changes generated in CA1 cells during perfusion 
with 95%N2/5%CO2 bubbled aCSF containing 7mM sucrose in place of 10mM glucose 
were the result of glutamate release; they further showed that these current changes 
occurred when the neuronal glutamate transporters were reversed and not by other 176 
 
proposed mechanisms of glutamate accumulation such as exocytosis, cell swelling-induced 
release and release from glia.  
From the present results it appears that glutamate release in response to ouabain is spatially 
limited to the synapse and does not affect the changes observed in the antidromic 
population spike. This appears consistent with the known literature reporting the effects of 
ouabain such as glutamate-independent cell swelling (Jarvis et al., 2001) and extracellular 
glutamate accumulation via reversed uptake into neurons (Rossi et al., 2000) and release 
through volume-activated channels (Basarsky et al., 1999). 
 
4.3.4  - Effects of ouabain on evoked responses: inhibitory transmission 
4.3.4.1  - Adenosine 
Experiments were also conducted to investigate the role of the inhibitory neurotransmitters, 
adenosine and GABA, in mediating the ouabain-induced orthodromic spike depression.  
Adenosine A1 receptor blockade during application of ouabain indicated that adenosine 
was not released in response to sodium-potassium pump inhibition. Other adenosine 
receptors were not examined on account of the lack of effect of A1 receptor blockade. If 
adenosine were released, it would first bind to the higher affinity A1 receptors before 
binding to others. This is consistent with the observations of Vaillend et al. (2002) which 
show that potentiation of E-S- coupling in response to dihydroouabain, a low affinity 
analogue of ouabain, was not prevented in the presence of DPCPX. It should be noted that 
in the study by Vaillend et al. (2002), dihydroouabain induced epileptiform activity 
without altering resting extracellular potassium ion concentration. They also noted a 
potentiation in E-S coupling in response to dihydroouabain signifying an increase in 
population spike amplitude whilst the observations in the present study show that ouabain 
induced the opposite effect upon population spikes. Despite the differences in 
electrophysiological effects and the use of different sodium pump inhibitors, Vaillend et 
al., support the results of the present study which show an absence of adenosine A1 
receptors in the effects of ouabain upon orthodromic population spikes.  
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4.3.4.2  - GABA 
The role played by GABA in the ouabain-induced effects in orthodromic potentials is less 
clear than that of adenosine. The changes in orthodromic population spikes in response to 
ouabain were examined in the presence of GABAA  and GABAB  receptor antagonists. 
GABAB receptors had no clear role in the ouabain-induced effects. In the presence of the 
GABAA receptor antagonist, bicuculline, the ouabain-induced depression in orthodromic 
population spikes was enhanced. Having established that extracellular glutamate probably 
increases during ouabain perfusion, the most likely explanation is that inhibition of 
GABAA receptor blockade increased glutamate release from pre-synaptic neurons. As 
GABAA receptor blockade enhanced the effect of ouabain, this suggests that synaptic 
glutamate accumulation resulting from sodium-pump inhibition occurs primarily as a result 
of reduced glutamate uptake from the synaptic space as opposed to exocytotic release of 
excitatory neurotransmitter (see Figure 4.43). It is possible however that ouabain, by 
depolarizing the pre-synaptic membrane, induces vesicular release of glutamate. The 
vesicles may not be completely depleted of neurotransmitter after ouabain-induced 
exocytosis therefore GABAA receptor blockade might contribute to further exocytosis. The 
possibility of GABA release during ouabain perfusion is therefore unlikely; it cannot be 
completely dismissed however as the effect of any blockade of GABA inhibition on the 
orthodromic responses may have been hidden by the resulting increase in glutamate release 
which would enhance the glutamate-induced depression in the orthodromic responses (see 
Figure 4.43). However, given that there was no change in the nature and time course of the 
orthodromic population spike in response to ouabain in the presence of a GABAB receptor 
antagonist, release of GABA in response to sodium-potassium ATPase inhibition seems 
unlikely. It has been shown by Matsumoto et al. (2002) that mIPSCs recorded from 
dissociated CA1 neurons with intact pre-synaptic terminals increase in frequency to 
approximately 160% in response to 100µM ouabain. Vaillend et al. (2002) report a similar 
observation with dihydroouabain on mIPSC frequency in hippocampal slices. These 
studies both indicate that GABA is released pre-synaptically in response to ouabain. 
Earlier studies however, report a decrease in the size of the evoked IPSP in response to 
strophanthidin, a cardiac glycoside that induced burst firing in orthodromic population 
spikes (McCarren & Alger, 1987). The authors attributed the strophanthidin-induced 
epileptiform activity to a decrease in GABAergic inhibition. This study examined 
hyperexcitability induced by various cardiac glycosides similarly to Vaillend et al. (2002). 
As there appears to be some disagreement in the literature regarding the effects of sodium-
potassium ATPase inhibition upon GABAergic transmission, it may be beneficial to clarify time (min)
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Figure 4.43 Possible mechanisms underlying the effects of ouabain on 
orthodromic population spikes during GABAA receptor blockade. The upper 
graph indicates how GABA and glutamate may affect the time course of the experiment. 
The lower graph indicates the possible ways that glutamate is released into the synaptic 
space during GABAA receptor blockade and Na
+/K
+ ATPase inhibition. 
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the effects of ouabain upon GABA in the present study with future experiments that 
examine the effect of ouabain upon IPSPs. 
Although pharmacological blockade of GABA receptors did not conclusively show if 
GABA was or was not released during ouabain perfusion, it is possible that the blockade 
by kynurenic acid of ouabain-induced depression of orthodromic population spikes was a 
result of reduced feedback inhibition (Belan & Kostyuk, 2002). Release of GABA to 
mediate feedforward inhibition is unlikely as glutamate receptor blockade would not have 
prevented the effects of ouabain in orthodromic spikes (Tomasulo et al., 1991). The 
GABAergic neurons comprise less than 10% of the overall neuronal population in the CA1 
area (Aika et al., 1994) therefore it is unlikely that they release GABA in sufficient 
quantities to mediate the ouabain-induced depression in orthodromic population spikes.  
 
4.3.5 - Effects of ouabain on evoked responses: calcium modulation 
Having established that the ouabain-induced depression in antidromic spike amplitude was 
independent of glutamate, alternative mechanisms were sought to explain this 
phenomenon. The role of calcium was examined in mediating this effect for various 
reasons: blockade of the sodium-potassium ATPase  results in intracellular calcium 
accumulation in the heart (Reuter et al., 2002) and neuronal tissue (Saghian et al., 1996; 
Dietz et al., 2007); the relationship of the sodium-potassium ATPase to the regulation of 
the sodium-calcium exchange mediates the action of cardiac glycosides in the heart (Reuter 
et al., 2002); increasing intracellular calcium in hippocampal slice cultures (Bickler & 
Fahlman, 2004) and acute slices (Pérez-Pinzón et al., 1999) is implicated in 
preconditioning.  
4.3.5.1 - Intracellular calcium 
The effect of using an intracellular calcium chelator on the response of the antidromic 
population spike to ouabain was initially examined. BAPTA-AM alone produced no 
change in the antidromic population spike amplitude. Upon co-perfusion with ouabain in 
the presence of BAPTA-AM, there was a dramatic reduction in the size of the antidromic 
population spike which greatly exceeded the degree produced by ouabain alone. From this 
it is possible that ouabain in normal aCSF increases or decreases intracellular calcium 
concentration; a decrease in calcium would explain why ion chelation enhanced the effect 
of ouabain although it might therefore be expected that a decrease in antidromic spike 
amplitude would occur in response to BAPTA-AM alone. BAPTA-AM has been used at 180 
 
much higher concentrations in hippocampal slices without any disruption of the recorded 
parameter (Niesen et al., 1991; Fredholm & Hu, 1993; Spigelman et al., 1996; Tonkikh et 
al., 2006) consistent with its action in the present study.  
It has been shown that intracellular calcium accumulation from oxygen and glucose 
deprivation can directly decrease the activity of the sodium-potassium ATPase in rat 
cortical slices (Matsuda et al., 1992). The authors observed that this effect was blocked by 
BAPTA-AM but not by removing extracellular calcium. If intracellular calcium 
accumulation itself decreases the activity of the sodium-potassium ATPase then it will be 
more vulnerable to inhibition by ouabain. The present results appear to disagree with 
Matsuda et al. (1992) as BAPTA-AM potentiated the deleterious effect of ouabain on the 
antidromic population spike. However the observation by Matsuda et al. (1992) that 
removal of extracellular calcium did not prevent the inhibition of sodium-potassium 
ATPase activity is inconsistent with their result using BAPTA-AM and the present results. 
BAPTA-AM is reported to block the large conductance calcium-activated potassium 
channels (Storm, 1987; Niesen et al., 1991) which contribute to repolarization of the 
membrane potential (Poolos & Johnston, 1999). It is possible that the Matsuda et al. (1992) 
results reflect such a change induced by intracellular calcium which is independent of 
extracellular calcium concentration.  
The other explanation of the present results is that ouabain increases intracellular calcium; 
an accumulation of positive charge intracellularly would result in increasing the membrane 
potential; this may lead to initial increases in spike discharges as the membrane potential is 
closer to firing threshold and eventually result in overdepolarization of the neuron thereby 
reducing action potential firing. This would be consistent with the epileptiform activity 
induced upon initial exposure to ouabain which has been previously attributed to elevations 
in intracellular calcium (McCarren & Alger, 1987; Alger & Williamson, 1988). Either 
increasing or decreasing calcium may result in disrupting action potential firing and 
therefore decreasing the size of the antidromic population spike. To examine this further, 
the effects of modulating extracellular calcium on ouabain-induced changes in evoked 
responses were studied. 
 
4.3.5.2 - Extracellular calcium 
It was observed that ouabain produced similar effects in the presence of low extracellular 
calcium concentration as those in the presence of BAPTA-AM. Like BAPTA-AM, low 181 
 
calcium concentration alone did not affect the antidromic population spike.  Using twice 
the concentration normally present in aCSF resulted in attenuating the ouabain-induced 
depression in antidromic spike amplitude; overall the results indicated that ouabain acts to 
decrease intracellular calcium concentration.  This is consistent with the report of Bickler 
& Fahlman (2004) which showed, using hippocampal slice cultures, that increasing 
intracellular calcium with calcimycin or ionomycin, small lipid-soluble molecules which 
bind to calcium ions and carry them across the cell membrane without inducing 
excitotoxicity, resulted in reducing cell death in the CA1, CA3 and dentate gyrus areas in 
response to a 45min exposure to OGD. Pérez-Pinzón et al. (1999) also showed that an 
anoxic preconditioning paradigm in acute hippocampal slices failed to promote recovery of 
evoked responses when the calcium concentration in the perfusion medium was lowered to 
05.mM from 2mM. These studies support the damaging effect of decreasing calcium 
levels.  
It has also been observed however, that 30µM ouabain in acute hippocampal slices results 
in increased intracellular calcium detected by Fura-2 in CA1 neurons (Dietz et al., 2007), 
an effect that was reduced by KB-R7942, an inhibitor of the sodium-calcium exchange in 
its reverse mode. The authors noted that intracellular calcium initially increased at 8min 
post-ouabain then returned to basal levels. This was followed by a second increase in 
calcium levels which did not recover. Zhan et al. (1998) observed that 50µM ouabain 
exposed for 4min onto acute hippocampal slices increased intracellular calcium which 
resulted in reducing intracellular pH. Removing calcium from the perfusion medium 
resulted in no elevation of intracellular calcium in response to ouabain. The measurements 
for calcium were taken no longer than 15min post-ouabain exposure. The studies by Dietz 
et al. (2007) and Zhan et al. (1998) are consistent with the known mechanism of action of 
cardiac glycosides in the heart which involves inhibiting the sodium-potassium ATPase 
resulting in reversal of the sodium-calcium exchange; this in turn causes intracellular 
calcium accumulation which strengthens the contractility of myocytes (Reuter et al., 2002). 
The relationship between the sodium-potassium ATPase and the sodium-calcium 
exchanger has also been characterised in cultured cerebellar granule cells (Czyz et al., 
2002a; Czyz et al., 2002b). The mechanism of calcium accumulation by sodium-potassium 
ATPase inhibition is also consistent with an OGD model of ischaemia which showed 
increases in intracellular calcium during 5min of OGD in hippocampal slices (Lobner & 
Lipton, 1993). This study showed that the initial influx of calcium occurred via NMDA 
receptors which was then superceded by calcium influx via voltage-gated calcium channels 
and reversal of the sodium-calcium exchange after 2.5min; the last two pathways 
accounted for approximately 60% of the overall influx. It has also been specifically shown 182 
 
that inhibition of the reverse mode of the sodium-calcium exchange by KB-R7943 in 
hippocampal slices improves the recovery of population spikes following low oxygen and 
low glucose exposure (Schroder et al., 1999). 
The smaller concentrations of ouabain used by Dietz et al. (2007) and Zhan et al. (1998) 
induced increases in intracellular calcium. This is consistent with the use of low affinity 
analogues of ouabain to induce multiple spiking in responses without changing potential 
size (McCarren & Alger, 1987; Vaillend et al., 2002). It is also consistent with the 
epileptiform activity observed upon initial ouabain exposure prior to decreasing potential 
size in the present study. It is possible that the continued accumulation of calcium in the 
present results may induce calcium sequestration and/or efflux via the plasmalemmal 
calcium-ATPase resulting overall in reduced calcium levels in the cytoplasm. As ATP 
levels were not depleted in this study by removal of oxygen and/or glucose, this pump may 
have compensated for any resulting calcium accumulation. The intermittent increases in 
intracellular calcium observed by Dietz et al. (2007) suggest that different calcium influx, 
efflux, release or sequestration mechanisms occur in a time-dependent manner which may 
also be true of the present results. As noted above, the studies by Dietz et al. (2007) and 
Zhan et al. (1998) took intracellular calcium measurements shortly after ouabain exposure 
which reflects initial changes in calcium dynamics only. The results presented here imply 
that ouabain initially increases intracellular calcium in CA1 neurons due to the presence of 
epileptiform activity. Intracellular calcium then appears to diminish if correlating with the 
reduction of spike size. Further changes in intracellular calcium may occur in response to 
ouabain similarly to Dietz et al. (2007), but the calcium manipulations prior to, during and 
after ouabain is applied may prevent their detection. It may be useful to alter calcium 
concentration after ouabain exposure in future experiments to better understand the 
complex effects of this ion. 
 
4.3.5.3 - Large-conductance calcium-activated potassium channels 
As the antidromic population spike represents the summation of synchronously firing 
action potentials from a population of neurons (Anderson et al., 1971b) generated in the 
absence of synaptic input, a decrease in spike size probably reflects a change in the 
intrinsic conductances that generate action potentials. The large conductance calcium-
activated K+ channels (BK+ channels) mediate the fast afterhyperpolarization which 
contributes to the repolarization of action potentials in the CA1 somata (Poolos & 
Johnston, 1999). The BK+ channels were selected in particular as they have a reported role 183 
 
in preconditioning in cardiovascular tissue in vivo (Shintani et al., 2004) and in vitro (Feng 
et al., 2006) and BAPTA-AM is reported to block the fast afterhyperpolarization mediated 
by BK+ channel opening  in CA1 neurons (Storm, 1987; Niesen et al., 1991). They are also 
regulated by voltage in addition to calcium; the voltage sensor on the channel is 
responsible for its activation which can occur in the absence of calcium. It is important to 
note that the modulatory effect of calcium seems necessary to allow proper functioning to 
continue (Barrett et al., 1982; Cox et al., 1997). Charybdotoxin (ChTX), a selective 
channel blocker for BK+ channels was used at a concentration (25nM) that is reported not 
to induce changes in population spike amplitude although it may cause some spike 
broadening (Shao et al., 1999). Co-perfusion of ouabain and ChTX resulted in enhancing 
the ouabain-induced depression in antidromic spike amplitude thus suggesting that sodium-
potassium ATPase inhibition decreases the open probability of BK+ channels. Given the 
results with calcium concentration manipulation and BAPTA-AM, it is likely that a 
decrease in intracellular calcium in response to ouabain results in blocking the BK+ 
channels although the change in membrane potential from ouabain-induced depolarization 
may activate the channels. This has implications for the formation of action potentials as 
the membrane potential will take longer to repolarise by reducing the fast 
afterhyperpolarization. 
It has been reported by Reich et al. (2004) that a depression in orthodromic population 
spikes in response to dihydroouabain was prevented by iberiotoxin, another inhibitor of 
BK+ channels. The discrepancy between this result and those in the present study may be 
due to the low affinity ouabain analogue used by Reich et al. (2004). They noted that the 
depression induced in orthodromic population spikes occurred independently of NMDA 
receptor stimulation and attributed this to decreased pre-synaptic transmitter release on 
account of BK+ channel blockade at the nerve terminal. This is in contrast to the present 
results which show that glutamate receptor stimulation is required to induce a depression 
by ouabain in orthodromic responses. Like the other studies using low-affinity analogues 
(McCarren & Alger, 1987; Vaillend et al., 2002) or smaller concentrations of ouabain 
(Dietz et al., 2007; Zhan et al., 1998) there may be a threshold of sodium-pump inhibition 
that is not reached in these studies to produce a resulting decrease in intracellular calcium 
following an initial increase. If calcium levels keep changing throughout the post-ouabain 
recovery, it may be useful to block the BK+ channels after exposure to ouabain to fully 
elucidate its mechanisms. It may also be useful to observe the effect of ouabain in the 
presence of a BK+ channel opener such as NS 1619. 184 
 
It has been shown that ChTX at 15-20nM concentrations was able to inhibit the 
afterhyperpolarization of stimulus-induced epileptiform activity in the hippocampus (Alger 
& Williamson, 1988) suggesting that BK+ channels open during such activity. This would 
seem consistent with the current results on account of the appearance of multiple spiking 
and the subsequent blockade of BK+ channels by ChTX. The greater reduction in 
antidromic spike amplitude in response to ouabain in the presence of ChTX is also 
consistent with a report that opening of BK+ channels reduces the effects of hypoxia-
induced spreading depression in rat hippocampal slices (Hepp et al., 2005). Overall it 
appears that initial activation of BK+ channels is followed by reduced opening in response 
to ouabain on the antidromic population spike in CA1 neurons. This would be consistent 
with a biphasic effect on calcium levels following sodium-potassium pump inhibition. 
 
4.3.6 - Effects of ouabain on the induction of LTP 
As glutamate receptor stimulation mediates the effects on orthodromic population spike 
amplitude, the subsequent effects on synaptic plasticity were investigated. It was observed 
that using a 100Hz stimulus for 1second appeared to reverse the effects of ouabain on the 
evoked potential although it was significantly less than the LTP induced in control slices. 
This may have been due to variations in the percentage baseline obtained for each 
individual slice as according to Leung & Au (1994), lower baselines will produce greater 
potentiations. Statistical analysis of the baselines obtained between groups showed no 
significant differences however, indicating that this probably does not account for the 
effect observed.  
It was also noted that when the baseline had been set to 50% of the maximum value, 
ouabain failed to induce a significant depression in the orthodromic population spikes. It is 
possible that lowering the stimulation strength lowers basal metabolic rate as fewer energy-
dependent processes (e.g. transmitter uptake, synthesis, degradation) required for 
neurotransmission will be active. The neurons could be effectively preconditioned against 
the subsequent ouabain insult as the slice has adapted to a lower metabolic rate. It is also 
possible that there will be a longer time to overdepolarization of the neurons using a 
smaller baseline. This could enhance protection as the damage produced by ouabain-
induced depolarization is due to cell swelling (Jarvis et al., 2001). With initially fewer 
electrically active neurons, the onset of depolarization will take longer. While the active 
neurons may still suffer some damage due to cellular swelling, the electrically silent 
neurons may become more excitable and thus are stimulated at a lower threshold. Also, 
delay in the onset of hypoxia-induced depressions in hippocampal responses have been 185 
 
shown to be neuroprotective (Balestrino & Somjen, 1986). However, using a 50% baseline 
for epsps in the adenosine preconditioning experiments against ouabain did not seem to 
alter the extent of depression induced by ouabain. This may simply be due to the 
fundamental differences in epsp and population spike generation as only the latter 
highlighted the preconditioning effect of adenosine against ouabain.  
It was therefore concluded that ouabain has a deleterious effect on synaptic plasticity in the 
hippocampal slice indicating that the glutamate-induced effects may comprise a mixture of 
long-term depression and toxicity. 
 
4.3.7 - Post-adenosine effects on evoked responses 
It was observed that following adenosine exposure, antidromic and orthodromic population 
spikes increased significantly in size by approximately 10% whilst epsp slope showed no 
change and epsp amplitude decreased significantly; this suggested that dissociations may 
occur between epsp amplitude and population spike amplitude if they are recorded 
simultaneously. The effect on population spike amplitude may be attributed to opening of 
ATP-sensitive potassium channels. ATP-sensitive potassium channels do not affect the 
response of epsps to adenosine but do mediate the inhibitory response of adenosine on 
orthodromic population spikes (Hosseinzadeh & Stone, 1998) and exhibit different 
properties at pre- and post-synaptic sites (Hosseinzadeh & Stone, 1998; Matsumoto et al., 
2002). This is consistent with the occurrence of elevations in population spikes only and 
not epsps in the present results. However, adenosine-induced hyperpolarizations in CA1 
neuronal membrane potentials are attributed to the opening of ATP-sensitive potassium 
channels due to the inhibition of this effect by glibenclamide (Li & Henry, 1992). Also, 
ATP-sensitive potassium channels are reported to mediate hypoxia-induced 
hyperpolarizations in CA1 neurons (Fujimura et al., 1997). The authors reported here that 
post-hypoxic hyperpolarization was always greater than hypoxic hyperpolarization. These 
observations suggest that potassium efflux through these channels changes the resting 
membrane potential to a more negative value which moves it further away from the firing 
threshold for generating action potentials. In the present results, the elevation in population 
spike amplitude may occur as a result of the increase in electrochemical gradient for 
sodium and potassium ions which result from hyperpolarization of the resting membrane 
potential. As the slices were stimulated maximally with current pulses, the membranes 
should depolarize sufficiently to prevent any decrease in the firing of action potentials 
resulting from more negative resting membrane potentials. As sodium ion influx will 
continue until the voltage-gated sodium channels inactivate, this will result in a larger 186 
 
action potential. Overall, the spike amplitude will increase. The study by Li & Henry 
(1992) agrees with the role of ATP-sensitive potassium channels in mediating the 
inhibitory response of adenosine on orthodromic population spikes (Hosseinzadeh & 
Stone, 1998). In the present study, the increase in response size occurs during adenosine 
washout, not during application. The previous observations by Li & Henry (1992) and 
Hosseinzadeh & Stone (1998) examined the role of ATP-sensitive potassium channels 
during adenosine application. While these channels appear necessary to mediate some of 
adenosine’s inhibitory effects, the other actions of adenosine may result in inhibitory 
activity during its application which disappears upon washout. The ATP-sensitive 
potassium channels appear to remain active following withdrawal of adenosine. This is 
consistent with the effects of pinacidil upon the population spikes which start to elevate 
during pinacidil perfusion and continue to do so after washout.  
It is also possible that the rebound elevation in spike size following adenosine stimulation 
is due to some direct effect on excitatory transmission. The present results show some 
similarity to the reports of Okada et al. (1990) who showed an excitatory effect of 
adenosine at submicromolar concentrations which were later shown to be a result of 
enhanced glutamate release (Okada et al., 1992). It is possible that in the present results, 
following adenosine perfusion, the endogenous adenosine content does not re-equilibrate 
completely back to its original levels, resulting in higher basal adenosine concentrations 
which could mediate a potential excitatory effect as indicated by Okada et al. (1992). 
However the studies of Okada et al. (1992) were conducted in CA3 cells from guinea pig 
hippocampal slices and measured the intracellular membrane potential and the epsp 
amplitude. In the present study the adenosine-induced reduction of epsp amplitude did not 
recovery fully to baseline but showed a very small but significant depression. Thus, these 
results differ from the study by Okada et al. (1992). This may simply be due to differences 
in species or the hippocampal recording site.   
It may be possible that the high level of adenosine exposure may have altered the kinetics 
of the intracellular ecto-nucleotidases which generate adenosine from ATP or adenosine 
kinase which converts adenosine to 5’-AMP, a precursor to ATP. Extracellularly, 
adenosine deaminase may also have increased the breakdown of adenosine to form inosine. 
The ecto-nucleotidases may have decreased their enzymatic activity whilst adenosine 
kinase increased in order to favour the production of ATP in response to higher adenosine 
levels. This could promote greater excitatory effects as a result of increased sodium-
potassium pump function and increased transmitter uptake. This could explain the 
elevation in spike size observed during adenosine washout. However, the ATP-sensitive 187 
 
potassium channels appear to open in response to adenosine (Li & Henry, 1992) and close 
in the presence of ATP (Noma, 1983). If higher levels of ATP were generated by exposure 
to high adenosine concentrations then it would be expected that the ATP-sensitive channels 
will close. Alternatively, it could be that adenosine is broken down more quickly by 
adenosine deaminase so that following adenosine removal the basal adenosine 
concentration is lower than before. This could increase the excitability of the tissue as the 
inhibitory effects of endogenous adenosine on potassium channels and calcium channels 
will be reduced. The role of enzyme activity in mediating these effects or their role in the 
preconditioning phenomenon was not examined, partly because there are few suitable 
pharmacological modulators of the ectonucleotidases. This could be a very interesting 
avenue for future study using enzyme assay techniques or Western blotting. 
Another explanation of the present results is that the intensity of the adenosine exposure 
stimulated all adenosine receptor subtypes; A3 receptors have a much lower affinity for 
adenosine than A1 receptors but at the concentrations used for preconditioning here 
(100µM adenosine), they are probably stimulated resulting in a desensitization of A1 
receptors (Dunwiddie et al., 1997). This could also explain the rebound excitation of the 
population spikes as there is no existing basal adenosine inhibition via A1 receptors. The 
report of Pérez-Pinzón et al. (1999) showed that blockade of adenosine A1 receptors with 
10µM DPCPX for 10min resulted in a significant potentiation of the orthodromic 
population spike during drug application and washout. It was also observed that such 
exposure preconditioned against a following 95% N2/5% CO2 anoxia for 5 minutes. 
Although this report appears consistent with the explanation of a desenzitization of A1 
receptors in the present results, it does, however, seem to be at complete odds with the fact 
that A1 receptor blockade prevented adenosine preconditioning against ouabain in the 
present results, similarly to several other preconditioning paradigms (Heurteaux et al., 
1995; Pérez-Pinzón et al., 1996; Hiraide et al., 2001; Kitagawa et al., 2002; Pugliese et al., 
2003). It is possible that, upon intial stimulation by adenosine, the A1 receptors become 
subsequently desensitized so that, overall, there is blockade of A1 receptors, in agreement 
with the observations of Pérez-Pinzón et al (1999). This may be consistent with the 
opening of ATP-sensitive potassium channels which mediate hyperpolarizations or 
preconditioning protection; initial stimulation of A1 receptors may induce a sustained open 
state of the ion channels which continues in the absence of further A1 receptor stimulation. 
The decrease in epsp amplitude may be due to a decrease in the NMDA receptor-mediated 
component of the epsp as it was shown in the present study that blockade of adenosine A1 
receptors protected the response from post-glutamate induced depression. A change in epsp 188 
 
amplitude in the absence of any change in epsp slope is indicative of NMDA receptor 
modulation (Dahl et al., 1990) as the slope represents the fast AMPA-receptor mediated 
component of the waveform. Stimulating A1 receptors may therefore be expected to have 
the converse effect on epsp amplitude. However, blocking A1 receptors did not appear to 
alter the isolated NMDA-mediated epsp, only its response to glutamate. Also no such 
interaction between A1 receptor blockade and post-glutamate recovery was observed in 
composite epsps such as those used in the adenosine preconditioning experiments. The 
effect of adenosine preconditioning on epsp amplitude was very small (approximately 2-
3% depression of epsp amplitude) and while it probably reflects a change in receptor 
activity, its significance in the context of the aims of the present study argued against 
further examination. In future investigations, it would be very interesting to study this 
dissociation between the effects on population spike amplitude and epsp amplitude using 
E-S coupling experiments. 
The post-adenosine effects on evoked responses were taken into account when calculating 
the response recovery following either ouabain or glutamate. Whether the post-adenosine 
occurrence of a population spike increase is required to induce a preconditioning effect is 
unclear, although the increases generally occur in groups of experiments where there was a 
successful preconditioning outcome (orthodromic population spikes, antidromic population 
spikes, AMPA/kainate receptor blockade during adenosine preconditioning) with some 
exceptions (NMDA receptor blockade during adenosine preconditioning).  
 
4.3.8 - Adenosine preconditioning: interaction with ouabain 
Having observed that adenosine did not precondition against glutamate using 
orthodromically or antidromically evoked responses, ouabain was used in place of 
glutamate to investigate adenosine preconditioning as sodium-potassium ATPase inhibition 
induced glutamate-dependent and independent effects in population spikes. It was initially 
observed that adenosine was able to effectively precondition against ouabain-induced 
changes in orthodromic population spike amplitude. Adenosine inhibits pre-synaptic 
glutamate release via exocytosis but not by reversing glutamate uptake. The results from 
GABAA  receptor blockade during ouabain exposure using orthodromic population spikes 
suggested that ouabain releases glutamate into the extracellular space by reversed uptake in 
neurons and  glia so that adenosine preconditioning would probably have no interaction 
with ouabain-induced glutamate release. This was entirely consistent with the lack of 
interaction observed in recorded epsps between adenosine preconditioning and ouabain and 
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the tests of antidromic population spikes, it was shown that glutamate released by ouabain 
was not the mediator of the depression in potential size. The adenosine used to produce 
preconditioning against ouabain may therefore affect the glutamate-independent effect of 
ouabain. This was confirmed when ouabain-induced depression in antidromic population 
spikes was attenuated by a prior application of adenosine. From these observations, it 
appears that the preconditioning effect of adenosine against ouabain is post-synaptic and 
limited to the cell body of CA1 neurons at the CA3-CA1 region. 
 
4.3.9 - Mechanism of adenosine preconditioning against ouabain 
From the present results, it appears that the mechanism of adenosine preconditioning 
against ouabain involves the stimulation of A1 receptors, NMDA receptors, generation of 
nitric oxide and stimulation of ATP-sensitive potassium channels. This section will discuss 
the role of each of these factors in mediating the effects observed. 
 
4.3.9.1 - Role of A1 receptors 
The involvement of A1 receptors is entirely consistent with the reported mechanisms of 
preconditioning (Heurteaux et al., 1995; Pérez-Pinzón et al., 1996; Hiraide et al., 2001; 
Kitagawa et al., 2002; Pugliese et al., 2003). As A1 receptor stimulation is the dominant 
effect of adenosine in the hippocampus, further investigations into the other actions of 
adenosine which may have potentially mediated this effect were not pursued.  
There is increasing evidence that A3 receptors may mediate preconditioning in cardiac 
tissue (Armstrong  & Ganote, 1994; Liu et al., 1994; Wang et al., 1997; De Jonge et al., 
2002) and it has been recently shown that they are indeed present in the hippocampus 
(Lopes et al., 2003) and may affect synaptic plasticity (Costenla et al., 2001); however it is 
also known that A3 receptors disrupt the protection of preconditioning in hippocampal 
slices (Pugliese et al., 2003) and even cause cell death if stimulated excessively (Kohno et 
al., 1996).  
A2b receptors are present in the hippocampus although their functional characterization is 
still lacking due to a limited selection of pharmacological agents (Volpini et al., 2003). 
They upregulate in myocardial preconditioning and A2b receptor knockout mice cannot be 
preconditioned against myocardial infarction (Eckle et al., 2007). The role of A2b and A3 190 
 
receptors cannot be excluded from the data presented here and considering their potential 
involvement in preconditioning they may warrant investigation in the future.  
 
4.3.9.2 - Role of NMDA receptors 
 
The involvement of NMDA receptor activation in mediating adenosine preconditioning 
against ouabain was surprising given that glutamate release induced by sodium-potassium 
ATPase inhibition did not affect the antidromic population spike. The role of NMDA 
receptors may be related to their calcium permeability (Ascher & Nowak, 1988) when they 
are in an open state and unblocked by magnesium (Nowak et al., 1984). The experiments 
examining the role of calcium in mediating the effects of ouabain upon antidromic 
population spikes revealed that the reduction in potential size was enhanced by the 
presence of the BK+ channel blocker, ChTX. Extra-synaptic NMDA receptors have been 
shown to regulate the opening of BK+ channels from outside-out membrane patch 
recordings taken from rat olfactory bulb granule cells (Isaacson & Murphy, 2001) and this 
is thought to underlie some observations of NMDA receptor mediated inhibition in the 
hippocampus (Nicoll & Alger, 1981; Zorumski et al., 1989). It is possible therefore that 
adenosine induces BK+ channel opening via NMDA receptor stimulation which attenuates 
the effects of ouabain in hippocampal slices. The BK+ channels have shown a post-
synaptic co-localization with PSD95 protein in the hippocampus and do not occur in 
hippocampal neurons lacking NMDA receptors (Sailer et al., 2006). BK+ channel opening 
has been reported to induce preconditioning in cardiovascular tissue (Shintani et al., 2004; 
Feng et al., 2006) therefore it is likely that it is involved in this effect. It is also consistent 
with the fact that BK+ channels do not contribute to action potential repolarization in the 
dendrites of CA1 neurons but are localized to the soma (Poolos & Johnston, 1999); this 
might explain the localization of the preconditioning effect of adenosine against ouabain. 
The role of BK+ channels could be confirmed by observing the effect of adenosine 
preconditioning against ouabain in the presence of a BK+ channel blocker. 
It is surprising that the activation of NMDA receptors by adenosine required to induce 
protection against ouabain appears to have no preconditioning effect against a 10mM 
glutamate pulse. It may be that the threshold of NMDA receptor stimulation required to 
induce excitotoxic preconditioning in hippocampal slices was not reached in this study. 
The concentration of ouabain used appears to be a milder insult than 10mM glutamate 
given that the effects of ouabain are partially reversible by tetanic stimuli; a lower degree 
of NMDA receptor stimulation may therefore be sufficient to induce protection. A 191 
 
preconditioning protocol in hippocampal slices showed that cell swelling induced by a 
lethal NMDA insult was reduced by prior transient NMDA applications (Bandyopadhyay 
et al., 2002). Cell swelling has also been shown to be a consequence of ouabain application 
to neocortical slices (Jarvis et al., 2001). It may be that in the present study, adenosine is 
acting to decrease cell swelling induced by ouabain via NMDA receptor stimulation. This 
could be confirmed by using optical scatter imaging similarly to Jarvis et al. (2001) and 
Bandyopadhyay et al. (2002) to view the changes in cell structure during the adenosine 
preconditioning protocol against ouabain. 
 
4.3.9.3 - Role of nitric oxide 
4.3.9.3.1 - Interaction with ATP-sensitive potassium channels 
If NMDA receptors are stimulated as a result of adenosine preconditioning then it is likely 
that nitric oxide is generated also. By blocking the formation of nitric oxide using an 
inhibitor of nitric oxide synthase, L-NAME, the preconditioning effect of adenosine upon 
ouabain was abolished in the present results. This indicates that nitric oxide production 
constitutes part of the mechanism of adenosine preconditioning. It has been documented 
that nitric oxide mediates the protection induced by anoxic preconditioning in hippocampal 
slices (Centeno et al., 1999) and studies in cardiovascular tissue have shown that this free 
radical induces the opening of mitochondrial ATP-sensitive potassium channels (Sasaki et 
al., 2000) via a cGMP-protein kinase G pathway (Han et al., 2002a; Deka & Brading, 
2004; Xu et al., 2004; Kuno et al., 2007). This pathway has been implicated in 
preconditioning against anoxia in rat hearts (Cuong et al., 2006). The role of nitric oxide in 
stimulating ATP-sensitive potassium channels is also implicated in delayed cardiovascular 
preconditioning; diazoxide induced an upregulation of inducible NOS (iNOS) when 
administered 24hrs earlier in wild type mouse hearts. iNOS knockout mice were not 
protected after diazoxide treatment 24hrs prior to a 40min global ischaemia (Wang et al., 
2001). The authors suggested that increases in nitric oxide following upregulation of iNOS 
open mitochondrial ATP-sensitive potassium channels.  
The peroxynitrite anion, ONOO
-, which is the product of a reaction between the free 
radicals, superoxide anion (O2
-) and nitric oxide, has also been shown to open brain 
mitochondrial ATP-sensitive potassium channels (Lacza et al., 2003). Another study using 
a neuroblastoma cell line in culture showed that a preconditioning protocol consisting of 
2hours of serum deprivation induced an increase in neuronal NOS (nNOS) which in turn 
resulted in mitochondrial ATP-sensitive potassium channel opening via a nitric oxide-192 
 
cGMP-PKG dependent pathway. This protocol protected against administration of the 
neurotoxin, MPTP (Chiueh et al., 2005). An acute study showed that the nitric oxide 
donor, sodium nitroprusside, enhanced the current induced by pinacidil in cell-attached 
patch recordings from rabbit ventricular myocytes (Han et al., 2002a) indicating that the 
effects of nitric oxide upon mitochondrial ATP-sensitive potassium channels may occur in 
the time scale of the preconditioning protocol used in the present study. The role of nitric 
oxide in the present preconditioning protocol using adenosine may possibly include an 
effect upon the opening of mitochondrial ATP-sensitive potassium channels. There are 
few, if any, reports in the literature on the effect of nitric oxide on plasmalemmal ATP-
sensitive potassium channels.  
Also, it has been shown in rabbit heart tissue that mitochondrial ATP-sensitive potassium 
channels, when opened, generate free radicals (Han et al., 2002b). It is possible that the 
source of nitric oxide production required to induce protection against ouabain is via 
adenosine-induced opening of mitochondrial ATP-sensitive potassium channels. The exact 
source of nitric oxide generation required in mediating adenosine preconditioning remains 
unclear from the present results; however the involvement of NMDA receptors in 
adenosine preconditioning shown here and the known receptor-mediated production of 
nitric oxide (Yamada & Nabeshima, 1997a + b; Bredt & Synder, 1989) make NMDA 
receptor-induced nitric oxide generation the most likely mechanism of adenosine 
preconditioning. 
 
4.3.9.3.2 - Interaction with BK+ channels 
Another possibility regarding the role of nitric oxide is in relation to its actions on BK+ 
channels. There are conflicting reports on the nature of nitric oxide modulation of BK+ 
channel activity.  Studies in non-neuronal (Bolotina et al., 1994) and neuronal (Shin et al., 
1997; Ahern et al., 1999) tissue suggest that nitric oxide stimulates the opening of BK+ 
channels. Tjong et al. (2008) have recently shown that intermittent hypoxia experienced by 
rats results in a decreased function of BK+ channels in acutely dissociated CA1 neurons, 
an effect which is reversed by nitric oxide donors. One report however, indicates that nitric 
oxide attenuates a voltage- and calcium-dependent potassium current in whole-cell 
recordings from CA1 neurons (Erdemli & Krnjević, 1995b). As the effects of ouabain 
upon antidromic population spikes might be due to the closing of BK+ channels as implied 
by the enhancement of ouabain-induced depressions by ChTX, it is possible that the nitric 
oxide is required during adenosine preconditioning to open BK+ channels in order to 193 
 
promote recovery of the population spike following sodium-potassium ATPase inhibition. 
Further studies regarding the nature of nitric oxide modulation of BK+ channel activity 
would be useful in clarifying this possibility. 
 
4.3.9.3.3 - Interaction with sodium-potassium ATPases 
Nitric oxide donors have been reported to reduce the activity of the sodium-potassium 
ATPases in hippocampal slices (Delwing et al., 2007) and from porcine cerebral cortex 
(Sato et al., 1995). It is possible that this reduction in sodium-potassium ATPase activity is 
due to a potential action of nitric oxide upon the ATP-sensitive potassium channels and the 
BK+ channels. Opening of these channels would result in decreasing cytoplasmic 
potassium ions; in the case of plasmalemmal BK+ channels and ATP-sensitive potassium 
channels, this would result in increasing extracellular potassium available for binding to 
the extracellular site on the ATPase pump. ATP and potassium binding exhibit an 
antagonism where ATP affinity for the pump is lower when potassium ions are bound. As 
the conformational state of the pump alters as potassium ions are transported across, the 
affinity of ATP for the enzyme pumps increases. The difference in energy for ATP binding 
to the pump in its different conformations drives the ion transport. By raising extracellular 
potassium through opening of potassium channels, binding of the potassium ions will 
increase and further displace ATP binding. This will maintain the pump primarily in the 
conformational state of high potassium binding/ low ATP binding (Jorgensen & Pedersen, 
2001). This could explain the effect of nitric oxide upon the sodium-potassium ATPase 
activity in the studies by Delwing et al. (2007) and Sato et al. (1995). As high potassium 
will also displace ouabain binding at the potassium binding site of the pump, this might 
also explain the requirement for nitric oxide production in preventing the effects of 
ouabain. 
 
4.3.9.4 - Role of ATP-sensitive potassium channels 
Given the extensive literature regarding the importance of ATP-sensitive potassium 
channels in preconditioning phenomena, experiments were conducted to examine the 
potential effects exerted by activation of these channels by adenosine in the present study.  
Adenosine is reported to activate the ATP-sensitive potassium channels in neurons via 
PKCepsilon (Pérez-Pinzón et al., 1996; Hearteaux et al., 1995). A role for these channels 
in the preconditioning effect induced by adenosine against exposure to ouabain was 194 
 
conclusively shown when the preconditioning effect was abolished by the presence of the 
ATP-sensitive potassium channel blocker, glibenclamide, during the preconditioning 
stimulus. It was unlikely that this was due to any non-specific actions of glibenclamide as 
the specific blocker of mitochondrial ATP-sensitive potassium channels, 5-HD, produced 
similar results when used in the same manner as glibenclamide. The results therefore 
suggest that activating the mitochondrial ATP-sensitive potassium channels, which will 
produce a depolarization of the mitochondrial membrane potential (Ardehali & O’Rourke, 
2005) is required to mediate adenosine preconditioning against ouabain.  Mitochondrial 
potassium influx via ATP-sensitive channels prevents excessive calcium influx into the 
mitochondria and thus maintains the volume of these organelles under conditions where 
excessive calcium could disrupt mitochondrial oxidative phosphorylation (Busija et al., 
2004); ATP production should therefore be maintained under ischaemic conditions.  
These reported effects of the mitochondrial ATP-sensitive potassium channels appear to 
maintain cellular viability following ischaemia but the role of mitochondrial ATP-sensitive 
potassium channels in attenuating the effects of ouabain upon the sodium-potassium pump 
remains unclear. As ouabain inhibits the pump by occupying the extracellular potassium 
binding site, any change in the mitochondrial production of ATP will not alter the 
potassium-ATP binding activity which drives the electrogenic ion transport. It is possible 
that the sodium-potassium ATPase activity is modulated by free radicals produced as a 
result of mitochondrial ATP-sensitive potassium channel activation. Diazoxide, a selective 
opener of the mitochondrial ATP-sensitive potassium channels is known to generate free 
radicals within minutes in cultured cortical neurons (Kis et al., 2003) and free radicals are 
reported to inhibit the sodium-potassium ATPase pump (Huang et al., 1992; Kurella et al., 
1999, Boldyrev et al., 2004). The potential mechanism by which nitric oxide and other 
reactive oxygen species may act to reduce the effects of ouabain is outlined in the previous 
discussion section dealing with possible interactions between nitric oxide and sodium-
potassium ATPases, as are the possibilities regarding the plasmalemmal ATP-sensitive 
potassium channel subtype in mediating these effects. 
 
4.3.10  - Pinacidil preconditioning 
4.3.10.1 - Rationale for the use of pinacidil over diazoxide 
As ATP-sensitive potassium channels appear to have a central role in mediating various 
preconditioning phenomena, the role of these channels was explored further by developing 195 
 
another protocol using an ATP-sensitive potassium channel opener, pinacidil, in place of 
adenosine and testing its effectiveness against ouabain and glutamate insults. Potential 
interactions with NMDA receptors, having been identified as mediators of adenosine 
preconditioning against ouabain in the present study were also examined. The use of 
pinacidil in cardiovascular preparations as a preconditioning stimulus has been vast but 
conversely, its use in neuronal studies has been extremely limited. Neuronal 
preconditioning studies have tended to utilise diazoxide in favour of its specificity for 
mitochondrial ATP-sensitive potassium channels over the plasmalemmal subtype. Its use 
in the present study was not pursued after initial attempts had revealed that a low solubility 
(50mM in DMSO) coupled with the need for a high concentration (approximately 500µM 
has been reported (Erdemli & Krnjevic, 1995a) might have compromised the results on 
account of a 1% presence of the free radical scavenger, DMSO. This level of DMSO has 
been previously shown to exert a delay against the loss of response under anoxic and OGD 
conditions in hippocampal slices when present in aCSF at 0.4% (Hülsmann et al., 1999; 
Greiner et al., 2000). DMSO is also reported to suppress whole-cell currents induced by 
glutamate, NMDA and AMPA in hippocampal cell cultures (Lu & Mattson, 2001).  In 
addition to the problems of using DMSO as solvent, 500µM diazoxide is reported to block 
the rapid desensitization of AMPA receptors in hippocampal cell cultures (Yamada and 
Rothman, 1992). Supporting this are the observations of Crépel et al. (1993) who have 
shown that exposure of acute hippocampal slices to 600µM diazoxide enhances the 
amplitude of field epsps recorded from CA1 and CA3 neurons, an effect not prevented by 
glibenclamide or tolbutamide. The authors also indicated the occurrence of an 
enhancement of AMPA-, quisqualate- and NMDA-induced currents and a suppression of 
the isolated fast and slow IPSPs in the presence of diazoxide. Although the preconditioning 
effects of diazoxide have been confirmed as the result of opening of mitochondrial ATP-
sensitive potassium channels by the use of the specific blocker, 5-HD (Domoki et al., 
1999; Rajapakse et al., 2002; Liu et al., 2002), effects of diazoxide upon glutamate 
transmission, particularly for studies like the present which examine effects upon synaptic 
transmission, make its use  unfavourable in spite of its specificity for mitochondrial ATP-
sensitive potassium channels. As the role of plasmalemmal ATP-sensitive potassium 
channels was not ruled out as a mechanism of adenosine preconditioning in the present 
study, pinacidil was adopted for further experiments in view of the evidence of its 
effectiveness as a preconditioning agent in cardiovascular  and neuronal (Pérez-Pinzón & 
Born, 1999) tissue. 
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4.3.10.2 - Protection against ouabain and the requirement for NMDA receptor 
stimulation 
Similarly to the present studies examining adenosine-induced preconditioning, pinacidil 
was shown to precondition against the ouabain-induced depression of antidromic spike 
amplitude. To confirm that this effect was mediated by opening of the ATP-sensitive 
potassium channels, this experiment was repeated in the presence of the blocker 
glibenclamide which, by its abolition of the preconditioning effect, confirmed the 
specificity of pinacidil for the ATP-sensitive potassium channels.  
To understand how the activation of the ATP-sensitive potassium channels fits in with the 
other mechanisms of preconditioning examined in the present study, namely the 
requirement for NMDA receptor stimulation to mediate adenosine preconditioning against 
ouabain, the pinacidil preconditioning protocol was repeated with NMDA receptor 
blockade during pinacidil exposure to the slices using the antagonist, DL-AP-5. The result 
indicated that NMDA receptor stimulation is also required to mediate pinacidil 
preconditioning as well as adenosine preconditioning. This was a surprising result given 
that the adenosine A1 receptor directly interacts with the NMDA receptor in the 
hippocampus and that nitric oxide, which is generated from NMDA receptor stimulation, 
opens the mitochondrial ATP-sensitive potassium channels in heart tissue.  
These observations suggest that ATP-sensitive potassium channel opening would occur 
downstream of NMDA receptor activation rather than the other way around; however, the 
requirement for NMDA receptor stimulation to mediate the actions of pinacidil upon the 
effects of ouabain as shown here does not necessarily preclude a reciprocal action of 
NMDA receptors upon ATP-sensitive potassium channels. Indeed, co-dependent 
relationships between ATP-sensitive potassium channels and preconditioning signalling 
messengers such as nitric oxide (Centeno et al., 1999) and PKC (Pérez-Pinzón & Born, 
1999; Hearteaux et al., 1995) are thought to underlie the continuing action of 
preconditioning agents after they are no longer exposed to the tissue. This would explain 
why, for instance, after adenosine or pinacidil removal from the perfusion medium, the 
ATP-sensitive potassium channels remain open until a harmful insult is applied. If a co-
dependent relationship is activated such as those mentioned above, each participant in the 
relationship will continue to re-generate each other after the initiating stimulus is removed. 
This is consistent with the reports that nitric oxide both opens mitochondrial ATP-sensitive 
potassium channels (Sasaki et al., 2000; Wang et al., 2001; Lacza et al., 2003; Han et al., 
2002a; Han et al., 2002b) and is also generated when these same channels are opened 
(Horimoto et al., 2000; Lebuffe et al., 2003; Horinaka et al., 2001). PKC has been shown 197 
 
in cardiovascular tissue to have a co-dependent relationship with ATP-sensitive potassium 
channels (Gaudette et al., 2000).  
It seems odd, if co-dependent relationships are initiated, that the time window for rapid 
preconditioning should be limited and not continue into a delayed preconditioning effect. If 
these co-dependent relationships do form the basis of preconditioning, the most probable 
reason that they do not continue into perpetuity is that the ATP-sensitive potassium 
channels do eventually “run-down” as has been shown by Thuringer et al. (1995) thus 
explaining an apparent gap between acute and delayed preconditioning. Why the protection 
should restart again after the rapid time window of protection has run-down is another 
issue but one that is not addressed in these acute experiments. 
Understanding the basis for the activation of NMDA receptors by pinacidil is far from 
clear. Pinacidil acts at plasmalemmal and mitochondrial ATP-sensitive potassium channels 
so this may occur by either type of channel. Plasmalemmal potassium channels when 
opened will allow potassium efflux from the intracellular compartment; the loss of 
intracellular positive charge will result in a more negative resting membrane potential 
which will enhance the voltage-dependent magnesium block of the NMDA receptors.  
With this rationale it seems unlikely that ATP-sensitive potassium channels modulate the 
currents generated by NMDA receptors to enhance protection. Studies that have examined 
the neuroprotection afforded by ATP-sensitive potassium channels against excitotoxicity 
have proposed that such effects occur as a result of the enhanced voltage-dependent 
blockade of the NMDA receptors (Soundarapandian et al., 2007a) or the inhibition of 
excitatory transmitter release at pre-synaptic terminals (Soundarapandian et al., 2007b), 
actions which act to reduce NMDA receptor stimulation.  
There are few studies in the literature regarding the stimulation of NMDA receptors by 
ATP-sensitive potassium channels. NO is generated from activation of mitochondrial ATP-
sensitive potassium channels (Sasaki et al., 2000; Wang et al., 2001; Lacza et al., 2003; 
Han et al., 2002a; Han et al., 2002b); it is possible that excessive production of NO results 
in  S-nitrosylation of the NMDA receptor leading to its inactivation (Gow et al., 2000). 
This is maybe a necessary step to allow continuous blockade of NMDA receptors after 
pinacidil is removed which is why blockade by AP-5 therefore prevents preconditioning. 
The possible roles of NMDA receptors in mediating adenosine preconditioning may not 
apply to pinacidil as it probably stimulates ATP-sensitive potassium channels more 
potently than adenosine, so that any need for BK+ channels may not be required in this 
paradigm. The mechanism of pinacidil may rely very much upon hyperpolarization of the 198 
 
cell membrane to decrease the effect of ouabain at the sodium-potassium pump, moreso 
than adenosine, so that the depolarizing currents produced by NMDA receptor activation 
may stifle this protection. Pinacidil may therefore show a divergent mechanism of 
protection from adenosine by virtue of its specific and potent effects at ATP-sensitive 
potassium channels. This may also explain the different effect of pinacidil preconditioning 
against 10mM glutamate as compared to adenosine preconditioning. This is discussed in 
the next sub-section 4.3.10.3 – Protection against glutamate. 
It is possible that pinacidil may have similar non-specific effects to diazoxide which could 
have a confounding impact on the results shown here. 
 
4.3.10.3  - Protection against glutamate 
The requirement for NMDA receptor stimulation during pinacidil preconditioning against 
ouabain is consistent with the observed protection against glutamate in addition to ouabain 
in the present study. NMDA receptor stimulation has been shown in several studies to 
precondition against various insults (Chuang et al., 1992; Kato et al., 1992; Pringle et al., 
1999; Schurr et al., 2001; Bandyopadhyay et al., 2002). Pinacidil only preconditioned 
against glutamate in antidromic population spikes and not orthodromic population spikes. 
Having shown that 10mM glutamate disrupts the induction of LTP in orthodromic 
responses, this may explain why pinacidil was unable to precondition against pre-
synaptically evoked responses. Also, the ATP-sensitive potassium channels show different 
effects on epsps and population spikes in CA1 neurons (Hosseinzadeh & Stone, 1998) and 
have different properties at pre- and post-synaptic sites (Matsumoto et al., 2002). From the 
adenosine preconditioning results, the ATP-sensitive potassium channels appear to mediate 
their protective effects post-synaptically. This is also consistent with the lack of interaction 
between adenosine preconditioning and ouabain in epsp responses. 
In spite of the opening of ATP-sensitive potassium channels required to mediate adenosine 
preconditioning against ouabain, adenosine was unable to precondition against glutamate 
in neither antidromic nor orthodromic responses. This may be due to a difference in the 
level of potassium channel stimulation induced by pinacidil and adenosine. It is possible 
that adenosine does not stimulate the ATP-sensitive potassium channels sufficiently to 
induce protection against glutamate. Adenosine seems to protect against the glutamate-
independent effects of ouabain. 199 
 
The observation that successful pinacidil preconditioning against glutamate was observed 
only in antidromic spikes and not orthodromic spikes may be related to the actions of 
glutamate at the synapse and the cell body. Although there were no significant differences 
between the depressant effects of 10mM glutamate upon epsps, orthodromic and 
antidromic population spikes, the attenuation of epsp size by glutamate will prevent the 
formation of orthodromic population spikes in spite of any changes in the activity of 
potassium channels. This is probably why the effect of pinacidil on glutamate–induced 
depression in response size was observed only in antidromic population spikes. Changes in 
E-S coupling as a result of ATP-sensitive potassium channel stimulation could have 
allowed for observation of changes in population spike amplitude without concurrent 
alterations of epsps. This is probably why adenosine preconditioning against ouabain was 
observed in orthodromic population spikes and not epsps. The different results between 
preconditioning protocols for ouabain and glutamate could be accounted for by the 
different effects that each compound exerted on synaptic plasticity. Glutamate induced a 
depression in orthodromic population spikes which was not reversible by a 100Hz/1sec 
stimulus whilst ouabain did not completely prevent the induction of LTP. The depressant 
effect of glutamate on orthodromic population spikes was therefore more profound than 
that of ouabain. As changes in the E-S relationship account partly for the occurence of LTP 
(Andersen et al., 1980), the effect of glutamate on epsps could have masked any changes in 
population spikes if they were orthodromically evoked. In the present results, either no 
change in E-S coupling was induced during pinacidil preconditioning using orthodromic 
population spikes or such changes were insufficient to observe a significant effect of 
pinacidil upon glutamate. 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 4.44 Diagram of possible preconditioning interactions. The figure shows 
interactions based on the presented results and observations from the scientific literature.  
NO = nitric oxide, PKC = protein kinase C, nNOS = neuronal nitric oxide synthase, PKG = 
protein kinase G, ROS = reactive oxygen species, ChTX = charybdotoxin, 5-HD = 5-
hydroxydecanoate. The arrows in bold indicate particular interactions which have been 
examined in the present results. References and experiments for particular actions are 
indicated. 
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4.3.11 - The interaction between glutamate preconditioning and ouabain 
Having observed that ouabain and glutamate could both be preconditioned by ATP-
sensitive potassium channel activation, the interaction between these two agents was 
investigated as both are reported to induce preconditioning effects (Schurr et al., 2001; 
Pierre et al., 2006; Pasdois et al., 2007; Li et al., 2006). Pulses of glutamate applied to 
antidromic population spikes and epsps resulted in brief reductions in potential size 
following each transient exposure to the agonist which rapidly returned during each 
washout. When ouabain was applied after glutamate treatment, the potentials rapidly 
disappeared and did not return after one hour of observation. This effect is remarkably 
similar to those reported by Stel’mashuk et al. (1996) who reported that cerebellar granule 
cell cultures, when pre-exposed to 100µM glutamate for 15min, showed significantly 
higher cell deaths in response to 10µM ouabain exposure for 3 hours compared with no 
pretreatment. Interestingly, they also reported that pre-exposing the cells to ouabain before 
glutamate reduced cell death. Boldyrev et al. (2004) have suggested that NMDA receptor 
stimulation results in suppressing ouabain-sensitive sodium-potassium ATPase activity as 
a result of NMDA receptor generated reactive oxygen species acting upon the pump based 
upon their observations using cerebellar granule cell cultures. If generation of free radicals 
upon glutamate application to the slices results in suppressing sodium-potassium ATPase 
activity, then the pump will be more sensitive to ouabain causing a greater depolarization 
of the membrane and resulting in the loss of potential size observed in the present results. 
Although NMDA receptor stimulation appears to attenuate the effect of ouabain as 
demonstrated in the adenosine preconditioning experiments, the level of receptor 
stimulation may not be sufficient to generate free radicals in quantities that will cause 
suppression of sodium pump activity. Repeating these experiments with lower glutamate 
concentrations that do not reduce the potential size may therefore yield different results.  
Using the antidromic potentials highlighted the similarity between the results using pulses 
of glutamate to precondition against ouabain and the effects of calcium modulation upon 
the response of the potentials to ouabain. As low calcium and chelation of intracellular 
calcium resulted in potentiating the depressant effect of ouabain, this may suggest that 
glutamate preconditioning as performed here results in decreasing intracellular calcium. A 
decrease in calcium might result from NMDA receptor desensitization upon repeated 
stimulation with glutamate therefore inactivating this entry pathway for calcium; the influx 
of ions into the neurons from glutamate receptor stimulation could also act to increase the 
activity of ion extrusion or sequestration mechanisms which may result in decreasing 
intracellular calcium; in the case of the sodium-calcium exchange however, this is not 202 
 
likely as the activity of this exchange will decrease if the sodium-potassium ATPase 
activity is suppressed by free radical generation via NMDA receptors.  
A novel mechanism which could explain these effects derives from the recent discovery of 
an endogenous ouabain-like compound which inhibits the sodium-potassium ATPase 
similarly to ouabain. It is termed endobain E and has been isolated from rat cerebral cortex 
and has been shown to modulate the binding of zinc (Reinés et al., 2004) and MK-801 
(Reinés et al., 2001). The same authors have also shown that endobain modulates the 
NMDA receptor in the hippocampus during bilateral occlusion of rat common carotid 
arteries suggesting a role for this compound during ischaemia (Reinés et al., 2005). It is 
possible that in the present results, glutamate stimulation may increase the presence of 
endobain E which will, in turn, exert its effects upon both the NMDA receptor and the 
sodium-potassium ATPase pump. When the slices are then exposed to ouabain, the 
combination of endobain E and ouabain upon the pump will result in a greater suppression 
of its activity which may result in a larger depolarization of the membrane and the massive 
loss of potential size observed in the present results. 
 
4.3.12 - Issues regarding the interpretation of Western blots 
Western blotting can produce difficulties in the quantification of proteins and the choice of 
loading controls. Housekeeping proteins used as loading controls can vary on account of 
the experimental paradigm (Ferguson et al., 2005), a striking example being β-actin in the 
hippocampus, which is altered in response to plastic changes or an enriched environment in 
vivo (McNair et al., 2006; McNair et al., 2007). The statistical analysis of the molecular 
study results in this thesis indicated no significant differences in actin between 
experimental groups so it may be safe to assume that changes in housekeeping proteins 
between samples vary as a result of loading. The converse may also be true however: 
errors in loading may hide any potential changes in housekeeping proteins as a result of the 
experimental protocol.  
The efficiency of the protein transfer from the running gel to the membrane is also 
impossible to determine accurately. Ponceau staining of the membrane was employed in 
the present study but this only provides a qualitative confirmation that the transfer was 
successful in order to proceed with protocol. 
If results of a particular experiment are across more than one blot, factors such as blocking 
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can affect the final optical density, which is used to quantify the result. As some of the 
results in the present study were obtained across only two blots, the influence of these 
factors may have been much greater in determining the outcome. To minimise the effects 
of these variables, one would require a high n number and as many blots as possible. 
For these blots, the constitutive form of HSP (HSP70) may have been a better choice of 
loading control rather than actin as this would have provided an indication of the level of 
heat shock protein that might therefore be induced in response to various stimuli. As there 
is a mere 2kDa difference in size between these proteins, this would prove technically 
difficult to obtain clear bands for the two proteins. There are available antibodies however, 
that bind to both forms so as to prevent stripping of the blot (eg mouse monoclonal anti-
HSP72/HSP70 product no SPA-822 from Stressgen). With the appropriate choice of gel 
and running time, it is possible to obtain clear bands (Moon et al., 2001) if only after much 
trial and error. 
A final point regarding the length of time allowed for molecular changes to occur 
following drug treatment (or untreated slices in the recording chamber): 1hour post-
treatment is a very short time in which to see a molecular change with 4 samples. HSP72 
was selected for this reason as it has been shown to upregulate in 1 hr (Araki et al., 1994) 
whereas other molecular indicators of cell damage or death (eg caspases) take several 
hours to observe a change. A Western blot analysis of hippocampal slices may therefore 
not be the most suitable indicator for assessing cell damage unless the slices are allowed to 
incubate for several hours post-treatment. Other methods such as propidium iodide staining 
may have been more appropriate as this fluorescent molecule is taken up into cells in 
which the membrane has degraded. Membrane lysis occurs over a shorter time frame than 
molecular changes and fluorescence is quantified by confocal microscopy.  
 
4.3.13 - General Discussion 
In the present results, it has been observed that 10mM glutamate induces effects upon field 
epsps, orthodromic and antidromic population spikes. All responses were initially lost 
upon application of glutamate; during the washout period, the responses recovered to 
levels significantly below the pre-glutamate values. It was also observed that the effects of 
10mM glutamate were not reversed by a tetanic stimulus suggesting that this concentration 
of glutamate is sufficient to induce some dysfunction in the slice as opposed to a change in 
synaptic transmission.  204 
 
The effects of ouabain upon the responses showed that sodium-potassium ATPase 
inhibition reduced the response sizes from the slice but that antidromically evoked 
responses were affected to a lesser degree than the orthodromic responses. By blocking the 
glutamate receptors, it appeared that the reduction in orthodromic responses was due to an 
increase in glutamate receptor stimulation whilst the effects in antidromic population 
spikes were independent of glutamate. It was also observed that, for orthodromic 
population spikes, the effects of ouabain could be partially reversed by a tetanic stimulus 
but that the potentiations induced were significantly lower than in control responses. 
Similarly to 10mM glutamate, this implied that some dysfunction occurred in the slice 
from sodium-potassium ATPase inhibition although to a lesser extent than that induced by 
10mM glutamate.   
For preconditioning experiments, it was observed that adenosine was able to induce 
tolerance against ouabain but not against exogenously applied glutamate. Further study 
showed that this effect occurred in population spikes but not in field epsps. This suggested 
that adenosine protected against the glutamate-independent component of the ouabain 
effect which was observed upon antidromic population spikes. By blockade of some 
known mediators of preconditioning, it was shown that the mechanism of adenosine 
preconditioning against ouabain involved adenosine A1 receptors, NMDA receptors, ATP-
sensitive potassium channels and nitric oxide.  
Pinacidil, an opener of the ATP-sensitive potassium channels, was used as a 
preconditioning stimulus against glutamate and ouabain. It was shown to protect against 
both types of chemical insult although with glutamate, the effect was observed in 
antidromically evoked responses only.  It was also shown that NMDA receptors were 
required to mediate pinacidil preconditioning against ouabain, consistent with the 
mechanism of adenosine preconditioning. 
To examine any potential interaction between glutamate and ouabain, a preconditioning 
protocol was developed where glutamate pulses were applied at intervals and the effect 
upon a subsequent application of ouabain was observed.  It was shown that glutamate 
preconditioning had a deleterious effect upon the responses of both field epsps and 
antidromic population spikes to ouabain suggesting that, instead of cross-tolerance 
between the two agents, the combination of the two resulted in a greater loss of slice 
function. 
 205 
 
5 – CONCLUDING DISCUSSION 
5.1  Main Findings 
1.  Glutamate and NMDA induce changes in field epsps, orthodromic and antidromic 
population spikes. The changes in the orthodromic responses may be due to the 
degree of NMDA receptor involvement in the response. 
2.  The changes induced in orthodromic population spike size following 5mM 
glutamate treatment can be attenuated using adenosine A1 and A2a receptor 
antagonists. 
3.  The A1 receptor antagonist, DPCPX, attenuates the post-5mM glutamate effects on 
potential size by modulating the NMDA receptor-mediated component of the field 
epsp. This appears to extend to the effect of glutamate upon the orthodromic 
population spikes. 
4.  The A2a receptor antagonist, SCH 58261, appears to attenuate the reduced post-
5mM glutamate potential by promoting the opening of ATP-sensitive potassium 
channels. 
5.  The post-5mM glutamate recovery is depressed using a maximally evoked 
orthodromic spike but is potentiated when using a half-maximally evoked 
orthodromic spike. Using a 25% maximal baseline elicits either a potentiated or 
depressed post-5mM glutamate recovery of the response. 
6.  A tetanising stimulus is able to reverse the post-5mM glutamate effects upon the 
orthodromic population spike but not upon the post-10mM glutamate effects. 
7.  Ouabain is able to induce depressions in field epsps, orthodromic and antidromic 
population spikes. The depression in antidromic population spikes is significantly 
less compared to the orthodromic responses. 
8.  The effects of ouabain upon antidromic population spikes are independent of 
glutamate receptors whilst the effect upon othodromic population spikes is 
attenuated by glutamate receptor blockade. 
9.  The ouabain-induced depression in the antidromic population spike amplitude can 
be altered by modulating calcium in the perfusion medium and blocking BK+ 
channels. 206 
 
10. Ouabain impairs the ability of the orthodromic population spike to produce a 
potentiation in response to a tetanising stimulus. 
11. Adenosine is able to precondition against the effects of ouabain in population 
spikes but not against the effects of glutamate. 
12. Adenosine preconditioning against ouabain requires A1 receptors, NMDA 
receptors, NO and ATP-sensitive potassium channels. 
13. Pinacidil is able to precondition against ouabain and glutamate in antidromic 
population spikes. The protective effect of pinacidil against ouabain depends on 
NMDA receptor activation. 
14. Glutamate preconditioning enhances the depressant effects of ouabain upon field 
epsps and antidromic population spikes. 
 
5.2 - Future directions 
This work has studied the preconditioning phenomenon as it occurs in the rat hippocampal 
slice preparation and has also examined the interactions of adenosine receptors with high 
glutamate levels. The latter observations expand upon the work in the current scientific 
literature, showing that the NMDA receptor/adenosine A1 receptor interaction extends 
beyond epsp recordings to affect the population spikes in CA1 neurons. Such interactions 
are useful to study as they may lead to a greater understanding of the cognitive processes at 
the level of the organism and possibly to future cognitive therapies. These results require 
greater study with E-S coupling experiments to understand how NMDA receptors and 
adenosine receptor antagonists appear to affect this relationship in the present study. 
This study has also highlighted the use of different chemical models of ischaemia and the 
various questions that these may raise. It questions the usefulness of such models and 
whether they do in fact provide an accurate model of ischaemia. The relevance of a 
compound like ouabain may until recently have seemed dubious as an ischaemic mimetic 
on account of the way in which it blocks the sodium-potassium ATPase. The discovery of 
an endogenous ouabain-like compound (Reinés et al., 2001; Reinés et al., 2004, Reinés et 
al., 2005) however, sheds an interesting light on the present results. The role of endobain E 
during ischaemia is currently unknown but its presence does give a greater physiological 
relevance to the use of ouabain. As strokes consist of complex and different mechanisms of 
cell death, the use of different models to isolate specific cell death events can provide 207 
 
useful information and greater understanding of the pathology. Further study into the 
changes induced by glutamate and ouabain as models of chemical ischaemia should be 
continued with these advantages in mind. 
One of the main findings of the thesis is the novel interaction which exists between 
adenosine and ouabain. Having observed adenosine protection in one ischaemic model 
only may highlight the limitations of adenosine-based compounds as a preconditioning 
therapy. The involvement of NMDA receptors in mediating these effects shows a novel 
interaction which might be exploited with further study. 
An interesting future avenue of research may be in extending a possible role of BK+ 
channels in preconditioning. The BK+ channel activity increases to induce an ethanol 
tolerant state (Dopico et al., 1998; Cowmeadow et al., 2005). This is potentially of interest 
as studies have shown that moderate intake of alcohol leads to a decreased incidence of 
stroke compared with heavy intake or abstinence (Sacco et al., 1999). Whether this is 
related to some form of preconditioning is unknown but the BK+ channels may represent a 
viable drug target in which the preconditioning phenomenon is utilised. Leptin increases 
the activity of BK+ channels in the hippocampus (Shanley et al., 2002); an interesting 
possibility is that this hormone may itself become the basis of future targets in 
preconditioning studies also. 
The relevance of preconditioning to stroke therapy, while still far from becoming a clinical 
therapy, may prove to be vital as cardiac preconditioning strategies become more 
developed. The nature of preconditioning is such that a cardiac or neuronal infarct would 
not be prevented but that the post-ichaemic tissue will be resilient to damage. 
Preconditioning agents for the cardiovascular system may therefore not be as effective 
working in isolation as the non-preconditioned tissues, such as the brain and other organs, 
may still suffer the effects of reduced blood flow. As the promise of clinical cardiovascular 
preconditioning agents seems to be drawing nearer, the speedy development of neuronal 
preconditioning agents may be required to work in conjunction with these therapies.  
5.3 – Conclusion 
The present work has shown the effectiveness of preconditioning agents against different 
depolarizing agents and the interactions between adenosine and glutamate receptors which 
may play a role in preconditioning. This data may be of value in the pursuit of 
preconditioning-based therapies for the treatment of stroke. 208 
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